var title_f30_24_31104="Connected Roux-en-O misconstruction depiction";
var content_f30_24_31104=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F62513&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F62513&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Connected Roux-en-O misconstruction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 398px; height: 443px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure depicts the miscontruction of the Roux-en-Y gastric bypass procedure, resulting in the formation of an \"O\" connencting to the stomach",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_24_31104=[""].join("\n");
var outline_f30_24_31104=null;
var title_f30_24_31105="Clubfoot3";
var content_f30_24_31105=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F72507&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F72507&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sonogram of fetal clubfoot",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 383px; height: 266px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The plantar surface of the entire fetal right foot can be seen in the same plane as the fibula and tibia. This fetus is one of a twin pair; the other twin did not have any abnormalities.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Urania Magriples, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_24_31105=[""].join("\n");
var outline_f30_24_31105=null;
var title_f30_24_31106="Recurrent nerve variation";
var content_f30_24_31106=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F53364&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F53364&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 517px\">",
"   <div class=\"ttl\">",
"    Recurrent laryngeal nerve variation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 497px; height: 251px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The uncommon, but high-risk anatomic variation where the recurrent laryngeal nerve (RLN) courses lateral to the tubercle of Zuckerkandl, which is often enlarged. The nerve is encountered much earlier in the dissection required for thyroidectomy and is at risk of being misidentified as a vascular structure.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Mulholland MW, Maier RV, et al. Greenfield's Surgery: Scientific Principles And Practice, Fourth Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2006. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_24_31106=[""].join("\n");
var outline_f30_24_31106=null;
var title_f30_24_31107="Piperacillin: Patient drug information";
var content_f30_24_31107=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Piperacillin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/13/35030?source=see_link\">",
"     see \"Piperacillin: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/10/33956?source=see_link\">",
"     see \"Piperacillin: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F3000477\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Piperacillin for Injection, USP",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10015607\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat bacterial infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10015606\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702746",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to piperacillin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10015611\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10015612\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698007",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea). Yogurt or probiotics may help. You may get these products at health food stores or in some pharmacies.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, vaginal yeast infection. Report itching or discharge.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10015614\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699018",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea), even after drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10015609\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10015610\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696446",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor to find out what to do.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10015615\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699187",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow how to store closely.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10015616\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11248 Version 30.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-125.39.66.146-3A500C5829-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_24_31107=[""].join("\n");
var outline_f30_24_31107=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3000477\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015607\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015606\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015611\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015612\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015614\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015609\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015610\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015615\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015616\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?34/13/35030?source=related_link\">",
"      Piperacillin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/10/33956?source=related_link\">",
"      Piperacillin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_24_31108="Malig nephroscl Light II";
var content_f30_24_31108=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F61658&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F61658&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Light micrograph showing malignant nephrosclerosis II",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 248px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Mucoid intimal thickening and luminal narrowing in a small muscular renal artery (arrow) in the early stages of healing in malignant nephrosclerosis. Similar changes can be seen in other thrombotic microangiopaties, such as scleroderma and the hemolytic-uremic syndrome.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_24_31108=[""].join("\n");
var outline_f30_24_31108=null;
var title_f30_24_31109="Peliosis hepatis high power";
var content_f30_24_31109=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F59203&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F59203&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Peliosis hepatis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 390px; height: 287px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEfAYYDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD1o3mXy6NuYAyLjgMO4zVqS2idhNC7mNuSPT/61ZuuopIlgBIBGxh3zVzSo2MLo2WZ1G4dMjNW2z2U/dUkUr3VZLObzIQcAZ2jqQO39K6nwpcPc6fFrF3YSWt1cxqrxOQWjAyQpx35Nc1f6QlxcRxvnqME9+Rwa7W2BtraWKUHyxk89qV2ZYmSkkiprdzbvMhjhzcIvyyEA7M/4Vxnihtb0u0e60KwTV2Zd8luZzHIxHdM5H4e1XbW5dm1MXciLJFcvtU9RED8mfcjn8at2Mnn2waTci8Hd1xmi91YuEXGF4s5jR9VvtV0rUbbVNKuNIllhEE4eYOXR0y20gYHXGfXNX7PQY4/BNjpNjfXM4towokuJNzkDpk8celVvE2kXEmqJIkw2AAYyfu9eOxzVrSWktWVQThTwD3FCfKdEaajy1U7yGaJaXFjCmTmZG5Yd/b8q1ND1SyvfFGp6XqELJNbwxSxbkJG1gfmz03ZGPXirk2yK3MmSY3x+HsamjEM9u0ZXZvC7ZQMMMcg++D2707szrzlVVxkGnHS9EmtNPmecks8YlPzbu34VzngTXLmHwzCdbvlvbsymOd4k6OZCuwAAdCQvSr2tPqFlenW7UxXttDEPtUBYpIVUHcyADBOO3H1rkrXxJa+J9SfUfDXhe/vLuy2PFcFVtiHbdgFmIyuBk9cgjik5O/qYyqJOzevn/Wp6D4bt7nTLGdr5fJvb64klncuGDKWIjAPsu0Y7VHFrdvAJYtMQ3N1GRuYgiLk4I39DgZJAz0rI8NaNq8uky3vjaON7iaTzEtmm84RFc4Ppnr09qd4V1a11eSWztbT7FHaAJHHgbQo4AAHTp0qt2OFLmTcdY9WXvCct1Dam1v5oLiYNvAhQqI0J+VRk/Njpnj6Vd1qzSfAvIgQG+XnrUBhMV1FLEFDr8quB29DRrF5f6fNcXV9DbppQiTyrgyZZpWbBBXsOVAPfmq52aXVOUWnuS7o4bMBFC7V+VR39qoeH9WvLhJC8XlMrDAwQD7fWls1kZVeWL7xOVJ71ctnMwO2MmReo/vCjmZs9E00cNrGsXmieNNJ8QpCyWl3cDTb+HBJO4HY49NpHIHUGvT9Kvo9SijliQxq/ZsA89x7Gs+602w1S7tTcI7y2shnWLPycqVBYdzgnFS31o0VqUsnaAMPlKjJUD0pXe5x2jJysrXOTvdB0221LUZdCs7vSb1lxeKgKQOv3hJgfLnr8w55OaZ4X17+1/Edto9reWt9GtqztOjlmjkU/wARHG0jgc5yOmK3NF07dfXM0813JcSsVczTEh1xxhM7R+ArB8Z6Drcdrpdv4Is7Py4Zw80ccqwGJV59eQT2x1FNt7ItzcIcmy+87e10q6Fsbm42QzZP7tZN49ucVxeseMLWx1iDSRBPHqcysTa7clGHXdg8A+veukuPEmoWcIhTw9qMswwql5I1iY92LBiQAc9ufSs3Rb2S5urV9YgSPVipEsh+cAk8qrYB2+ntTTl1IpSqyd97fkacGmWj6bbrLHNBe30guXcNlyy4wCT2xgY6Ctmz0OxQholZWUf6tTgLz6VZu8wyRyOcgZCg45wOorm7lP7H8VDVnuJES4TEluM7T05o5mTHmqL3Xbf/AIY6zVYrtbCX+yiq3ariPf8Adz70+3lkitkW7ZTcYwSBgE47egp8V3DdRF4nJUYOR9KqSs13HOImALIUVjWa1VmciTatJFF/EFs1w8LGRlAwzAfL7/5FeLeKPiJDpOtXdpPpt4bRmYQXoTK8EjBPTkgjI9QDivSLOyaJZleVmO7gEfdrEsZbqXxLcabqtusvh+dGSaKWLepPZwf4Tz2q2tD0vZypRcsO9V+J5BpXiD/hOPEUAETJYWZ3uHHzuSOARnoPT2r6S8C6dbppazwqNr8ADocV4QPhzf8AhX4n3DeH76CfRxaieNbg7nw5I28dSCp+b04NfQfgeUvokccsaxTx8OgGMGs1dXIrYmpWw3M97m+wXoVBB46ZpgtoR0ijB9lFE86wxPI2NoGeD1qlDrNrdeati32iSMgMqc4z60lfoeZGM2rrY0lUKPlGKhSVlkSORTvbJyoO3ipNxUDdkknsOlR3U4t4HkIzgE/jSJV27BJteR43QEbckkdadGGA2nGB0IrhbjxDZx3sUd1q629/PxFCwIGewJ7A+9dlply15p0M7DZIw+Yeh6GqaaRvVoSpxTZiSXmqW13Mbu0kaHzTHBJBh8qR95h25qz4ck1CPfFq1yZpABhvJ8sfWrd9qljbuI5rnY3J+U9Mdc4rlLnXZGvDcWtwLiFeFUtlSOu4Y61V7qxtCDqx5eWx34II4wRS1k2l1KiwEx5t5uQR1QnsR6Vq59Khqxxyi4vUWikBzRk9qRItFFFABRRRQA1u1FK1FZSWoHl2vXVlY6c97eTBILVDI7gcADvWZpviK5Nit1/Yt4Qlw8M0ceS4xyroCBvUjByOmfarltbPrV5NFfW0f9jBCjwzJzcMT1weiAfnmuks9HsobpLkwu7DlQ7ZCj0Arb1PUc+hj6XqLa1qMZjsbuGJHxJJNEYtmBn+LBY/TNdfJKrxvHIpGCQrHk4rnNY1+Cy1OytLBBcTXEuNgcAxqASXPXgcD8aSV9Xm16C/iu4/7LEflT2bR7iXySHVu3Yd6REk202cNpaLY/FXxbaTyZeZbW9QEbgUKFCP++gePeuz0y0kudPEktwkpVm5jXaOvAxk9BxXKeEja3tjqmuahbNb3up3Em92+8UVisYB54CgYx607SpJfDupwafYSpeR3ciyTBv+WSHgEe55P0FOKtodNGN6fNfW+nzOqaCe5mNnbArcqAyyyxlo0XPQkEckZx+dczcW3ifR9WeTVFttQ0aaYr5kEbLLacEhinOVBwCBkjr7D1ny0jgjliA2YGcDt3okSCZCqyYY8jJoscjrybutDgPC13b3kM0Saha3jL8xEUgYpz3HUfjW7Ft3lQR0wB2I9qrax4J0vVdTg1WRJLPVYhtN3aSeVIy/3Hx95fY5rzjWrTxR8O9duNTmvLnWvCZj824Mz754ADj5B6jv2IHrTNXibu8vwO78Vyiw0t7lZDG7AKuOeT1H5Zp+kajHJotq8pSMlQFKrtX/AApALbxLo1tOqt9nnRJVEgwcEZBx261V8R6Us2iNZ2pEa5XaQM4x2p3sdkOSUYqW/fyOhgkjuEdSxlUcew/+vWHrktt4at7i/lO2MAyFQu53wMnaByTU+iaLeW2mg2VwgndDlpQWUEDrtyMnPuKpaHoqQC61DxRA15qUyOoNxh2RW7IPuouOy/jmm/IwlNxk1T1Oc0zxnpfiGxivtTuVsNEuonaKNpvKlcKxDSOwPyIcYC5ycnPaug1jVr3xX4cuI/DUdudJuYjBHc3KMrSKeC6IeqgdCcZPIyOuX4R8GeGNJ0ya3GhQTwyOTIbhBI8h65yR+gwK7aZIzGIwdiMMRsvAHopHY+lCVmZezlde0XqZuhRXFvYwWt4PMeNFUyZJLYGM57n1NLLKNOimuz5reSpbbGhcvjsFHJJq6qNCoQsWI6muG+LFzLFpttp322Wwtrti7TWxzPIVI2xRgdS3rg0G9aooQcjvfD9lqpN1c6hKjR3W10RAQqegAPI9/en3Nw0s0kcnHk4XHTjAI/nVb4e6pqM3h6yg161ltL3yxjzZA7HA4LkfxEYz71sazo7XDpeWb7LxU2FCcJKM5wfQ5zg+9F7nHGryzTmjL+zNContjlDyy5wQc1U0yzSx8QS6h5jssoPfgZpqT6jHInmQmFzw8TkHH4jgj3q/cRiRS8XykfejHQ+4qjt6W3TNG4ZbiNpoMeUPvDPNZt15CyecXGCOe2Pc1U0izubYTvLcGSFs/KM5x61zvhfUpNeTU5NXMdvp1y7W9ilrzN5ececzE/xZ6AcY5oZm7Unyp3O+0rULC4gjkinjuV8vC+W4cYzWb4kt3uLaJwokQcbjxtHr+FO8E+GtM8NqtlYHzUVQAW52gDgV1FxaxzQSrgAt6ccipbSZzOpGlUTicnohksidhJYjacnhzXSzT2drGkl/9ntQSAC7BQWPYZ71z91slgeGJWjZDjpyprE1e7fU7iwsL7RmvLVVd2u/MwsLrjaCp/vAnB9qbRtUpKq1J7dTd1IYvpY4sdQwYc5BqGG5iScW0wjWdudhxk+9fP8A8SbTX9HuLm/vfEmppaysptzG6wqOeE2jnKjt369jXovwb1q68fRpd63ZRebZMFju4pOXx1Vxj0/nTT7jjVivdl0R0un+EYdM1vWtdhkkJumSRYpB8sXy/Pt9Nx5PuK6rwp5U6vdx+cjn5HjkGMY9PWtm5tVkjO0lGA4I7+1edLq17F4gmitJSsceTtIwGFTe6MqMXXpyhHQ9LaGN1IdFYH1Gap21haaXBK1lbRQ7/mYIoG4+9Zun+JYJpY7aU7bl1ZgGG0HHXHrWEuoapbTXWdRF+JHLJG0YURDPQEdaSi2Yww1RtwbsdwZVig8yZgmBubJ6cdK8o+LvxGOj+HGk0qKeR5JkgEiR527mAyc8eoHuRWhB4ktNYaSzEtwLoE48wEBiBzjniui03wxYfaP3wM+ArFWAKqeo49eM/hT5bams8OsPF8/xdDhNQGkXtuur6q4iNqvmeZL8m3bzg+uOaNF+IseoT6NpGliWQ3u+R3jOXhjxlXkA+6GPHPPI/DS+NngdvEng26i0cIt2jLLF3G5WBwR0OR2PFec/BnRdR0+We+uIxpltcBYXiuD5lxPsJ3SO3bLHgDgAUnd7mrryruMYrRf1/Xqa41LX9E8bSCdGurOeQq0bJlGQnqOOMcflXrfgrStOtdCtxZ2EcMfJVdvCjcTx+dc/qsv2zUYLe0jRpHkCuw6jPfHcV6JbwpbwRxRABEUKBTkPMKylGOlmUdO1Ky1C5uorOVZHtn8uVR/C3pWdc6/DZanJbTPs2kABvunNattDa22oTrDEiTzjzHKpjdjjJPc1yvxB0Bbpo9RiX50+WQeo7GkrXOXDqlKryy2a/E7WJxIgdcgEdKoDVIxqBtG/1mcYx+tVvClz9p0S3G8mWEbHz149axPEcrJrcph8wSIiOQB97HvTik3Zip0E6kqb6Hb5orJ1OTUJNBlm0TyW1Bow0Imzs3H1q7bSyLZwtevEs21RJtPy7++PxqLHM42Vy1RRRmkSNeimu3HaisZbjOQSNWkJXhCcc1S8T61beHrBZZFmupXysNvAu95WxnCj26k+lcrqnxJ0LQLdJdUkngeUSGNPIYs6ocHjHHbr606XVLJdTt9QuUkW9ntERlzuWFSSxIHYnOCR6CtknI9KEXUbjDVlzwjpf2SCXUJ0eW/1ECaZXOTCevlp/sj+ea34rkJEjKuCTgoeNw75qjeXdvawi6NwkUUY3mVzhQo6k/SrgniMayF02Och1GR9cemOeKdzVRtoZ9xaafbJaaejJArnyrWDcAWbGdoz7Zq34d8Ox6W0El+I5NQYFpnj5UEjG0d8AADNcx4y03VbPxj4e1nT9Jj1a3ijkgO2ZF8oMM71ZvfAz2/GpdN8Yaq8hS88OTaf8wXz7y5DAkgEkKuS2OnUA460tXsZKo5PlXT/ACPTre+iiQxygeUB1A6CshrqO6unSyk3xrg71+6Sc/L7EY5HvWZd295NdR3Ed0kcAYFFjYgSLjqRjg9eOegqpp1k1yb+K+t2srdyyxC2nKNN15OOh75GD09KdnYcaagnNfcdiSbqNUlJRlGCenFcf8ULjy/COqRRSNJcRwGRYY0DvIBzjaeoPQ1m2ug2BYb7a7meM4/0i6kmOPTDNgnGaki0zRbLXLKe6tLW3kSQR28zAK4Zs/LnvnnilJdxKjOKOF+DfiZ4PCBtbkTy3TXciWUEjlnMRIK4OOFAJ56ACtvw8fEHj6/1O8TVX0vwyk72qJbRqZZwjbWYSH7oJzyBnFepR2Nj8xeziJddu8KBkY9a5rUPF/hzQzLYWsoMtqwR7GxhMrqTzjao4/GhvqZJy5VBuyRs6Bo1lpEbQ6cJI4goRYd52KOpPPOSeSSec1m6bqk2rXmotdBFijuHt4CvUomAT7/Nuqle+N5IbKO4tPDesTR9QWEcP5hmyPxAryn4fahqWr+MddEGh3kEkd01ybVJYw0SuOhyRlSVJ3DIyaaubU3FSXM7I9zYebKI3PG3hlHQ1HAqxysxOQV2kHv+Fcpb3HjpLRLh9As5pY5DutjeBX2HJUhuhwMAj15BI6a9h4htdR05J7u0msZju3w3IAKFTg5IJGPQ55qvM1hUjN8qNDV9XsdHt3u7+QKqqdkYG6STjO1VHLN7DNcxZWkWreII9f1UymZVD6fYzgD7CpA+Ygf8tD3zkjpXJ2U2kw6vPqWg22pXskd4k0l9JAbkOrH94sUhzgBcdOwIFdNfa5pccX9qwSKRIAxcv8oUjk4HQ54oFTjGpN83Q7bRb+LUpJognmeVkMwHeukt5A9nBu+bI+93BrA8KxQWWnyyWiJi4/eYGDktyTkdc1h6XqWq2Ud5DBZSXNz5khgieQKigLkb2ydoJ9iae5jVpqo5NaWOr1ywN9p7xyyS27xMsqXMJ5wp3YPqCAQR6GsuU+XGssSvs/u47etZ1l4j8Rahoeow6zo0Oi3qoY4Zo7oTIxIPzggAgDjrzUXhr7XBottHqOoLqd8oJkuQAu/JPGB6DA96SuLDKe7WhFrMn9r6TqOk20zQTTwsgmAJ2EjGeCM/nV74X+HZvDnhGy06eC3tgExGOsgHX5z0J5PSsbV9C1C68RGe18QPZWMca7rOCCMuWOeXY5ODjp7Vf1vx1aaHfaNo0lrc32o6hvS3WHAHyAFixJwAM5p3Lrvm1gvI6/T9GSyE7tNJLPMdzsTgVrjhFL4yPxrK0vU47mJIbpvLuscqwwD9O1aLnJCEHaeQanfc4avO5WmcV4rlt7fxJa2UkqQvfIxQ52livXHYkZrFltbnw/DJHYNNcw8yFp5DI5J68nPvx2rqfiJ4f0/XtI2XzRW9wit9mu2xugkI4ZT9QD+FZmnXM00qWl8g81Yxtu87VkbAzkds9a0jqj0cLVbim1eyMqfTtK1GC01fX7QTTLGwAfoig7twHTI9fc0vw0/sO2vCugXqXJul+1OwBUspwFZwR945x7ge1V/iNpM+teHZ9PguGtXYD94vUYOfyrgPhdqVzpWuHw9qk2+/RMwyKzSJOuAN3X5Nu0jGKTZNelrzJb9f68j6PuUu3u7ZreWNbfnzVI5b0xXKeJNNfSy9zptv5jyMSXPJjBBz9Rnj8a6mwc/ZIhJKpkCgHnvWf4sk1GPR7g6NDbXF+V/dpcSFEz7kA/lUrc5KVSVKR4RoPivXtb1LSLm5sYLewtdSliWZwyeYDG6cYByc5/Lmu58K6tdzXV1HfLHbxBgIwc4PGWXnGcdMjipItSl8PeC1DG01TUDgRSwqT9puWc7zhBkKp4z6Keaw9M8H3umeKb3V/wC0Dc6ddoxSCUbmhlZ9zBT/AHepGPXHpVHVRqSnO767nXLolqZpLzTGhe4jO54woD4zzjHWu102/tb+F/Kba54cDhs4rxrSNP1nRdckvluy6bujZO4Z5GPpXcX/AJV80F1YyG3lb/WKhwVb1HrQ9TfFUHNpOV10f6HRaJpNp4Y0CS1WaaWCPfK8krbmOSSfrXl+vaJe3ohuNIlkBYktGTsI9D/9auvBubpmS6vZZYlPClhj2zV6zuo41jt1Xfcfd2EdfekiKDnh25t3bOa0C8Wx1q2huFMjxxDfKq4UODgrn1716ak4ngEluQ3fH9K53R/Cy2i3Ess7S3c0zTGRlGVB6IMdgOKwo7/V/Dmvy29zJDNpzHeMptY5Y9OccDA96Hrsc9V/Wpe78R6Ngdcc1R1yKafSLyO2UNcGJvLHq2OP1qxZ3UV3bpNA4ZGGQQam/Gszg1jLzR5n4WutRtLOG4mTy7jA863fqfb8Kw9e+IFrZeLrTSrlJjdXQwkTrk7Tn5t3pxirnxXgv4L9ItPEyJeOG85DxGe//wCuqd34LGt2VnrE8rXWo2avHHKy/e4Awe4AIzx3Oa2v1PZm1yxrq15fkd/4s1W60DwpHPp0KS3BKRqWHyrnucVtQMr28SXWx5WVWYAcbvUfjXI+B9Ul1rSJtL8QWYt51OxUZw4kXruU/wCTVrShc6ZfzR3xP2OIhIAxB6nru659vekkmrI4nTTi49Vr6nZqwYZH60p6g54rOM489QTsbqfaqmo6hcW2lX05Kh0JEJA7djUcjOZU23ZGJ47sL+7vbR7DVrmzjRGVo4mIDEkYJwfaiq/hOwvLmC6nvr6WZWlIUPgkGitOdQ909JTjR/d3vbyOf1HQ9GtNYOoX1us0ssItgXAdCgJPAPT7x/Cn3mh2t6pnjid5UTMQjYDzF/ujPft296sSWZ1K2VBgiMhjjkhT3HtxWnp8XkPDCMlVAZecHjvx/Ws9ilaldw+Ik0jwxpcUclxLZbru8QeeJ/mIUj7hHQemBXNWujy6FqF1pNvcXFzbqBPbeaQxjiY/6sc5IXGMn1FdwRcRwTDJYsCVkXHPXisCzhmEtvPLM7yLCA6btwU5JP488/SlczpxafNcbe3sWm6Vm8mVIVcLwMkOxAUD6kjisnVJZbgLaaxp86XcefMNqfNCnPAxwxHTnbit/Gnz6lp8uoQF5GmItzjIWQKcv9cHj610F9ZRrMkzqruRgS45I+tF+pTqyjNW0/zONstXc/YI7AJcWLnY7YOVwcEexGO/PFdM8KQKejZ5Bx0rE1mwTT9SuLyxhv7i5uoVc28YzEWU43AngMQRkk8gCuhu/DljqFpC2oI1w8Kk+UZDsOeuVBw340J3RMq6sn1M+S8t5pEjhljWdsjZvALY6nHtXFeK7mMeLLCyuro2sVpG08zuvDnYSeTwNqgD6yA9q9AXQNMs4XfTLG0tp5CWEscKq6t/eBx15rgPFehRX2tQ6BqF/Nf+eBe3uH4SNCPLVhnjc2D7hDQ9SfaOS00LVnZ3PiixQ6rqd59hZg0VnbT7I2TnAd1wzZBBIyBkela2jeH7bShJBYRpb2jHcIkGOT1J9c+vWqWj6bLoF2wDmSCVwM4wB74rqoyjnJcb4+D83ODTWh0unGk7x1uQzxRxxqyLjOAPUf55rI0fwcn/AAlFxrwuVi3W6WyIi4YAMWJLehyOPb3qXxBqUui26XUEDXtxPMlvb2yHBkdjjnAJwoyTx0Brqrp2t7KKbMayFB5vlj5cgc4zz19aNDCpUbapp6liNrOQCMOjMp5wckGs3WfCOj6paXMF3bAxXS7JNhwD6H2PuK4uYXerXc4h1d7KN2VlW1SNQrDuxwS2ecgkV1Ph+5utPX+z9X1FLqWbc0Em3bkADIPbvVW0IqUJ01oxdB8N2+jWJt7XCWoYmOMkYT2GOMV5n4h+FGnyatf6lLql7DaXDrLb2kEu2KB1AywHQ8g8YwM17Hbqk6JHISTkHg9weK53xzYX9lFFe6dbPe2iOTc2SYLFSPvx99wIHGeQT3xSuRFwUlGe36GR4Q0uXTLa487U72/eVzJ++f5VB/hUdcDHcnvWxB5NuCYkCMTu4459T6mk0iazvtOjvbN99q6BonjbgfWr+n6fBrK3EdwBJbqxjlXPDEjJH5EZ+tPodUpU6ab6Ip/aYNe05hpckV9ucQuLeRWCEn5snPAAOcVpaZ4fi0tBGsuQ3XPPNaGg+H9M8P20sGkWsVrC7mVo4xhNx6kDtmtJ082Mq/cdqXN2OKWKk1yp6GadNj8wCVyWHRsAEj3rE1zwPY6p4h0XW4X8m70zzgoCjEokXBB+hAINdDJPaWs0UV3coJSMpvIBNXwRjIxj1pXaMZTkkjzzW/tENykD2xeYt98cce2Kz9WHiOXVIl07xKLKHaubVolYsQc53HJ5HGMV33iOwnu7JnsDEL6MZjMudrf7Jx2/lXH69o1+YZdXh0ye5v4E3LZpIqeaR0AboKpNHo069KrD95pY6G6vbK7nstI1NmNzdqzRrg87MFiCOmMj061cvNCtZrVIYRsCrtHPUD1ryjwX4l8V6n4zH/CSeGp9EspLMxW5kbIaUMGIz3yPb+Gt7xBq3iqTW7aHQNQ06NIiTNBeRMdwwMfMvOep49qWpyx5n71J6I6e60tktzFboZwFxhz0PpWV4K8EWtjNcajcWixX75RCeSqE5wDUvhDxRrV1qEdhr2heQZC3l3lpKJYGA/vZwyE+hBrsJtRs7e6W3mu7eK4cZWJ5ArMPYZzQ2E8XU5HT7mH4gtLvTtHurrSvLe+T94iSD5XIx8v4gY/GvNrbx9qXiPwvqT6Em7UHlZBFEgae0j37GaSItklRk4HUj3rvPHOqQyaZcWcN7PFHINjz2uC8Wf7p5wetczoGn2XhbS7OPTLRGSIAG4f5nn3clmbqxOcmml3NqdCrON31Of8AhXNcw6lqMrQ3D6cYIYLS9lTy1lRM5wuB1Zic45+tegX/AO4tolVsKeQR+dEVnElgqQxLawooWNY+E2Y6AdquSxo1lEruGKr16YqrWNqMfZpIxdE2XvjIWd7E5FnbG4Rlz5bB8L85Ixu4OACeOvau7i0qxQfLbRj8K5GOaS4ihSC5NtLBcI7yKuSyAnK+nOcc5xnpnFdpb3AmVSvOecCol3RxYlVIzd9jj7nwtY6Re3lzpfm+ZdN55sg4w79GZM/xEdRnFL4F+03cmqSahZ3Nrvl2RxThcog4zkevXkmuxCo0hYEMRxjrt/wolwjbhjL8Uk+hkqr5eQLdAiFQWIzxmuc+IGgRazozM0jRSwfOrjuB2NdP0+lcz8QtRksfDsxiVndgflHcDtSW48NzOtHk3uZfw7uEsZJ9FnZxchRPHu6OnTj9Pzrq9ctJr7TZYLW5a2mJDJKvYgg/lXlXw71A6p4ksbp2SKaDfFtYkhkYcgH1yB+temeIxqZtoU0qKORmmUSln2lY+5HvVNanTjKbhiddNmN1+xOp6OyRbXuYuVJHVgOR+NY3gBx5c0R81Bt+WNj8h9SPetbVYtSjRI9OkRTkF3bsB7VyVh4iubXxL9imtVNs0h2TLngk/wCeKfLoFKk6lKUU7rcm8TWrwahOLaSO2ljdZoZNu7aRz0/DBFSaSb29uL6TVlie3RvMthtO5WH8WT14NO8UWslxrEnlszRG3y+0cI+fXHUg+tR3t/cN4Tews5YkupU+zwNK2ASevPrtDVSNOb9zzLV7fcQ+E/F6a3q2o2Uiwpdom+KRSWV0HBz79K0PFUFw2iJDDI8KzPsLZJ2EdPwNcp4X8Nx6F4iW7hZ9saFBEemCMHB71o6truqWV/La6pbfatHvblIbe4hGPshI43DqQTx7fSqjvcuooQqKcNtP8jo/DEVxBpK2l4+WjbJmyPmPaiuT1XxLF4Wt45byQsk52qoxngent/WilOneV7GNZRVR3kinomkzrr15dQazfPqMcb/6DduDDuIG3BAGACB+BNb+lTXGqRmW9sJdLv4xhoZWDLn+9G44YH8x3FYFn4+0NHSbUtmh3CoVe31EeTIu3g4J4YemCanh1DVNWvl1e8kisNDUMtvaA7pLrcBiR+y98KOecmudNt7BFq65He5v6noz6xYfYJ7y8tFDiRjbSmIuB23DkA+2KS5S30DSpZlQJa26M21F6AdgO5qTTL1riBArJtAOyQnlCD90+xps6z6gl2kZCsEK5xnafXafTrj0quhryOLd9CxolvL9lQ6gY2ufMaZEMYX7OG6R9+QOCe5zV/Ur57XSbm5eNpFhXIjX7znso9yeK41fH/hu2sVl17UrfTtRDmGe3nYrIHBwSF67c8g9xzU+m6k2rXUtzFO50knybMg/LNjlpfx6L7DPep33M42lZJ3ZQludc1C7uol16XT7qSJUa3jgjmhgbHzbScMc5657dK3PC1vquiFxd6m995oAVpVIAIHXqfarV4kDTLcbUE2Dl1HJ+tMk1CzEEEt3dJDbh/L3scqzg/Mo9x71emyN+SKjZdTS8MLrV3FcNrSWiskm2F4C2JR3ODkqO3foTVVLG3/4SPWW+VXlkjLgEbxiNcc5zjrgcd63LaO203SolsNxhRC0a7y5556nJxzXFRPeR+PrppRn7TpscrIRjBWV1HP0bp7UHHTUnJSZv+IHjt9NuJ1t5rl7eEyrFAMvLgZwo/vVg6J4N1yfRoLjVPEV7b6s4DzxwRxBE7hMMp6A469a2NTtbq4t5oop5bczRMm+I/NGSCNy579/wrA0bxhe6Gh0/wCIEkFjJGRFbakr/urtOxI6q/qDxk8UMurzJpJ6HUaDokmmLJPealLqFyv3WuFVFjB67FA4z3OSTXO6jevquvN9knzClpLGrRjCn5kyWJ6EHGPUZrpLvy9RstyyGaCZM70J+ZT6Y9RR4W023kt2C6clvak52SAliR0znrTsVFKnFze5x3huJrsS3NgIb6Zlbb9mbET7Tg5bopyf/rVuPqtvaW62mpRmWZGUGWGMqC5bCooPJHv7E9K7JdOgtkRbGCOBFJOyMBF568CvLfFUt/qnxI0z7FCn2bTpJVuGP3VVox1/284x7Zp76lRruu7v+tUiz8Pk12w1VRqWuyarBO0hkjljA8ljyojYc7cDGDXqNx5jWkvl4EhQ7friuU02yhivIiB5bN1ZeOcdq62ZisbDAJ7UmYYqMYzSgeOeDHurPUNTthaTadDHKzG38orCDnIdG4HzA8rzyCa9M8NaxbXqvAPLSdTkheA3qR71j+LXkl1TTbWKRArwyPJGUJLAFQCCDxy3I71hSaNdyzvb2F1JZyTDYtxEAWjyeSM5GcZod2dXJCtRblo9T0+SWMZDMD7CuV0nxxpOoa1qWnW0skkljJ5UxWJtkbjqu7oSO+M4rR8JWkttoi21yXdondFeQ5ZgGOCT3Nc5Do8ejTS2ogCQlmdWA4JYkk59STSt0OSlRhKcoNnU3UelawI1uFinP8ORyK04oxFEsajCIAFHXAryrSL6/t9ce3NjfXDBly1vBuSLJ4LPwox165xXqsTMsS+ZksepFD0JxNJU3yxldD2ztIXg9jUSseAq7l/vZqbP0oACg470jmuZOuAzWhjWya7yR+7Py49w3Yj1FcxrdrJ4Y0OXUhbzag8CfM7YeZU9W/vYHXHP1NdzNF5gUZIwQc1DqcLz6fcRRECRkIUnpnt+tUpWNqVXkasefeF9U/tiwTUYmRwxJUxnjIzn6c8Ypuv6TZ65dQnVNLsrxl5ElxEGkTHQAnkVHpFyLS2ll3xg72EsZIHluD8wIHcGs/xJY3zXlrfW2ri3tJisSAZYiRjgcd+SKprse04Ql707WOa0Pxf4a0641xtQvmhgt75rGQS/MrsOcqFycc4/Su8jtrzxFaFdJiEentDuS5lJQls/dCkZ6d61dN+Hvh2DT7KwfSoHhs5FuBvG4vMOfMY/xMSSTnvU3iIxyeJtMti9/HIT5kQiwIm284J7ULV2OGOLq1J9mlco2WlaraaQlveq7Eph2U7ipHT61ni+ghjNr9oj+0qMbGbnp6da9MTLIpYYJHI9Kzp9A0ma+N7Jp1obwjaZ/KXzCPTdjNTz33Ihj39tHl/w7Gq399eF2ae0J27gchGBOcH+leo6XGsICsf32MEe2auwQxwRLHCixxjoFGMVgeLb650t9OubNWctcCKRAuQyt3P0xRfmdhVcRLFz5UrXJdG0D+ytSvLm3uZGiuBzE54DZzmtmSRcc4yOcVE95Globj+EjIzWPY6/pmo63cWFpciS8s1VriJQfkLDIBPTOO1JK5zNSm+aRT1XX78a01nYQwNCsQJMvIZi4B6HIwofjHJxz1rO1fVf7S1O4tHtL2CO3dVWaVVEcuR1jOeffIFdPa6fpst5eXcUaPPKQs0hHJwOBn2rzrxY+p3GqPZ6dkRA48wEjp2z2qorXQ7MFSjOpo7W3F1GbS9J1bTbCJJn1K7kMkK20e7Yi43SNjhVGRkmvRdD1FroNFKwaRf4wMbvesDwrb2MfkSLOJdTceVJKByyr1UH0zzj15rqL64ttPtXuWCKsYz8o5NJ9icTNzlySWvQuMob2J71x+raK1uLq7iWaVISZvIXA3kDOATW1pev2l+rFGCFecMccVNc3lu1rNK+4xeWchvu4+tKN0YQ9rRk1ax5P4l8S6nqmh2EVtILa4lcyTKgwVU/dQnuQMZPeuy8JWtz9jgW8gkcFsq5TPQZyf8AGuY0BIb/AFMAwMhe4Mh80884x+HTivXY0WOMIihVAwAO1U3Y7MVU9jSjRS13Mm90iIq0sKBZMfdH+eK5qK1htbTUYpEQ+bI0jo44OQAfr0rpvEkmqxWgbRYIrmXPzRyPtBH1riboav5Hna7axotxLtXymLbF64b6eveqg+phh/espPchtmjlLQPbZ8j5VDKMAe1FXn0tRDBMu5iV2hVbBA6/jRVSmk9z0JRpyd7EEyxXtwI7+2gYgf8ALSINgj0zU+p6d9q08gNuRWBBA5BH9KLMSXlv5jyBnhPQHBYVcibZbuwBAI+6ecmsXoYx913W5xFno+p3mrwQ6NfxWdrbSNLcy/eMsmP9UoPVBn5j6kDsa6bRpUkuby3e5L3FrKI9xyD0BCt68Ec9xj3qLwTaw3Ol6bqTTl5xEYwyoVXzAxDgr6lsn9e9U9DFnqGt63NZXMs269ZXWRdvlyIAjKvHI+X3qetiIz55cze5a1Tw74d1u8hutbsbaS9tTsjd0y0fORg+ntWiugNEHe2uVdCdyrjj2xSzwedIMphhjDZ6jpWN4im1C3s3No7kqcZJ+6P8+tNG1Omub3HZs1nYIoSZBycDZ1BFUvDVxpjx+INFE1rPJaXPnsswyqGUb15bjOc9OlcNqn/Caa3baYNNv3srOGdjeXMMSPKycBdqnrgk5wOnJ6YrRXwP4V0vS0iv5yJb6b55prgqZ5yCc7fuFv8AgPbihGVfm5+WK+Hqd3Nq8Ol2yrc3DT3IC7be1HmswJCrgDpyQM8Cs7SpJ9wvta2f2jcHawQf6pMkrECOu3PJ7kmsv4feHdP0OGeO0mu5jM/703Mm98ZJVc+gz0rqJ/JyUYDZ1GRjGO/4UyowfNeRLLqP2eORpHEdvGu555GCrGPUn0rmfGmuW76QkkWmf21byIZJLcwsQ8QGSwYjAIHI9fatdrBfElpKLIQT26kYlZjs356js3H1GfcVpa/G0+ixaYkkjPIVWWReoVSCfpnGPxo3MqkrvlpnLt4g1K0hsk8PaRp0emRKmIbicrJtwDtVQCqYHqfyrttB1katZS3NvFIjROUlgbh1I9McEEcgjisJNKRZGkj3F2G4AngH/PauI1zxbeeEtdYWds0kQhM9zIQdqLnA+vUn2HNHki54eElo9fM9RbxbZHKIcXDZEUMjBGmcAnauT14rnvD8KNIy+couJHaSTdwHdmLHB+p/Sub8HCy1qCTxapGoXkrSRvcBtxt/mwUVegXgYI69a1Lm7aO4WWGDaVGQ23ke47U7pF4fDx1lHT8TpdUk+wRtJOY4JOI4jKcKZGO1Bn3YgVZ0nQri1tNG83VLmeSxiKygtnz3I+Yn8STXA6j45h028srTW0kuI7mYIu1AxjYEENjrkEjivYkjUBMDOBilfqcuK5qUld6nG3GpW0usvZpzPbxKzHHOGYjGevVentWz4Zj8wz3DDJztH+fyrC8YQN/aUj2hWKUKC5HG7610/hqMx6PAWOWcbyR703saV/dw6a6moBgdKbJEkgG9FbHqM1JVe8acQN9kEZm/h8zOPxxUHmrfQmVVAwAAPQU7FMXO3nk96dn1oEZ99au88M4uWiSM5ZR/EKZFrNpLM0aSBiDg4PQ1m+L9WSzCWzMwZ43mKohZiqYzgDr1HHvXL6bpU0M0N5FaPBd3GGliLZK59fcd6tK+530KMKkP3j9D0V72FTgtVe9v1jty0GGYggZPQ4pF08Oi+c2WxziuZ8deFtQ1OXQrjQrgQzWN6JpEeVlSSMgqwIHB4Pei0bnOlSTRwPg3wvfW2k6g3i2XN7d6jPd7lkzgORjPYdOgrsbSwWHT5DbXSyQxski/KHMZB+9Rq4juorqzilYMAQzZ5FXPhHYJb+BNOy3mh0IDt1dQxCtzzyMH8ad7HpVaio0VFs6vSpGlsIndi7EfeIwT9atFQSDjkd8URxpEgRBhR0FOPX39Kh6u6PHk+aTaHUUmaM0hCVUub20j8wTzRDyhlgxHy1bxXFfEPRor6G3lY7UjfzJBu2oQOSzH2Aqoq7NsPCNSajJ2MGz+INn4p8b6poWmRyNHo6LI8hJUOxyGU+w/nWlrF6INNa4tCYSD8zH5SnuTXgmiaH4t8IeONX1fQbV1068uCzy3W15ZId5bCoDxn35xXqWleKNI8Uw3lqLmGOeMNHdRuSFQgcgnp/WmtD0cJFKClLRFn4eeMc6ndWdyZWtmYsZHG4MScZBrqktPN1428TowwZGX0XscV578IV1W/Fxpmq6G9s9sflvEYvBcKTnfG3cdPX+lej+I7ceH/Dt+2mwyzavfp9ljlXPEhUhCT/Cq8n/65ovqLFYmkpOpQ+0ef+KJ9c0LVLm68LWV1qMVtIscqBQscbsVzsycuwDZx0Hc9avtDqT+CreXxJeR292y+deytLlPMJ5GegHQYHpgUzWxrKeHLKztLueW5tVRJZmba8uFwWye5PNT/wBqvZP4ct9XFveSzXUfmwnaxXCt+8A9iAc+tVvqbOM6aVebu9kjmtV8VaZ4a8PLeJdiaRgVhEQyXboMj0BI/OsC1+Ieq+JbLSNFaI6fDcXSpfdTJ5eS21TkY3ADgAnnsOva/GPwInifXtMmtradRGp34wI35yobvjIB461e8J/BuztdUGtardXMuosxYqrkIpOOg+gA57UtjlrVpzanPSJraDqFpf6xFFBC26KThm7D/Ir0setUbDSbGwJNrbxo56tj5j9TV6plK5zYqtGtJOKtYjmjMkLIGK7hjI6iql9Zwzaf9lk3bAAFx1GO9XiQB1A+tZGs3RtykitypB68Ad/0oim2ZUouUkkcnrVrNaaiVMgyUGAOmPpRWJ481Ge615Xsr1Le2SBVErRmQF9zbl/ILRWza6nt0eZwTaNTT43tJ2c8RuflYc/ga1Xmjmt3YKFkTO5RxuHqKxdNaVDPBMrfKQGQjGfQj6VeaGeOKS7uHWG2jGXZvvBfpWBhJK4zwZZvAdYWR5PKku2nhU7QFDAMWXHuSD9PeuT0/XJfDB1Oz1bSNS8y1llufOtrYyRTIzF/MRhx0PIPIxXdaeI0t41gEpjyT5kmSx3c8+3P4dK3rhDLZiJ0R0K46feFQmczvB6HEa1fzz29vNaBmt5F3oyDJGRkBh9DW1pFwL7T44tQjAmCj5u6moLezuNNacXciTWUj5tSE2mFcf6tvUDsfTr0qDWbhNK0+6vRyYomlwO+AT/SrcjqUlUgo9upzPiTxjY+HPEMWkwpcSXLwrNugQSLGCxXnn5fx9atWGi/2jplxDd2vkia+F6ty0xcvCPmVVGcoykAY6Y6ZzxH8KfC1vrPh86zrnkXd9q7LeySQEABQMIgI64HX1PWu5l0yz0iw8i0t2igUnADFgA2c8E0aL1OZ1FVsnvf8CmPLWUOm1P73GOay9Wng1XU4fD7eYUvI2edlVvkiXn7w4G4jbyRxmtRY7e6xGHETsflBPB+vpVSbT5pfOjMjxsvKMTgowzjOOq9eO4NB0VPei11NmDVNO09YrTT2hjsEj2qFAVIwv8ACPoO3tXBWmsadq51fWNMuZ3hgumE0gDOshVQAY8cMMADjvmucgF7f+KLTwp4piha3tYzdQeTgRXpVuHbvlQeV6Z55r1uLwzA1laqhENrjMkMaBQ/1wMfpTW5jTlCnJS2X4kdnZXWotFOBttJUDl9+1hkcFRg8/Wr2v8Ah6xvtBntJrdZ4nj2MrHmQdwT3zWzaJElskSIEjQBVXGBimNAI5A+87N2SGPGKPI5pVpSlqePfC3w1qOg+FvJsEKanu3zpcZZWDEHbj/d4+orb0jw74jSC4kubmO9CwL5UUqCLdMAd2WHQHgYwa7HwrcRXsEksLW25XZGW3nEqqAx28jvtwfxrosAUN7lPEOnZQ6JHxx4vsNRuvEzS26XFnewyrfyKhy0BAQNyewLenQZr6wttXtY9AjvnmLQpECSzDcxA/DmvN9Oa1k8T6/JdmK5nvbtljdEJ2RouwR5P+6SccZPtWJ4i8ORvLKst5dJpMsiTSaf8vlPIuORkZA4GQDg0Pojo+qyqpSe7Ox1SF9aUX/723dyG8pvvKPQj1xiu28N/JpUMf8AcGOa4Wx1iO90VnsoXeeIBfLVOW5x+VdxoEE1vZr9qTZKwyVznHtTexeMTjSUJbpmvSYopag8kQc+tRzSxwxtJK6oijJZjgCpKztb0+01Sxay1Bd0ErLld2MkHIH6ULccbOSucn4sDjxhpl7FIDGbCZYzu+UnfGSR68Y/CtrQb176VTJ91AcH+8aq2MVzrT3NtrOji0gs5l+xPG/OACM5+nbpg4qP+07XRb+TT7NBItvE1xdybWbyEGCAAB8zNngA54rTpY7OeMKTpte90+Zu2kt/JfMZ0hhthkBScux9fapr++itkdWceZtyAPyry7Xdb8eXdxeS6fY6Jb2bBmsriaeRZUX+ESoAQT9Olcn4I0/VLPxZd6x4h8Q/2nrN1bLC8KLtiRcgkL0zg+1JrqOlhpVpJ8vqet2dpHNdStGVMnXJ4rW8MRwW9pLbWylVSRnxkkZYknGe2c8Vw2tLqawCbTGbzAckKcHFdf4eM0dtYPMqrK67ZQvQtjk4qnrE6cZS9zmvf/gHR9cg/pWHrGvWWiSwJqUjCSeQRQbFLFyccYHpW2SdwwQPrXC+M9CvNQiFz5ghmguQyTwjLrF6fnURV3qefh4QnPlm9Du88dOfQ1hwXWuPrBWaxtotOGcN5haRh2OBxWXouvXaSeXe4mh/56jggf1rp7S9t7tcxSKSOozzRsVOjOg2pK5NHJvYjaw4zkjFcR8U2lvLC20mAyJFclmupE4KwgcgHsWJA+ma6zU9SisLaWVg0rIpYRR4LNgZwB61zEFjPq9wbuWN7aS6RZGjlOdg2jC8HGQPTihLqGHppz5p6JHPaNr1nrCXFlJE0c6Jtjlcgbh0596y/h18LIND1YzLaBrUbmE1yfMaRm5yM9Pr1rX1bw81tfRbI2jO8ZZR1GeteiNfWVlao09zGiIuNzMB0qm9D0MZKEVGVFXv+Bat4VhiVFAAUdhXOfEDUTYaOBEWMztuESjmRV6jPYDINaZ8Q6Otubh9Tso4QNxeSZVAA78muG13U7/WPElnJZuq6Hbxv+93BvtTttKlcdFUA855JPHrKvc8/DQbrR5lszLm1Wb+y1uxYTSSE5aGI/MR6iuX+E1noms+MLnxNqGpW639xO8cNnIrAxgfKi5bgNtUnHXmug1Z9Ze3uLNgf9JR4re7gxuiYghWPHGDg1zFr4bHw48P+RNNJc3d9IZopo41kmV1ALRqp++SS2GwMevNU0d+YcylG2259GKquoK7WI79aW3E20+eULZ4215T8PPiEl3avFNp+pw+UyoBcW5jZgTjOCe3Un/9VenWGpW1+rG3kDFeq55FQzzalKUVzW0LuTVHVdQj0+0eaTGQOFz1NM17U10jSLm9aGS4MS5WGMjdI3ZRnArxfWtU1jUtZMECtFPNiaQbgyjKjI+g6fhTirs2weFeInrokdHd63eyak32mRgXIEUSkkH2wO1al/FeW9i99cRO0hTaIc9QOh9a2vC+jwWOnrfywRNfNFzJtzgYyQPQZFS6nbXV1pEkrCMyKu4ZU52jqOPbpWkZWZvKvGNS0UrLQ4qAWV47zLCu6XDurLkZAA4HbgUVs2iRMisMFWGRkUVck76HoqajpYq6bfLd+Krm1kubM/ZYkMcQfMzM3OZB2HYeuaveMr210/TXuNUIt7cnDKDksx4CIO7E9BXlPiPT7fw5qVvq+gQOt7q+pQx3LgZkIOSVDH7oJHPXj0q54/n1LUvFek3D29zLpukTJJOsaeYuZI2AfA5JU7eOwJNc2uiPLcnCd2dBfeH73xMi6hd3l9ZS+WUhtbK6aIQL15I++/qT07D17DSb6dLAWt2FlaEALIzfOygDLH0askana2enQTyTbGIDDB7etaE9zbPpVxqURDbYC8yqm/jH3goBJ/I0ntc1nSsuZ/eZVz4x0jU/E76TaTN5lnbC4dS3ySgnBwCOduOoPfFXX1SyubK5eHf5dvGzvG6HdgA9B36HivPPhppdzokd2vilYLcX8rGzlEQRHUsTtVsDBOQdpC/SuqstKvbPUiAubcjaSWzleePyNPpYMJyzptvR9Da8EaKdEhVLZSun+SojQEYYHkNx355q342v5NJ8PJdohmt7aVTdAEs6QHIZwB128HHoDVHwPObWwfRnumuTpjC2MxABePaGTOM8hWUHpyPpWl5mm28jaZcO8z3BKFZUJDgjp6YxQnzXsZaytLqv0ORv9Sh8uCe1ZJlcbklU7lZfUEV02la0uo6YVliAmVflYd/rWNZ/CrQLLYNPN5YKqlWjtZyvmAnPJPI/DFXDoSaMqQ2M93NHJlVFzJ5nln13Hnn3NNbnQq0aqjGSs+5la9bWhk0fVLtMLpl357umcoCrITx1HIJHcCvSre5VA0PDFRwPUV5vY2NxZ3kkd7DI9tIHEol6MD6VzGkWviOPTbnwje3N+oMskVnrCTYYR8NGAcgnCkgj/Z702jPGU0pX3T/M9C8ReMljaez0SE6jqMbBZFiP7qHOOJH6KcZOOT7ViT6/d6hqC2WoyRrp0sZjntlUsXz6vkduwA61reF9Et/D2h22mKgMcCCNiyBTKe7tjuTyTVHxBprJM9zYWcl5dBQ0dvGwUsexJJwB2yaLdTShTpxT9r2OhsI4tMVUsFS3ijwBHGNq47YA7V0tnefaMErtOMkVxNhB4iuLuOG40ZLe1BXdcy3Sn5cZYBVySc4A6Z9q72KNViQKPu0HHiJ05L3dWee2mnWmka69ncW8UV3NJNcQFAxEqlizMCRgNluV6/hVnxHp0WpaeGDYUHa/H3SOldTe6dPe6kkk0yHTxEVNuUGd+eGz/SsbTPDN/pd5dSW2pxvBNvfyWt1Xc5GAWI689Tjmmma0sTypO+qIvBOitZWqSQhFUnkkcnnmtzRNRu76W8W806SyWGQpGXOfNAz8w9P/AK9S+H3vH0mD+0bVLW5GQ8cbZXg8EfXrWkAKTe6ZzYis6k5Oaux1FVNQuxaw7gMsegrKg1tjlZ4mx/eQUrdSIUJzjzRRWuvF0Vlrd3ZX1nNbWlsoY3smBGcjoPzx61nyfETTWvbe3jsNVbzZBGsj2Tquc+pH6+lc/rPjCC98ZxaS1rdIYlDqZBw6n+MYyMZBHPPHSul0pVVBFBDK0eDzgnJ75q7I7vqsFFTa6HVxXMcibgwAPQk9a5PUryCzn+x24YKzvKeScsTknPvk1UvpTFaq0TqyKx3knp6/Sqdld21/OJEkYyk7C5GR19DQlY0oYSMP3m6NJbmCfZFEu+WQcLjnFMk8C+bcpdxyQwXI6NtLfmOO1dVpdpJBp8IleJrkgGSRE2hvoCSR+daKkEZHSpbOeWOnHSnoc/a6BNBM5N+XgKBViMQ+U5OTnrzkflWvbWUcCrj5mHc9qtYpcUrnJKrOW7MTWFvH1TTvsu/ylYtIAcDHv/hWuVBznGCMEU4dqjcurJsQMpOG5wRRe+gpTcklbb/hyjcaNaylmQGMt2Xpn6Vi3WnTWJUqCyjnetdYTjrR1PIFFzSniZw31R5qt9YvNJevqWPsxZZCJAQOM4PoRU3hnxxp2rSxqtyssMq5hlBwcHuD6Vq+N/CWiavpFyb3T4JSiM21V2lhjkcc84r518OPr3hvQ7bVrnSF1DS0tl2fZW2z20Y55VuTx1PHSm29zvhWp1k1UWlvuPpfVHSJfmfcuNwI5yK5XU9QNtDPcT2fm28aghsbiwPHH515dN480zWdGhhkmhPi+aeO3tYLWfdhM7kbzOVXGTuOM5GMEV61JqNlMY4FkTzupjLg9R1HrVJ3LwrUtErpHL6p4D8La/cafrc2lLINhZoGkcRE/wB4x5xnPeretWl7qFui6TcrH5L/ADRRvtx6dK6SQQpCVdvlKkbRx2rG0CxNhdzpayNcTSgHywOQmeP/ANdM6KShS5prRmV411GDSvDcEeuJO9vOVtbiSBW+QEHL/LzgY5qfwJrunaz4bElpcxXUdiGs9wkBZlThWHJxkYPNdfF4ZXWoUl1q3a3niJMKLLuK5A5cDjOBjHPesTUPAsena7calbTWtjpjRnzEigC545yFHY85+opHCq8Z1W29Dnb3TTrM0V7ok0iCOTDpj5s5GK7zR9H1PTliniSLzDy69DjuDUngXTrALJe2F9Hdq/ykx8YPuPWuxIyOv40m7aFY3Gtv2UdkeRa9YeJD42i1LVp/N0gq0VvbRsVWHK7t7D+JsjHPQYqfTryO41gWkSkO2Vfiuo8T3stxHc6U0EyPLhILmOPcFY9CR6Z60ukeHpbXUWuZvLaQ4+b2qloOhVVKm1PTqjoURtsUIyBjLkHn6VT1LTrq51jTrmHUZLe1g3Ca1A+WfI71Vs9QZfEz2k1wD5sRkijIOeDg1Z8RaXPqn2NYLl7XyZRKZI2w3Hb8aVrSs2cPK4TSbtdfmc34isLnT7lBaylLdgSPb2ortbq2huEUTpuAPFFT7ax10swcYpNXPMJdKGt36Xl1bXNoltI2yxlUKXkwR5hHPAycYPOc+ldjoVrHY2KfaS0khOWduTmvLvGfjubR/G+j6FbW5mmuwoM8hKiMsSATxhhwcc5zxxXo0upRW2mvLMgeRAGIAwT/APX9qhNvUi3NeK1fUr+KfBy6m1xe6VORdMgxBK+It3r0JUkVBomky6UR/pkxIiEflKAEU+vTJP41ow3ZuGiuoWMQcBhnjirxZLndIdoJ7joT70m3sUnOMeSTujD8b3NvF4R1dr+1F5ax2rvJC38QAyeex9xUfg+0jj8MWcVrNNPGIvleaUu+09CSQCeMckZ+tbWqRW19p09vdiNomjKSA/3SMH9K8k+Geq3vh+1k06/QrZ6ZF8mos3ySx5YneD0IHufrRHrcUYu90iy3wvvtNd9T0PxDejXkd5RLKBtu2LbgsoH3hgBfYdq9Q8M6lHqeh2uobNrsCJIW5aJxwyH0wcj8Kry3MMlkJ7eRZlkXerI4KjIzwfSuf8Ivdp4s1uGRnWxvNk9sqqGXzNuJSWHIJKjg8fiapvsTKnZcy2Z6H9oikhZogCB1UiuC1m41Y+L7e1uZVXT5LWWVYFUYba6AMT16E+1aGuXl3E0Nvo01qL7z086K4bbmM+nqfaq/iGa0fxlaxoFkvLO2YTybj+6WQqVQdsnbn6AUdLlQh7OSt1JItZhlb7FqCrgcRyZ5Gen1rh9Wn1yy8QQNqFvcxab/AGi8KyEDy2jcFYnUg+uB6/N9K6zVLWe4vY3gtTPbwq886LhWYKvChv8AaOPyPSuq0W4sdb0eEtCVhmXKxS+3bB9CP0qulzWrPk1gtOv5lCO6W7lWCZcnZmN/oOh9c0nhLWodWsRIbQQ4YgtkHnJBHHp0P0rF0x72G8urLUGDXOnT4eUDCOp+ZGA/3SMjsc1p+DbN7eXVILm6tZLKS4L6dFDDsMERGShPRvmyfxP4CM6jXLeKun+DOrhcOAUbIBxgVbRSgOTnNVbdtkxjlUq38J7GrnPcUNnBMXH5U11Yj5Tg5HJ9KXNQ3FwkEZd8nsAO5qSEm9iYClrLTXNPEoguLqCC4K7vKkkUNjIGcfUj8xVXWtc+zRstnDJPKF3fKpK4zjGfX/A00rmkaUpS5UhviRhFLFNK+2AKdxPGPfNcbdavNqg8vw7C97ZTI8b31uyt5bEEAIOctnBJPAArrdVs7DxbocSXUAuLKXmSFyQG9mA6jPP4CtTSbK30vT4bO0hjt7eFQqIqhQB6AVS0OmNZ04qNtUUdF8O2dlY2yTQK88cSxl3O9uB3Y8mtqG3ihUCNQKkFLipuzllUlLdmVq+jwalbypJhZGBAdV9u/rXj3gq8vbO81LSNXt3W8tblvLl2bBIpJIG3JPAA74ORXuuBiuZ8caclxp/2lFxPF/GBziha6HZgsQ4y9nJ6M1NEvhd2oBI8xOGArTXAXivH/BesXiXsrzxSRhW25Oef/wBVemW+sQSJuJwKLBjMHKjUfLqjVornde8X6Zo1jJcytNc7MZjtozI5BOMhRzxU9r4ksbuCCW1MjrNGJUBQqdp9QeR+NFmcqozfQ1Y5Aw7j0z3rlr3xJcSRzJDbzWcgneBDMvLBWxvA9Djj2rF1WTVJ7lLia4hM9vIXtobfKoqED72eS3Xnp7VoWokvY1mu2USgfOSePwqlE7aOEUbVJ7djl/EereINQkm0h5JYouCZoco5HXqK7Lwzr8MWnw2lz5xeCMKZZDuZ8cZrHs759YvZDodkt9b28gjmufM2RjjkI2DvYdwOnrniqrT2+rx+ZYTSQnzCGSRCjKVO1gVIBwCOtOyZ0t0K6VJK1u3c6bxNqlrFY/aIg7z/AHQy54HvWVpFhFqjLJFGyOyAvIc4x9OmaLya0jRTKXCL8gPfNbfgqC5tvDscd7OLq/Xd5kvl+UHOSRhecDGB+FD0M5v6tRtFa9zyrUPhJpHhXxxH4k0+TbbSh8xTY2wysw5Q+/zDHbPFbV1pVkdSiv5d8ckXIw3ynrgkV6PqGnw+IdDNtqcC+XKMvH1AYHjn2IB/CuF0Pw1qt3rNzb6/ArabG4IyOHw2Rj1HAPNSGCrKnSkr2a/E3tJ8PPezW91dyyx2qEsIF483I4JPXHt3rroLeC3BEESJnrtUDNTYFFTc82rWlVd5CYGc4oZVZSCAQexpaTvQZFLTNKsdLWVdPtYrdZW3uIxjcfWrmPmPJx6VkarrIs5/Jjj3uOvtUPhjXbfW/tZj3rcW0pglRkZRuHPy7gNw5HI4p26msqc7c8upukDOcD61ztz4ghh1dIG5QcEg9K19Ze4j0q7ezQvcCJjGoPVscV5dZ2cmoahBL9luCFTLfKQxb6HpVwSe50YOjCpdzex6gbG0k1CPUfKU3Kx+WsnfaecVLfRtNaSIhIyDyvX8K8t129uppIdLbV57CcAvHDG213VRzn2HrxTfDvizVLYNECbkRDaFnfaDyASWwSDjJo5exp9Rny88ZXsekaVeTyWyrfQmGZeMFs7h65op8GqWVzGpSaPOM4zzRUSV38JyyptvWNjxG4sL7XfEGp2OplTP5dzJps+VG6P935YwP7hY5zz0Ndzotpqsul2aa1BCt3tUyeS25A2OQD1wetZr6vAuu6TCIJJbxi2xYkDsiYwzuMj5M9/XFdopYDcSOeo7VDlbQ6YxdOcuUhvlaHT5ZpLd2aNMrHCuWOOwHrXAazL4putEljtNRWxu1fzY1twADgnCMzA5GODx15rttfsl1KwEclzNbxxSxzgxyFNxVshTjqCccd6wobyC4dlhyZIz86bf1FJLqjWnDnT5h/ga6i1HS7mctdPsne1uUuCNyyr1+7xj6etdItnaGPyFgjMZBUoVG1gRgg/WuX8G30cGueJtOu5Y4iJYr2IP8m9HQKSM8EBlIJHfr2rqru9tbG1ee5cKqDLbVLHHc4HNJoyUnZpnGJYr4YebRI2U2rq0llGuf3cRPKZ/2ScDnoR6Utnpt9aXa3lpKEiIBjyBxyMjH5ik060fWNav9duppUtrpI4rSCVdpjiTncQeQXYk444x3rqbOaNE+yuFMWPlY9RWibOinNqly20/QyteuJr/AEUTHR7W51ZSP3SzbFyG4YOcHpyV79Pes/w3pd6sFzeajbNb6he3ElzMJCGbLMQoJyeAgUdat+Jllaw+y2lnBfXNw4hjguP9WRnl2I/hUc/hxV+FDYx29jM22a0hjj8xVO2btlSSfyJz70bmS92orPZFbQ49Sh8Uh4ygsfJ2yJI+0rgk5Axzx15rrTBwCFC7DkbTwPeub1a3sr63lWd3QdA8bFHT3DDkH3qlqt94g0/VIZrPThqVkkW0+RcKjycDAcPgDnnIP4Uwqp83NsO8c+JLTSLqyt9SFz5upA20ZiCYDKRyckHnd1zgbasaTCbeyUMrBX2yKdwOeAQRjisqfwtc694ofVvEItJbCGMLYQByHgbIYlscMSRyc4wBXoNrZWzaZFDFFEEjTy1VRgADsPajoZxrOmmulyhbaidwt745jfhJs8g9s1Jo+t/ar2a0KhzEcCVDuVgDg8j34ry7WL+88F3M0SebqmhIP3cu7fNbSdBAcfeHcM2MDg54rrvhHdyXGl30k8KW7SXsriNTkLuwSAfqWPHXOaFqKqqaje2vbt5nQeMr28ttOi/sqW3iu5JkTdMCV27ssAB32g4rIvbkzSwG4YGWPmNs8qT1I/lWd8W7iCCLSrzy9RNxa30Riktc7TuOGVuQCCoxyepFTabNp/iK0S/0m4S4jRthdDnawAyp9xn8Ka0Lwns7WkZp0jR7fxRP4iayjOq3CiN5nJPyjHRScD7q/lXU391am1jMsixsxAQ56t2A9TwfyoeCBiBdGNfLXO5hgfnVm80yYS2l1p5VQCTImBzkdapI1nKnFrlVmZyi81LRUl0WWRLlZ45gQSizBWG9DkdCoI+tWtWgTX75tI1OzuorWLEizxylPMPPAx1GM10hmWNSZnVQMZJOBVB9RUs+6JvLBwro2SaSbOJSlKbklr+RpQRLBDHEm7aihRk5OB71LVGy1C3uCEjY7/Rhg1dycVBzyi4u0ihqGp22nNH9scRrIcIcE5PpTNTAvtFnNsQxeMtHnoT2zVm9sYL1FS4QMFbcuRnBqdI1SMIowoGAKZalGKTW55NJfzR6FDK1srTMAs6IciNu4z7HitOwEs5SQ/KCudpPQkc1unwTZR6nfXljdXVp9ukMs8KMGjaTGNwBB2ngE44OKmtPCcVtEyfb72Vy+/fIVyP9nhQMVV0en9fpyjZrU4efw8DqwvhN8uf9W30xiuo8y1sfKildIpJF2orthmFbFn4ZtLcSl5rqdpH3kyyZ2+yjsKo6t4Rgv72G6eRpJIfuAnGQDkA+vNNMbxtOs0pu1ipZWUk9yxVn+QZwfSrPh7SZo7q5mupfMgJ+VT0FX7K3vLSZSItyNwfmGFrj/iV48t/h5BFfSWL3FxeOI9hkKoVXrg9FI3Zzj60X7GNfEvlkovQ7bTb6SS7aBbIR2nPlSxsNpHoV6g5+tcp8S7nS9AvrPXdRaNFaGSycqN03zEMpjUcsQQcgc4Oe1WrzxbJc6Gl94V02DU5ZASn+kLGp+j4IPPBqhdtNf3lrr3iNIdOGl2sjpFM6tAkrgAuX65HK56cmla+qOZ05xlzRVrWOP8H69YXElzZwzXNzfyRtcQW1xA8buvTeoccjJGfSuhuJfFsTWKxzWen6VBCks92r+bKzKRui2kYAIByx/CqXg+01wHVdf1yC0TU7xRHawW+CkUC5KgN1JYnJ59K6XR7iXUtHkh1K2jhkfKspGA49cf56VXqei+avHnqd/wACQ+IX1Wwt47Bpt8txHEWhjycFvmJzjAx1PatDwhdPBBPBfawdRleVnjeSIxsiZxtOQM4IP/6q5/wpZXFhcyWgiRI/M3RleTk++emMe9db4l0uW+sM29xJbToVd2iUFnUHO3kd8YpNW0MMVCEJ+zXws3s56Utclo/iK3WEhp/PjDbWx9+I/wB1h1B9jzXTwXMU6B4ZFYHkYNQ0cNSjKG+w6RS0bANtJBGR1FcqmsPplzZ2+s3SzT3k3lQLbAsSR3Pp79cV1hGRUK2duro4hi3rna20ZGeuDTTsKnNRTTR5folxNFqWtRapdM8s2ozvAjuCyxFvlHtwM4+lbsGqLpsUt2CroifLEXCl25+UFiBzWZqehQr4luJHbEisZVUN1B7mqGo2d01/HJFPEgiyyKy7lJKkYYdxz2Iq0kex7KMqKjB9Eeq286zW0cwICuob72QMj1pJlmJXyGQLn5sjJ/Csnw4jTaZbR3kkUssUahliXbGGA/hHUD0GTW4MAcdKzaseNKPI7FW4sIbmIC4jR3H8W2sW+8JWkiO1oxhlbtn5fyrpf5UuKak0OFacPhZ5Hc6NfWd8RPHHEpDETAEu+SOD7DFFeoajbJNGu4ZINFEq2p6kMz933lqcZZ6bBY3M0yKftMn35W6sB0Az0A9BxWtEUePc+ff3rPu5J5YLiC3dBOQRG79AfWuN1O913WEi0jR7gwpCxj1DVoSAQ69YoQepzgFug6demFm9TFq0bm14r1YXNrNo3h/UVTxBJIqRvGQTCAwZt2QQAF6jryPWpptG+wagkjsxlI3b16MSOTXKt4Tg0bTTc291eQmCEmWRpS0joASyhv4S56nk89utdh4NbVtW8MxSeIIVtYrmNTBbQ5D2yY4y55LHr6CrTsiY1JUp69SlrVhYXdncxXyRT2rxkOkijlepH0yM/lUdjrVlZ2mlxyShrFmW0L3JPy5TKZLdc8DnqSKreOPh42o6TcrpWv6tZ3SqB++nMsUik5KsvXpnkEHtWPpHg6z8Ly6bezzXerS2ipbHzm3cSOAZGXvjd3zx9KSdxyqOW0fmdu+iXt1NNLdatNZRNlY4rOJOEyR8zOrEtjHTGDnrVu38OvDIrrqt3Pb7cGKZE3N77gBitpWW4hEcoIO4rgjoRQEVcLuO5emDTTZCb3T1KVppc1vc+bdsjhchEjzgD1JPVsVz2stdWXg/WJ/EU8BmTzGgeDAOP+WRGf4wcY98V2t5cQwWM093II0jjLsxPQAEnP5V45c6K/jayn1jUJbuwmuwi20EwVhAik/Mq56vnO4/MAR0ptsIznO6S1LfgjxJfeK9Pt0TSBBe+RulnuJ9kMuOD5Z2kvzjJxtGeprfuNa1LQ7hU8SaSbWylZIYru2m8+Hcx2qrcBlz6kY5AzVTwVcva2cek6q9k13ZYhtpYRjMZAIUj+BhjG30xjNdBLqEWv6NcWVhcRSJ5hikaSPcgKON69RzwQD2PPahS1sJTqcq1u+xV1rUG07R5Jxbm5VSr+SELHG4ZOOvGc8c8VtDW3t7+zWCyabS7xR5V3EwYBiOAy9QPQ1lfbYfOliu1CIgJ81jgKB657Va8O38Os2rvps0kcEcpRpjGQGAxkJuHzA/3hx6Zpp2Nq8EtZHI/EeSy8LaT5GlJHPe6vfxx+RcsWDF2GTxzhev6Vxvg6PxFpks15PJcQwvNmV5xsMsYGFRIhnYCWYseuTjPeu58d2aWGl69r2n2VxPqEDw3LRzEkSCIqQqH+EYz07kmuhljtr/AE2GUrG8c8SsMNnORng96aFTXNU99nMaPbR6pJb3Gp3xnnS5NzHFGTHGrCMRgFMnOAM/U5rX1C//ALGt3khiSNd5Zwg272Pc1QuLYpPJB4agS71aAI7WzShFjVj95j24ycdTUWs6Nr+mzfb9TkS/0ue2DXsca4FrIpA3Rrkkghjn/czRe2x0+0oU6iitma2nJF4ztZrSfC2UqFLqHcVaRDx8pHTmu7gs47S0t7W0jEdvEojVMn5VAwBXE+HYf7P1BDCwYkAfLwME130mcBlOMfrRc48ckqt47dDyrxjJq1tr0kq3T3sAl2x2ygCODgdl5LEE8t68AVuQ66ljY/vba4nyyokVvC0shY9MKOceprIutb0+18X6zYxwr508qXAVAcygxojPnofmGOPSu68PW8P2N54VXdJlQfQelPVG8pxhhleOv6nLXGvtbTgTWlzaSsu8RSqNzLnGRgkdeOvHeup0DXINTREVv3pTdg8E+tUb7w617YQRXci7rdzKki5yc5ypB6gj9cHtWDoKNZXqXEIkSJjsMZAynb6cU3qLlp16bj9pde56PRTEcOgYEEGn1B5QUUmaKAFpMfSloxQBnazLeQ6fK+mwJPcgfIjNgE1wXxO8Kw+IJ/D9zrUTS2ti5kuIY1ZklYgAKQP4c8n6elem7abIgZCCNwx0NNOxpCaVk0eZ3b2d7a3WlWF0kLRqsZEIwIjgEDjpxjj3qfSNPGoeF59H1h2mV4Xt5Nx+ZkYEd/Y9a7ObQrCd1ZoApB3fLjrVe60HTVKTyQyN5TBxhzwR361Skd7xdOUOSxxeqzNo2laXpWlyRvOyraRy3cufLAXAY93PA44z6irXhXU9O1PUrvRYbhtSntY1F3MUCqxcEYG3gdDwOlc34y+HmmX99FqfhTUri01C3zLHFHcl4Y2JyzeXkgZzggcfSul+GHh8aM10zbTcXUzXE7r0dzjt2pWsRefK29EdpYaNZWARbaMqEG1fmJ2j8av7RjHX607FBwKRwSk5bnO674fFzMLjTVt4LhnBuMxj98vuR/EOx/D6cre3mpWKWoW0ks5nYgxuQSuCc4wcEd+O1ejwypNGHiIKnvXP+NNBk1mCzntSn22xl86ASfdJKlSCe3BNOLszqw2IdOShPbzKmjeKUcul252x8MxU8+4rrY5UkXKMGHsa8g8VJrthaQmS2hhYkF/LIYEntn2//VV74XeIri6urq2lgYLn5eCcHt+tDR118FGdN16b26G98QEvLe402/sbdZog5juhnDBMcEfQ9fasmSG21SwVxIVwQQyn/Oa9GRS8AW4VSxHzDHFZzaFYOz5tYkQ9BHlfzxQmc9DF+yjyvocnaTzWVy08E4MQG0gMCp9c102ma3DKgErY43A+1cFa6ZaeAtW/swXEMWk3jZs4pSd28kl13H73JBAPPJ9Kl1PX9Ns5oJLe7R1kJCGL51GDg9PQ1ejOpU44pKy1Z3GqeIYbbSpbm1C3MwH7uINje3pmr2i3kt9pNvdTw+RNIm54s52n0zXjfjfVrq2eGUW3mqQCDGSPfgj1r0T4W/bpfBWn3erTM99doZ5AUC7MnhAPYYFTJJI58VhoUKcWt2dJdM8kCNbgOSemccUVR0TSpNHjuo0uWmilnaWNX/5ZhuSue/OT+NFZyir6HG1Z2i9Di9bvIblrmysZmWQAJNImQ0asP4T/AHsfl9as+HrG00q3RLW2WC1C4Cqc7fXP165qhZjT7+wa4trgz28vHmR8mI+jDqKy54dYe7XR9Blj3yL5k9+6nbaoTgbV6M55wDgDGT6UrWPScYwi3LdFvVNQtPEPiKPRLa3iudNhkI1CSRiqqyAMiDB+Y5IznjjBzXeuyQQFmlVVRNxYkADFZHhPwrpfh3TY4rVXklIPnXE5zJM5OSze5JJrjPF9nJ461ubR5Gkg8OWEoWcRuVa9mC5MeR/yzUnB7k8dqT10RzXvtuadxrzeJvEa2umeY2ladlp7leFnmK4CL/eVQSSR3xU0Iujdu1wFKAYBHBPpirWhab/YtpHbWNuI7WIBY4YxgKtWZgVnWQKNucsD2prRWOukuROL6nQQ3Au4IJlDIZFWQBlwRkDr74q1NGrlGBG7+LHevNdM8Sr4UMdlq1rcz6dcTyuNQhO8QMzFgjLncAAeCM4x2rodRnudTigFjefZLR8uzx8m4jYcYf8Ah65yOfpRqcihJuy3RBrGpW2v61JpNqjS2NszLfTn/VO23iJWzyQfvDtjB60s0GyOREjXAGVJPQelYkV3JP4kk0HRIVS4Efn3dztylspyAzf3nYjgd+Sa6P8A4QSJLWZ7TWNUS8kTCzzTecFb+95bfLnrwMdaL3NFVjQ0vc5yzslt5LiS6t4s3JAklHDSBfu5PtTLvTj4R097jRjJcT6lOqWVpI+VExUnbntnDMSSO/PSk1FNU0+6bTdRCGfG63vI0wtxGMbsrnhwTyOnII7gdp4TjjktLdLkJIUO9dw+6xBGR6HBP500tDas1Kn7aG5kaF4RmuZU1LxXMl/fFVLQLkWsDD/nmnfn+Jsn6V2v2dVthsX7vQdeKklKIdjLhTxQzGJljydu371M89ybsVp4Y7mFopFQllwfRgexrz/SJYrCHU9Pskubo6RMYIkkQRrsAyI1bo2B369M8132qX9tbWrvI6CXGEUuFMjdlGe5OB+Nccs1vpUk7X0YVrmczShSWG9gBx+XT2zRY3w8ZSlodN4Ya2vLL7VawCH7UqzHKbHORxu9wMCtMyiIMkmCCDwTXMRxzWMseo6detPpzjHlEZCc9j+GOc47YpL/AMWpLYOdLsZL28UcxM4iz64Y5BpidGcm2loc3oesyR2+lYJkmuIGmSSUADYhBO49MhWH1wa9T3qUKoRjAI+leC6b4W17XvD19ceFb+CDTdTkI+wXaFJbBt2JlRh3yGXb05ruNA+JWjIYtM8Q3a2GtwJtuIZYyFZlJVijDKkZB6GgitUVRryOnXw3pDamL5rKJ7zJ2yMOUz1x6Z71uJEsUeyFVRR2UcVBBNDMEuLeRZIW6MpyKtLkjJPft6UXMakm9ytf3cdnB5jlQnUsxwAO5rjrXWLXWZbi+0+eKWwaYpHJGOJAoAJB6Ebs8jg1zvxp8QXh1HS/DelRSFLlln1O5jkKeRbbsEbgc5bkADng0/VoJRoNsfDjxrCiKsQ4AWMDHf0o2O/A0eZ8z0Xc9R06eCWEJBIjFANyq2SueRkds1O7usiALlTnLZ6V594OvJXg2SSqJyQ0vlY+Z8YyT+FdBqM18stskTTyRyuVbYOQMdSewppXMKuF5Kjjc1E1mylj8yGYSRhihZeRkEg/qDVy2uIrhN0LBgOvtXEJoc2mqLVWKxbdkTjpzz+f1rU8Mt5N7JEzbi6Ak+rDrQ0rDnhoKnzxdzqaKTPFGeak4haKQH8qMn2oABTZoknieKVdyOCrD1Bp1FAGbpmi6fpcbpY2yRB/vHqT+J5p3lC3SY2sSm4wdiscAmtDg1Vu0w6SLhSO56Cne5opyk/eZZjLFFLgBscgcgGnEZHNQwDEajzC/fcampGZGsYVsqcDGNo6UCRTuGcbeDmpDUc0SyqA3TOaA9SK7tre6iK3ESSIR0YZrEsrjQrHXhpNqETUZIxNtCknb2ye30roHVZEKMPlIwRXOWWkWOi6xqOs3V0POvWWMNKQAgHAUH3po2pNWabfkvM6GaQRQvI3RFLHNVrG5OoWUVzEdiyDKgjmsPS9F1XT32SavJdW8kzSyCZMkBjnYPbFdFaGEQKkBAjXgAcYptWFKMYLTUra1p9tqemS22oRJLEyn+HODjqPQ+9eKaUbWXxJ/wAIpfWZdLGAXFtehNm+LcVwwHQggg9jjNe6XaF7aUIcNjjPavB7HxhbW2sXk2p6Pcx+fctbvPu+dljbarYPbOSB6fWnE68ApOXuPX9Du9Tto3tWxGN6AEd9uO9XvCWuxwRpp+pyJFuO2BnIUN/s59aoX7SRRK1rMGKklGXv3x+NebeJ/iBpUV5pljrOniFrmVmMpIMUKoM+YQemD6fWq6anZVgp0rS2/Jn0LJKkKIrOxPbHNFeReCfG2p6taXNzfwhrNpmFlIq4LwjgMcnvyR7YorKU4xdmc0MvnJKSOa8S+D9a03RLh/B2qxQ3aEm6Mq43x4JA/Agfma7D4T38WqeB7Ix3DSTxwItzLuywd1DEk9j83TtxUd9Zz+JtBuLezD2sV9G0M0sf/LJSMHHueme2eeldT4Y0mz8PaRa6dZwi2toYwixIODx1PqfeokyazlKrdu/f1MnxXqEvh7R59QubyRLe1jCJkcb3O0M5/ujIOfY1X8P2CWelWcVvKZAgDvKfvSZ5Lk98kk/jW94j0a18Q6Rc6RdyOlvcpgMvVfTrXOarZPJbyafHcRy3EWNzRkjBI6fQ0LU2o+9U17f8Ob7R3EgR4Z1eMEn3HqPes/xJO7WzfYQzzAhQRz19u9VdHsZtF0iSe5uAsaku4zxGoGSSfoCarroOr+ItSa5k1ibTfDziMwxWihZpu/mGQjKKcjgDOB2p9SpzjRldalC4uGt4UE7gXrxlvLHUgdTj2yPzrpPBE7anpdxbTg7kO6Jj1x3H0rm/GXw90nVbKSXQ7y/TxHYhpIZWu3cyMMNtcNnhiq9BW58N5J5dH064liWO7mgDyoMgBtvIH40kJ1/aQcXGz3RJ4ZddP1e5S223FvfXUgnuu6zqMeWfZVUKPp65r0Fn8q3UoA4HBx2rzjwy0eh63daTPG0Nlf3Lz2r7sgTN8zxYPfIZx7EjqK7K2uImZkhkZnVtpGMAGnc5Jx5tOxneMgdS0KWWyheTVbAm4tYQQplcAjZzxhgSD9c1haPfxajpBkuVms5Eby7iOObDQyr95dw6/hXWT25aZv3RJHJPTFYs+muRdJHDEIWIkXy1w2/+Ld2IIxj6UJmlJJaX0Y8+Ibm3vlkvbcT6fMR5NxbAt5fqJFJyPXI49h1O9HeRXtktzb3EM0DD5Zo5AyY+oOK5/R12wCGRQUO47GHIb1Fcb4q8DS3l5YJ4Y1M6RcT3SvPbrKY0nQf6xgB/Fjr2PGexp2vsFanyarobOnavDq0l3dxsJ/JupIoxlTs2HaCME9cbs+hrRi0yTxBas0iBJFOWDcZ44+lV/Dfwu0Hw3NHNaWkxuFh8kzeeyhhz1CkAnnrjsK7LToLexVltrZU3gByBlmwMDJ6kgcc0X6BHEyjD3VqcVJqE3hS9tNNv7O4awvZBD5qoWjRm4U7hwOcDnHXjNa8OlW8csqW8Y3E5OT07/lXTalY2+o2clrdp5ltMuDzgjuCD2IOCD6iuT02SaF5bS4nB1K2bbLkjc6g/JJgdmHP1yO1O+g6OIlKTvuyv8ELe7t/BPm3YbNzfXNwgbgrG0rED/PrTdQsdK/4WVJMloE1GWxUmZlGZEZyPlPqNh496m0jVbmwa40/S7T7R9njEnlSHylcsT91+RkDkqR3HvVnUNHf+3E13EjXaW/kQxOQywA8tt927n27VW7MIQaqaoLy0vrYRw2l/NahXLkRqpEgx905HHrkeneumMrCzXczKSmN45wfWsmwaS/tYzdFlmYbSFGCPcelbkNpBDYrbJuMKrt+Zyx/Enk/jSasPENJ6rXqeQeEdOmTwkkfiSFpNTud0907E7pJCxwTnkHG3jt0Fdt4K0CCGyGo3UEnmzr5cds7hkgjDHGB0yfvE9ecdqxHv4Nc1DXIYkeOXTLtrSTcPvMFVgyn0w1dt4RWf/hGbAXh3zeXh8qAevAIBIzjGe1FzbETtQgosg/4RXSMzNbWlvGZjlzGgUtg56jBrctoEghWJFAVaR2aPb5ce5e+04/Sl81vNVdh2EZ3eh9KDglKUtwnhWaNkcAgjFeJeONR1Pwd4hs9QuJL6XTx5qrFaozmR2ChAR65LY969wGcc1514/klvNTiCRyrBYMk5lwjLI390ZyRjPXj60LU6cG5OThHqX9J8WyWuiRz6zHMJSxA8wKjEZ4yASM/54q5L4ztxbQzRWk0iSSpH8vJVWYLuwOwJGfbNcvemx123gtWDi6dTIsaA7iBxnjp179ap6Pper2OpvvieLT40ITzFwQP59c0HfLCYeUXd2kdrrmrXtzo8i6UjW923H71Tle56fl9a43wZf+K9G8NPP4tv0e9eQyLGoBESnpHnPzHPf/8AXV3REv8AS9GEN7dnUb1TJI820gEs5YKMnoAcD6VLdWtnrqxw3DtBMoywXoQfWmTRoQSTlsb/AIT8XQ6wpiuQILgHC54Df/XrrM56Yrh7vw/b21vGtqhVEA3AHv61c0DVLiCd7a9YPCAPLfOSB70NHNXw8J3qUdux1RJ3qAMg9T6Vz/jHWbfTNEvpnniSS3j3EFumfu5+pxUuq+KtF0wXP2u/iEsFv9peFMvII84DbBz146V4l470y18Y+BLu8lt9Vt5LiVr0QByHcjOzeuCSMYwvGM9jSRz0KTk21ujpPg98UI/EdnGL7bDPuKSxbshW7Mvcqa9lByMjmvijxhor+G47C/0bSNT0nUUMUUUqTB18x1+40YySx5yAMV7N8JPiD4rujDa+L9Ga2twuz7QSN24dOM55+lI0nSdR2S95b+f/AAT3EthgMdadTFYMAy4IIyD7U2OQEAY2n0NBxjzwCfTmq80cV0Ak0KSIMP8AOAcEcjisDVvGmnWOty6NETcarHB55hXgKD93ce2foaXQtTv9SM4vFtLZiAYxCS27jncTj8KaRtGjNR57ady7quuWFkGS5mIPdVGT9aVbcXVsl3YTOfMUFQW4NcXLbtcmYEkyM2CzHn/9Vd14atTZaLbW7bsxrg7vrTemx1VqUcPBOL1Ldq7tHtmx5g4bFeV+MPs9l8QbbTZLMtHqEL3CyHlVZCoOPT736V65iua8Y6S18trcwwmWe3Y42j5tp64/SkmYYWq4VU07XMBEQWxjUhWH3dvPT2rmNf0e3e21zXNZtLQ28WnS2cImUMH8wAl8D1YKv4Guq07RbyWeSeeGWJiOjLjj2965O+0zTNG8Vahda65u7y7xJAsrsogjjA+UKTtwGwQe5PtWi3O3ENTtTi73Y3wXpt3o3hLS7KW3k88RlpPMbJXJyFz7AgfhRW/o2s6fq8DXNnP5qKxjYJztYdQccUUpKnf3tz0IVIwio22Nfwjpun6BpCaXpETLawrsVSSTnOSSTySepq8uJHGHD7ThlH8q5rTPF2nR69Pp9n5lzcW3NyVQhYyRwDnqSPTNdDNqtkdKfUYkbYJMzEceWOhZvQDqa52jyeX2fTQsmIbDtIwD/SuV8S6b9r1TSr7Yolt3lSUhipYFQFOAcHkeh610+l3trf26XFtLHNHIN6ujBkZT3BFcX8R7+3h1DSore8MFwlwrytG43JB1fcD/AAnZjPrjpQtxXS3NSSFri0mtL2NZbSZdrxseHU8EV0FjMY49lxsCL8kW3kFcDH4+3tWLNPFOhe1PmyDDBSQCUPtVXSJLgTSfactG5wpPPvT3R0ypqa5uxNpskGiXF/5A1G+hMm/91F5qxuOsYIyQeh5HfvWV4ZgvNHimnkhZEuLyW4WMycokjFtuMfLjOMe1dXHL5EMgRAvO5gB37k/lXLJ4il1K+nGi6XeanZxfI88BjSIPnkIzEeY3+6SBii+pjfllzTZd8XaTJqcDTEGOBwHjnib5opFOVYEdMH9M+tXvCsjaozaoXWO6CmC6giYtGkoOCVP4dOozzVixuU+zyWrf6tiQVbja349KpeCWntNQ1ixeKVLUMlxC7YIBfO8cejAn8ab7oKjcVdenyOzcZVCzAuBjjvWN4gkgt9I1J7k+Xb/ZpA7Z2kAqehHf6VrvNCYctxIozkd8VwUr3fiTVvtdxKn9lRbTb2m3BVxyWlHILA8AdB6Z5pbmME37ti14Ck8/QLKzaWQ6jb2kYYyHJkIUZ3e4pLiRF8W6TLNlQBLAoHUSEKRn8Eap7G0TTrtbuFWHJOc9P/rUeLoba5Kq5eJ5tsitEcNG6kEOD6ggVW+x1OCu4R2a/I7azuRcxtlcMvBBqrM5Sfy8kc9q5LRNbnhvLTTtYmii1WQt5LKwAu1XlmAHTgjIPfpmuq1W5tIPLkvJhCjA5ycdBnNLc4+XllZdSGLXbQ6w+kM5a5SISvgcIGJwCegJwTj/ABrjdP8AAmkeGdUv7uygka+vWLPeXMplkKnkqGboM84rnIribTbsz21wLuO6naQ3DDDyhm+U5xzhSoHsBXp2juviDRfL1KLBbIUq3LKCQGB7VXkzd0fYclV9Thbq3urO+a9gmZ4l5IycgjtWxD41sxZB728t4nDBCm8ZYnpheuTkDAp2o2mmaC0/m3DpezlIoTLKWTPRRg9Mkjnual8EeFY9Lmk1DXjDe69NzJcGMYjUfdSMc4UfmSTTN69dSgny6/oWLD+35ddgmt7S0tNHVczy3JZppOeRGoOAMd2/KuxDxJgb1Gfeq7OGiYqCCKppa+ZG6F2ZipG49RSucElztykzk7y+lmvpTbR4WVi2QMcjjn3wBXR+DbWe1tr15ZS8NxP5sUZH+rG1Qw/76BP41wmt3k+k38unW+mTC4Ia4MijbE/uWPToM+9ej+GZhNpFuTkMVyc8Z96djsxi/cRscMPEmqw6w9mZS1/K+9gFyltb5PzEdN3GAPXJ6Cu1+1iaza5hmMJ2lmVj0/CqOuSf8TJo3jRVUAKQRluM5x27/lWZFILq6S1VcmXg4PG3vTuCpRqxVS1v8jV0nxPDdWkzXH7toshm7cVxvg7xNBr2if2lNH9nS5kk8kPyxQOVDfiBnHvW34t+HlrrugS2CX11bMQWXyZNqM2QVL45OCB3rE8mDSpdC0a5jaW5FsAZbdMwIyAAgnORntkc0eaFRnS9o+TSL/pHfeGbC1t7Z7m3jjElwdzvtwxx0BPsKuXk80VzCoh3QNw5xyKpaXPHAC0koSLaPlPAHPWtvqPakcVV2qNvU43V7dLO/k8p2dZ/3mHJIUdML6Vi3lpNGks1oA11t+Qj6/zrS8a2d3PqduljIyr5e4k8KOeAT6nPT2qC6vBptlG867zwCVHQ4607Hq4e7pxad2VbS71a6Q2dqLY62EDvDNNsKxk48xgMnHtjmuy0PSRZ6csF6EubllBnuCoBkb/Adq4TQruPxHrJu7RJLO/sgu26VRuePPKNwcqf7v48EV1uo+JJooriOztUe6VGEXmttRnxxk9hnFDfQ5sVCs5uCXnoYFpoyaN4n1q+vIw0l9MoSfkkQqoCp7AHd07k1eW3t7y6iS1dZt3LbP4QDzmtrR7yPWbOFdQgSO8CBnj7c+mecVqWVha2MHk2cEcMXJ2ouKVzNYl042tqYXinwpZarouowwRJFezpuSZR8yyAfK34GvLNLN1qumQ3dqjRMSVmjPDI6khlI9iCK96CgAAdq4PVdLXQLq9vAJHs7qdpzhd3ls33s+2cn8aXmPAYmUKjTe5q+G83tjbLcXLiSA8xq2M4x1rb1KeSGwuLizjSe4RCY0L7Qx7AtzgVzfhq4jW5UQYaKcEnHOeMgg1N9jg8KeF9RbTknmZvMnhtpX3HzCMhF9Bn3pmWJh77/A5fR9DNq9xd6kYpNRvZTc3kyLtDMRwo77VGFGewrr9BsYHu3uEwyRgJtzkBuuceuMVyw15Tb20eqGG21Jo18yOJi6BiOcHuM9PWuy8KTWs2mGS1VUJcmXHdsdT+GKGdOIU6dFJKyLzaZaNdLOYgJAc8cA/hV3FRySKkZkZgFAySemK4R/ijo6+MYtCijuZ9/wApuYYy8SvgttJHA4GeaLHnJTqeZ3/agiobe4iuI98EiyJnGVOefSm3l3FaIrzHAJwMDNIhJt2JZY1ljKOMqRg1geLfDkGvWEMMvlkQPvCypvR1xgqwPqO9bMd0k8LvbsJCpwQD0PpWQfEtgL2603ewvreLzJIwCdoPTJ6Z5HFNJ9DSnGd/d3RxcfhNoZEGh6hcaVZxoY1tbVIjEDnJIDKTn8aKZZ61KdWu4ItoVOcbhn8aK6HGL3R7jwc+hg+FJFm8PnUINMvrWeZ2nlhaMtKGPHI78AcDp2ra0TXIBMFtpGSTrLFNE0e8Hj7rAGuujuEtQxDIVU8qQKLiGy1S0b7RAksUg5XHI+h4Kn6VxNnCpySs1dHFat4OsvtUF5osl1o7oMxnTmCKM9Q0ZBVhnsRXA694e1qDXrfULq9u9WgsopZImkjVATtyyPt5IZQVxgDJFeyXlkunW0Ulo7SW7AIpf7w9ifWsXW4We3jezRjPKwVV4xkkDn270XH7OE4dv+AclZa/aWmrL/a1pdwSSxQrbzQW0jR7SoHUKRg4B56V2Ph/WxeNJaXSGyvUkbakq481RwHXIGc/pXVahpsV3DFEpOI8DCEqGx64rI8a+FrfXfDcsVxABewKZrS4iwskMqjKlW9zgUcyRkpuK3ItetrldG1IWcZnlmtpEWPg5JBHH51rRQR6daxJBtjghjAwAFVQB7dMVneBNUg17whpd0Lnzrx4F87cNuZAPmx+OaiutftdK1y10O+gvJH1KQ+VMUzGuQSVZieOnA9xQ09inNaSZS1HXNMvddMMs+23ZFV3j3K3mEZOeMFcFfxzXTaZpL2CSyrI1wjqoV92Rtyf8etcrdeFRHMqQWcbzSSbpSmUBXIG4t3woHHXjFd3o0kVtB9mJwi8KD/Km7bFVJpU0ofMzdVMKWMouJRHbyKyMzNswMHPPauN8ATQxeG7G2i86K8Cs8kM8u+RyxJ3buhJ6498V2PjrQE1XQb62ZmWKWF1JVdxXKkZA7/SuH0xYbaSyntnZowqOgUYQ4AwcDp0oirbl4dRq6p9DSfUL06/Y6VpcSySTq0880xOyCAEAnaDksScAdOpPSuouNAzG8sV1cStn5POCsIwOwAAOPqTVDRprGXxHq6oDHfrHB5gY5HlEMVx7Ft9ddGCIN8TbgRkr1pp9Dnq1Jc3Mcbc2Eb+KtEa6s4pRaiaaOaSJyYztAyrD5VJycgnnsKy/i5fSTwaTo1nbvN/aUrJJIj7WigxiQg9iQ2M9OvtXaanDLcafdQ2jBbt4z5fYE1y2tabD5GlapfRy/bNNkEaup+UrINjbv8AZyQfwoWmoNc3vX1uWLXTLY2kaRQR+fGgjjyOAFAAB9Dgda37O5S2itlneOK4dQuAPlDY6D8ayZrhIoHdV6jGPSrdpBDqGiCXWGEKKeJfM2kc9z074qk7m9ZaLm2MH4o297ImlTaPZ213rIuFk8q5fEIjTlix7dRgjvitifUNT1Owtp9Nit4LuKVRdQTsCDGOu1h1+vHvioPE0Kwa7p1wbRGNxC1sLgONxx8wjx7jJyP7ppkltBcSrbyqQHA+XHHHOM07szowUo819Udc0kKxJLvXy2GVbcMdOuawtM8VaVqOsvY6dqFrcXS8vFG4LKM4J/OuRgttA8Ka3ETDbwSSlvLZ3LHJHIXJ4z7Yqh441axjj/t/RWSHW9MeI7lUHfE0iq6Pn+HDZOOmM0bk/V5Ri5bo9XvbCO6+WXDJ1KmmzRPAqPGVVUHXoMVZWRJVUhx83T0NeX/F7xMI4pfDtrFcz3E0as6woSoBbozdF6d+3Y0GNPmk1E6XU7hdTc3NnbyxclC0qYZtpI3D/ZIGQe4NcHreqan4fEmrWxjZLZxiKQ7d43D92Dzy3IHvV/4eeJ5/EMzwQQ3UltBEbdrhYQLYzKefLfq2M49OBXW2HhaxE0d1q4bUbwfxy/di4xlEHCn35PvU37Haq6pUnTWvQbZeKLm4023W9s47O8mizJEJd/l57bsDNc3qP2bw/cW7x2n2iWUMTO2C20nJUH8uKjl05rGW8srEzzwW9yTFNcOxZg3zFNx5O0tjPtjtVDxXdTWepaBa2au2pzGR4HSMzCPauWV0HJjJwMjocEdKq9jWHs6VJVEtH0PT/C0m63kB8zHmEgSZyB+POKk8T6v/AGRZiUFRkHr/ADH51leDrq/fT9Ot/EASPWzBuuUgHybu/wBO1ZfxO1FbWxhRkVkju7ZfnOTJ5rmMge4zmg4FFOqnJafoPsdRW/WSVpCzEclutc1rPiq0k1q80OCK7vL2ODfI1uMRwbsYDOQQGIOQMGl1OyvNL8PalLYTJBP5REMjKSIiTjeRzkDOcd8V3HhXwdpfhrSXs9Oj3TTt51zPKS73Evd2J7nn6UjtxFWNKajHb9Dm/CN/LbXj2GqRPFdiMTwyMAPtMLHhuP4h0YYGDz3Fa2sSbVWSKEEj0qXxpZXF3o0F5pqONT01yUjVQS6sMMvJ6dD/AMBrnvCN3reqA291aFmVx+9l/dlVOd3bnGOB70+g6DcourJ7fkarXKRRg3Ur28UsZHnKxDR5GOD2NNsvGtxpmr6Vo+qWtzdpc4jXUkQFZGP3WIUYAPr60a9YI6Q2U7SNGyNN5oG3btIwvU5PP6U7SbizFjHZq7o6H92xOcH69hTVhTpwrx5/kegn8KQqCMEAj3qtZmZ4x5wAx+oq1UnkNcrKrWcIX9zGkbDptUAV5l4y0vXpms57h4PLtpJBNzgyQsv3l9Cvp3r1fFVNQihe3k+0MqwhSWJ7D1zRfobUa8oO54j4Iu9F8T6Q+qaWs84glaJmmQxncPbv14q5eeLtQ8N3G3RdL+2SFkWS0YlQ6k4JDdiM5yRjr9ar2Gm/8I14xsoNMuGk8K6hbyImGMgFxvL5Ldt2W+pX6VsaloA1fU7IwzPE0bjIXnI6k/WjqezTn7em41Tbvtcn1SG5sdTFpp1jcxIIJFuf3kmRyMEYGDx1rEuEsNCsILOxtPLhj+VQOmO/1J9e9emW1hayWoWS33IV2lJlB4+lcr4s0mPTfsLWlqHsnk8qVTz5XBKsPbIx+IoXmcOFr04z5WtBPhlFNbz61E2TayzrcxZOdpcfMv5jP413Txo5G9Q2OmRXGeGbmK21d0aVcToB6DcO1dp+VM5sVDkquwgjUAYUccjiuM8W3VtBq9tYw28Sz3Ub3FxMuA+1MBc8ZOSf0rtcV5b4g1dU8S6nFdSqUEgjhPUooRcj2+YnrRHceChKdZW6DfD2kabr0moXts7SGG4a1l2ZAEi4Le35UV1nw/0+z07QPK05NsLyvMWJzuZ2LMfzNFRUu5PU3qY6vGbjfY878S+HZdU1S3uEv54ChA8yNvvc+5I4BPb8a6nwvdLGtxbxyiVbdsB+A3I7j3rlLGeY601qX+WI5kgdhjHHOOufQ11kunRE+WZcxSEMh3YIP16gik0zWdNJ6Pcv6vZW+o2Bt75pYI3ZZElicK0bqchlJ4P0NcJrfiCHTrqbTNSuDazSRSNY3EZ8xbhVH31IHDDgkEDHuOauz6LczK1pb+Ir5pVJYW10sUwdc5wCVB9uvSix8G6QgFze232y6U58245ZT6KBwo7YFTZdTLlkk3HR/gdj4T1GSeI284EWoW0UZniZtxII+8D3BwefaneOdXTTPD87Bv3058m3jzgvI3CgenJ69hk1yWiXFoPEdxPaLcLMsfkfPIzJtUkgAZwOSfzrRvrG31DWIr64AN7bqUgaXJVQ2NwHoTjrTaF9XnGWpx+i2F/oNtYqrNIVhCbhyS2Mc9vWur1q9juvC92l9I8E0URlSaJQxjYA84PUDPT0rRje2uCqlF8wfLj19jXPatJG17JE7RgEENF2KnsRQ2ztcVWjyNbfodp4W1aHW/D+mXsF2khnijl8zA+bKjPAPByeR2q/qBihtWe4KIWOFOcfTmvJ9A07VtFkni0MxXWirEfJ04NskgbLMfKPRhyflOO3Nbmh31jq9iun+Ib5DOz7o4JN0LrgZIYHBz14ppJ6nDGlyfG7NHodleYgCXbowPAfsR7+9ef6QqyXGpWt6mJLK9lhb5eNv3lKnHTay101zd6bZyabayXCGe5by7SGJC5IA6kDOFAxljwOOeawdV1NWhmvZprW2UTvG+1852nbzxy3HQZ7UJ3CjyxqaOyKuviHStSt9aW1eTYFhkkQknyCwOQo+8VPP0zXWvc38d1bNYCN4Cw84k/w+orm7nWtLtYIoruY2wIyjzKUQnpjeeM5B4zmua+Emozy6h4g0/TtWme3tr5po0uIhLGsMhzhWyD94NgE9McUX6l1Go7a3PXTInmCRdx29DXO+OL61vNFk0tXK3V+fsh8vJMQcElmI+78oJBPfFbesMkNmwtpNkkwKISM7WI4OPaud0m0ks7MQahc/aXY5aUgKWPYAAdKEZRpqohkUdta2tzLPIsUEYLM8x+UJ3yT9M5qbR9IS88HR2OpRyN9tXzrgM3zeYTkkY6dsAdAK474i30N3pl9omnNJLLOY4pAqkxgNIoKM/QEgkccjrUHgjxnfWmt2PhKWFEEDXAkWYs8ojX5kZG6bcsV7/d+tM0rVG5rlPU11XTrSFNMWZHuLeFQ0RcNIi4wpYdRnB/I1U0fUEub97W9hBAO6OU4AHtUUtlBva6iRXkfCyMQN3tk9xVDSbRbrX5JvPfNoNrwo4KszAEbh1GByPrT5mhxpwjTl3DxV8M9G1u9vNSdZvts4iYfvSEDx52tgfUZ+grz/wAAaLMsd4dXInmjlmtrhWYMrENg8ehHQV7vayFlAY1x1xo8Gn+JdQuLdgBflJp4zgAuq7c/iAv5UXJwlWUJOHcwNLbVtK0yWwsdXaSMzO8MtzF5zqjDhRzwVP3T09RU93pULR2NtftdXBv3+zmRskuSpLFyBjOAf0rTNsikeVGsYU4K+jHuap6gbq+ZLVdiXMMi3VqzybAzoeRx2KkqeD97pQjpcFTTnT3O3sdPsbCGK1so4IIY1CxQphQAPQCm6hdQwFwGVZD0GQK5G+0651Ka3vlSaz1eyGxLeSVG+VicPkEjP3sc9qp6XeLqyNPK0zz28rW04b7wkjO1v5Zz6Gjoc1KhGTT5jQ17U4bOxuNSvtzQWyb3CkZAHUDOBn2qb4eW76hbTeI7y2kt7q+O2GGVQHhtlJCL9WOXPu3oBWJNNY6p4ok028Qy6fp8SXV2hTKM7HbEGHcDBYj2U16dCVMS7QNpHUHii3UzxM9bR2RHa2NvBK80cYEsnLN3Ncd46hiu/Eeg2cpBQebeMh6Fk2qjfgXJ+uK7hFVAdp+X0z0rlPHt7Z22lPfmMTzWJBJQZeNGIDEe3c+wpsxpNuab2M7WrmK1PlSY+ZSuQcZrsNHuoLvTreWA5QxrwxyRx0PvXkHjMuwgkLszdQvI29OlR+EddtJ9fl061uXku4ot8iI3ygeh569/wpbHrYnCRnTjLmsz0Lx5d38enPB4eggnvpmWF2kk2iGNjhn45JA6D1pfD6ZvVCZDQYVxkZXjvj1rNs1MusmC3kEkwUPtU5IU9z7da7WztEtoy2weawG5upOPeg4alqMeVO9zi/GU0EfiC10/yId5tJrtJW++G3KhA9sNXP7LewmsY5vPkuLqdI1SJe57kngAdST/ADrrPGVlZ3GraXfyxkTWySoJB12PtyvX1Cn8KNK0aHUryO5ZmEERV9qnksDkA+2Rmi+p0Yeq6dBt6HaIoRAvJwMZp1JzS0zyQqK4gjuIZIZlDRupVlPcHtUtFAGRb6Bp0GnpZQwBbdAQqk5x371FY6BaWtyJUZnMZyoPY471t1EFYS7l2hCDuGOSeMGhmntZ6q+5LVXU4GudPuYY9vmOhCFugbHGfxxVndz0xTXcKuScelBmvI8q02Q/aNk5gj1eKNXuY0bcqMfvY9cEEV6dZ3CS28TLIJdy53LyDXi3xf8Ah9r+u3ZvPCEttZSc+bLBI0MhJzv3Y4YEHPrke5rqPAemHwlo1jpiO08FpGIxJt27vU47U2d83LErXoel15F8SoEi1Z7qWLJLgLjvx3rZ8c/E228H6fDf3tlPPaNOkMjQjJTdnnH4dK4iz8cad4r8Y63b2tzDc2EEcc8JUENgjDhlPOVb2HWnHR3HgX7GulI9D8GanAmnJGJVQ7c7G4A+lFcxoOp2moGQ28bYj+XnjiinJ67HoVsFGc3J9Src/D9Nc1s31zd3MUscokje2kMbgY+6W7jrx712lholpa2rW0YnXYd/7yRpMe+WJNcbZa94i0W1hbxBpURkG7zZbK43pgd8EZyfy9+1aFp4w1O51e3kbThbadJCrJdTtlnyxGMA4HA7+tc+q3PObk1z28hfFdte2Hk32l2kd1chwMGbYq9tzcE9OcCtyxiuLpYr25+zOs64HkIybHPqGPI/I1oCT7XapOI1VZMkKSCfrU4H7kxq4G0ZIPWi43NyS8jL0/QtUsyz3Eenzyu3714d0e5ecHac4PTvWDqdv4mk1/yYtNsYdNfIa4kvMuvPVUC9cc4JxXY2V0LO8le4MhFwRgsc7QOgqxqMlp9n+2CQBVODjPX6UyFOopJNmKPDq22lbo9Ql+0upVZ5UDlX7MQMZx+Fcbq2gS6XcRT6pc/a7hiA1wIzGjN/ESACF+Xnk4OMZr0O11K3vrN/KLNGDgq67TkdxWdrMtvKiwal5D6Q8brcCTuONuR3Gf5ihbmtOdSDbv8A8McxZMtrexlOCDuOO1dHq9tZahp4u5YElGQ2JVyof1waw9TgUAtsIJJAIGFI9qs6HqhuLZrC2glurd1JE8K5jBHYN0J9hmheR0VnFpTZYsbm2jvPtE8Ue/y/J89UG/ZnO3PXGat6B4cs7XVBrVxHHJcksbY4+S3jc5wi9AzdWbqSfTisV7eGa4U2lwC0e0vExwyjvkda6bS9ThvbaSJI5F+zstuWcfKzBQTsPfGQD70PRGGIhF2a6mte2NnqUEsEqxyo4KvDKoZWHoQeKxdG8O6d4fjkGm2kVvG5G9UUDAHAH0FJrWpxaLZzajds6wQjJ2qWZj0CqB1JPAA60/wzqlzrWlWt1qFsYLq4dyYVGPKTc2zeCc5wBn3NTuY6wduhZ1qWGHTfOKjKyLtXOQc8YFcJqWuXy6TdRMCly0kcMLhTmMu4XOPQKSfwrtPGFjc3ugXtvZsYrrZmFwAfnUhl6+pAH41k201pqemwIFS11B03YlT5kcdmB9DkVpF6GtKXuyguv4HU6fZwWMEUUMSqiD7pGfx+tcf47tbeLxToN5DGqytFPudQMsqhcLn0+c1en1bUoNUhS4NsIQpDx+WwZvQhs4x7YrMguLvWNQkm1azgtHjDW8DQzGVQhKkswKjBJUfhUrzJhTkpJtaFuDWBBcxGIKRJhOTncx42111jp0VgrvEi7p2MkjY5J7c+wwPwrz6DTrazvXuWMkrWEnmKAPkZ3BUH3wDnjvXaXM+oyWaQoYUO35pi2Nv0q9OppiYqcly7FmObN2373YozyTgCuYvtLfTZ5p47mW6aeTzZJZCCznaB24AAAGBWBol1ca9Jc3Za7SwR3t7Yy9Jgp5mGOoZs49APet7w/OyJ/Z+pSJJGzYjY9VJ9aSKpwUV7VdBttqiXtxNaRlZNRjiEnkg4LKScAnoMlTzXL+KYoPEHiO10K7jurK+sj9vQNwZIgNpKsD6sAR7V3OieFY9Fku53JnuZ5WZrhupXcSq/gDgfTNO8YX0VqdDn8lJbo3yW+CPm2OrB8H0AG4/7tTcyqVrv3djzzX7ySx0S7ht7q4327fa7eaeQyyROvIClv4cAjBPQ4p/hzw/qfg/VLlptQF9oV0TOsQRhJHIxGWB5wP8AZ7djS/EPSmi8NapcRqTKkErAA5ONpyfy5/CvUPDaxT6Tap5cjQvAjI0ww5G0cnuDVqxrX9lTmpRXQ4+5sbnw5DquubftQuSrCFSRutlGAHz958ZI6DPHvV3wB43svE3hz7TocM1vBC7QotwPmOOnfpgiuznj86N4ZkAXGAcda8ui8FXng62WPTrSfV7ed/3iRuFKnJIb5iPUDr2FFzlhyydpbGsPGq2Otpp2pXQiL7BHcSfKJZCGyG4wOg6VV8UTX7aVqtpD5ZvL23ZYblcCBNy9zkk9ewNZ/iLw7r0huJbvS7SbTTEJHElxskReAyArnORknPHaor1re6uIrLTbmFZYUDJbOdrGLoGC9SvGM89PWi510lTqSai7R7mf4OguNUujoPiJjcjy/Kufn+dUKnbKsgA3A7SvQEGuy8O/Cbw9oeqDVY/tl5qPTzppycjoPl6ZAwM4qv4L8PTNrd1fzo0cSwpbR4OPM5LFvoM4H416YirHGsecbRx+FJHLipWlZO9iKKJILXbaQCPAwEUAVZAIXBOT61lazPqKRwHSYoJWMoEiyNtIT1FaitlQTj3qjkktLnDfEzTLK9s9Plu7t7VLS8STCOR5u4FdhxzglhVPQNeh0bUo9PdQkTnaVGePQj8Kw/F1/ZJ8VtF0rUbp2kuWe6hEcmBGI1OFYd87j+Wa6fU9GsyvnSlWlzhZM9u2aD0qEafK4S1T/Ox3SurIGBBUjINKrq2dpBxwcGsvQ2EunKhfeijGfSnaB5508NdwCCZnYlQc8Z4P4ig8+dPlv5M1KKM0hJxQZmT4h1u30PS3vZw0kYYLhOcknFXLa5ju7WGePJWVRIuO4IyKiOnW1xazRXEYminO51cZB/zipUghSSPY2zYu1YwcDH0pmnuctlujnvFN3qtnqumTwzRQabu2z7iMs5PC++egxVO6ury9O4yMmWyVHAUVP411m1S7g0dWVr94vtXlFeRGG2hs/wC8cVl6ZcyuiLeHbMeE2jJPsaLnfhlenztLQnbXZ9OvVsGXzDcQSTFj/AqAZY/99CucjmnvVhvLW6W4spF3IyHIYHuMda9J0vSo4VE91Gj3jptZiPuqedo/Gsm28JC01Z5IJ400tsv9lWMLsY88EcYzzQFHFQhORiXVtHd2SGeJJY2GHRlz+Y9ag/s/SbJzLDZWsV1IGEkiQqHIJyQSBnnrXoCQ2UEKIojCMcLznJqrJY6TO7eZbRtvHJKnB/pTRP1pN35TyzSdd0izubmOU2dpGD8r7x8/Pt9KK9QsvDOj6XA0elaXY2qO29gkKjJ9TxRUyqa7DlmMpO9jCvRFe2ptrm3JWRSGz78cEVyWkodMnm8N3ZuLhoY/PWaSLbGyMxwik9SOmATgY5rv4LMGUwn+EEqa4jXdSuS9uZrZEu084OchtuxlBAPvkHmp5bipxbkkjHkt7bwVI+rWlgZrcEI3lEb4txwAoJAKkkAjtXb6XqaatpkGoWoxbzhlwxBKsCQRwccEEVz8FvBrFo9rNbR3EUqbmhuTlWI5GcdsitT4Va7aeLdBvVs4Y4FsLh7PEaFEbb/Eq/wj0Ht+FS4hWj7CdnsZvime90LSb/UlNxqdxJtit7TKp8x4ABP1+uKoeFda1eDB8Qrbyo7KT9nQr5eOoOSd3PQ8V1/iK3j1PTZoYjJ5scirIFcoQwOQQfwrlvDNxJcapqGgan5LahYIksjxphJFkBKsPTpgj2p8rNYyTfvdf0PQLi6t5oFlghVIWG7zeOfUV5p4x0ka1r+hahYXDS6dbYvPMRvklYq4QKR1wefxrtTp7QKYmxLCcEoelTW97BBCLA2UKxxAKI0GE2+w7fSmo21IVJr4dUcRcfbNUhi0q6lENpeTGCc7QSU2sSFz3JAFenRaTFp1jFDZIq20SBEQDAjXHYVzOs6Fb6ggjt8xx4EsLjrG6nKt+BA+tdN4euHaxjgu2JlJZOeckd/TnrRyk4h3fOjJv9Etr6dLwwKl0g2C4j4cDIOPccdK09Mso7C2fzbpp4vMMimRVXbn+Hjr35rQkh8mUhDlSMnNc/4htLwTrcQMsm1AqW7sQrEHJz2GR3waFHuZxtPS9jL1gwarI0MyArBLmJgM+W443fUZ/ImoLq6t/DdlDqd3cyiwtSZLkKecdMDuQCc471SttSuYNXFvdRowkCg7OgJzyB9ahXW7iTxK1j9kzpYlFo1wCpLznsVJyFAzziq5HtY6q8VRgoy05jp7jxfp8Fnp9ysj3UF+he3FvGWaQAZOBxjA9ea8y8OatHrk2s2iTXMOoRXczrDcK8cghaQsn3gDjGB7dK9A1KE6dKoUBbeMgIsYAwPYVH4h8O2/iWyt5YR9k1lSotr2IASDnJBPdcZyp4NTykKMqFqq1Q7Q1ll0o2l8v2iRVLQsOXXHRc9xQzqjtEqr5ijnB5qzbeD9U01S6av9qlDkq7RCMqvYADiqH9j+L38RT3Kx6TLpku1g0jtHKBg7hhQQecYJxQ02V9Yhfmvox91c/b4JbYeZBcKoyY2KN/vKfUVgeL4de/4Rm8RfEE1rJlWjlaJIyAD0ZwOhOOcCup+yMLtvPXbztOCM1S19Vn0e/wBPu4hcW8sTKqk4IJ4Bz6jP6U7GlSnFx07HO+A/EXiTUrcWOq6fDcxpPLAb20k4TaoP5ZIHvzXZaZ4b8u6ivtcaK5nRy1qI4yqQ+h5Jy2O/5CugtdPNnY20KbAqRqvyjGTgZNOvPtEWmS+XEJZtpMKlsZbBwM9vSla7OLn91aj4LwiPZJzEOGY8ha5LxFZXd7rypcIkdpZfv7X58tLJtI3tjoqhiAO+SfSs3T/Dd3aGaWW+mur+7cSXLzuSpIHRV6KBwMD0rrbxLmXRojFGJbqNcINwG/jgEnpRys2VPkak+pwOrXWof2ZJayCKW/nIigglYASqxwwOO2Cea9OS5gtbETyNHDHFGCwZwAnH8qo6d4Tsre7GpTRB9VeMK8jMWVMDog6KM57Vx3xBhuptftrNXdba1tWu3jBG24Zm2BXB6hcMcdyR6U32E6ixU1GJ2GleLdL1C9bS0ule+VSyqMncB1wa14pZBg9QT+VcV4TtEvfKfJt7qMkxypyPcY9K76SOTBZVjLgcDoDTaMsRCNGbiZWu21zqNhIlvM0JZSpKjd8vfisvRNDtbEobeIyTINqSSKC6cchTjIB7irujavc3ejNqFxbJDMHZPKjbIJBx+GTTNG1ua7dftEEIuQDvWEnbn0BOPzp8r2LSqRjKnbRGzcTpbW+5I90ygMYoyN2OnSsPxtrdzplmhtYTI8hVFGDkEkAE+g55qwgsrrytSu4JobhVDiNmGVxzg7SQfzonMutPZtbxw+QS3nM5IZV25BX1OcZz2zRZLYxjFK0uhk6nrscUMXmIVlP3ZV4K/jWpY6wBpAYymWbH3ivLZPHpXmPj3w38RVY2miHS9Qs5mcRTyv5MsGc4BHRsdiPbNeieE/Dd1YeGtFs72bbcWsa/aMNvLvjn5jz1pWNqk6DSUV6nD3vwvk13xm3ikXLRXLW/kBJOFHP3hjnpxXoGneGHhtkhu7rzFVQPlHJ+prqAoHQUYpWOd4qaTUdEQWlvHbQJFEMKv61N06UuKzfEKtJo13HHdTWkjphZ4cb0PYjIIpmGsnr1LV3dxWkTPMwAAJx3NcH401qa/jjhsryS1sgCZyi4dx6Bv4R1z3+lb1qx1bzmuOCi8d+PWudtdOvfENs02mx29vpbthJLglmnXkMQq/d59Tn2FM7KcKVGX73cb4P17bbR2Wn3RnCAkJMSWx9Tzj86i1W/vx4nt5nupIEx/qlAwx9/WmQ+HINB1G3jlYC7kR3Vo2YgqpGSM+m4cH1p2raSb2eG583Bjx25yO49KasejCNKU+eC0ZJPdy32rwQCNpby6RtjBCdqKRnLYwByOprstF0YWgWW62SXAGAccL/9en+GrP7PYrI4zLL8zH27CtfFSeXXrtvkjsJimyIJI2U5AYYOOtPFc7deJIpPNTTCJWid4pHdSFR1OCMcE856ccUHNCLk7RNJLVbSOGO3WJYIySS/UfSuDu/iv4bvb5NL0r7Xe3TXDQOY4XRIlUkPIXK42jBHueKv3Gp32qxzQvsjEfJ2nrWR4a029Rp/thjkQNwAcZqrdTvjg5fFJ7HR3Wp3Gs6fE3hy4huTG+Jd4wRx6cUVlrob2V+1zp7PAZ0+cK2AeaKvY6FQivhat5o//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power (40x) view of reticulin stain showing dilated sinusoids with cyst formation and reticulin frame drop-off.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Tracy Challies, MD, Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_24_31109=[""].join("\n");
var outline_f30_24_31109=null;
var title_f30_24_31110="Reactivity of paraneoplastic antibodies";
var content_f30_24_31110=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F56327&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F56327&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Reactivity of paraneoplastic antineuronal antibodies",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 403px; height: 306px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Reactivity of different paraneoplastic antibodies with the nervous system. Panel A: Reactivity of anti-Hu antibodies with human cerebral cortex. There is predominant staining of the nuclei of the neurons (with sparing of the nucleoli), and milder staining of the cytoplasm. Glial cells are not immunoreactive. Panel B: Reactivity of anti-Yo antibodies with rat cerebellum. There is intense immunolabeling of the cytoplasm of the Purkinje cells and of neurons of the molecular layer. Panel C: Reactivity of anti-Tr antibodies with rat cerebellum. There is a characteristic dot-like immunolabeling of the cytoplasm of Purkinje cells and the neuropil of the molecular layer of cerebellum. Panel D: Reactivity of anti-Ma2 (Ta) antibodies with human cerebral cortex. This antibody reacts with the nucleoli of the neurons, and shows mild immunolabeling of the cytoplasm; glial cells are not immunoreactive.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Josep Dalmau, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_24_31110=[""].join("\n");
var outline_f30_24_31110=null;
var title_f30_24_31111="Evaluation of mediastinal masses";
var content_f30_24_31111=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation of mediastinal masses",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/24/31111/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/24/31111/contributors\">",
"     Nestor L Muller, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/24/31111/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/24/31111/contributors\">",
"     Talmadge E King, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/24/31111/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/24/31111/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/24/31111/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mediastinum extends from the thoracic inlet to the diaphragm, and contains many vital structures, including the heart and great vessels, and esophagus. The evaluation and general management of mediastinal masses will be reviewed here. A discussion of the specific causes of an anterior mediastinal mass is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/40/32392?source=see_link\">",
"     \"Anterior mediastinal mass lesions\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MEDIASTINAL ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mediastinum includes those structures bounded by the thoracic inlet, diaphragm, sternum, vertebral bodies, and pleura. It is typically described as having three compartments: anterior, middle, and posterior (",
"    <a class=\"graphic graphic_figure graphicRef56637 \" href=\"mobipreview.htm?10/31/10743\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The anterior compartment (also referred to as the anterosuperior compartment or retrosternal space) is anterior to the pericardium and includes the thymus, the extrapericardial aorta and its branches, the great veins, and lymphatic tissue.",
"     </li>",
"     <li>",
"      The middle compartment is bounded by the pericardium anteriorly, the posterior pericardial reflection, the diaphragm, and the thoracic inlet. This compartment includes the heart, intrapericardial great vessels, pericardium, and trachea.",
"     </li>",
"     <li>",
"      The posterior compartment extends from the posterior pericardial reflection to the posterior border of the vertebral bodies and from the first rib to the diaphragm. It includes the esophagus, vagus nerves, thoracic duct, sympathetic chain, and azygous venous system.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Alternatively, the area from the posterior pericardial reflection to the anterior border of the vertebral bodies in the middle compartment has been called the \"visceral compartment,\" leaving the remainder of the posterior compartment to be termed the \"paravertebral sulcus\" (",
"    <a class=\"graphic graphic_figure graphicRef53534 \" href=\"mobipreview.htm?37/40/38531\">",
"     figure 2",
"    </a>",
"    ). In this classification, the cardiopericardial structures, the trachea and the esophagus, are part of the visceral compartment as juxtaposed to the paraspinal",
"    <span class=\"nowrap\">",
"     space/posterior",
"    </span>",
"    mediastinum.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ANATOMIC DISTRIBUTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of a mediastinal mass can be narrowed down based on its location within the mediastinal compartments [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31111/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The primary masses most often found in the anterior compartment are thymic tumors (thymomas (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef73685 \" href=\"mobipreview.htm?28/53/29520\">",
"       image 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef50638 \" href=\"mobipreview.htm?15/34/15919\">",
"       image 2",
"      </a>",
"      ), thymic carcinomas, thymic carcinoid tumors, and thymolipomas), thymic cysts, germ cell tumors, Hodgkin and non-Hodgkin lymphomas (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef80695 \" href=\"mobipreview.htm?9/27/9648\">",
"       image 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef63292 \" href=\"mobipreview.htm?11/5/11344\">",
"       image 4",
"      </a>",
"      ), intrathoracic goiter (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef64247 \" href=\"mobipreview.htm?20/60/21440\">",
"       image 5",
"      </a>",
"      ), thyroid tumors, parathyroid adenomas, connective tissue tumors (eg, lipomas, liposarcomas, lymphangiomas, lymphangiohemangiomas, hemangiomas), and pericardial cysts (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef75728 \" href=\"mobipreview.htm?31/34/32303\">",
"       image 6",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31111/abstract/2,7\">",
"       2,7",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/40/32392?source=see_link\">",
"       \"Anterior mediastinal mass lesions\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Masses of the middle mediastinum include thyroid tumor, goiter, tracheal tumors, aortopulmonary paraganglioma (chemodectoma), bronchogenic cysts (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef69147 \" href=\"mobipreview.htm?27/41/28319\">",
"       image 7",
"      </a>",
"      ), and lymphomas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31111/abstract/3,8\">",
"       3,8",
"      </a>",
"      ]. A middle mediastinal mass may also represent lymphadenopathy as a result of infectious, malignant (metastatic), and idiopathic (eg, sarcoidosis) etiologies. Thymic masses and pericardial cysts have been reported in the middle mediastinum, however, these lesions generally occur in the anterior mediastinum [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31111/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The posterior mediastinum is the location of most neurogenic tumors (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef51095 \" href=\"mobipreview.htm?5/50/5920\">",
"       image 8",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef63818 \" href=\"mobipreview.htm?18/62/19438\">",
"       image 9",
"      </a>",
"      ), esophageal tumors and duplication cysts, hiatus hernia, and neurenteric cysts. Extramedullary hematopoiesis, pancreatic pseudocyst, and achalasia have all been reported as unusual causes of a posterior mediastinal mass [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31111/abstract/9-13\">",
"       9-13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Aneurysms of the aorta may occupy any compartment depending upon their anterior, intrapericardial, or posterior location.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is important to remember that a mass may transgress the boundaries of these radiographically-defined compartments as it grows in size. For example, a substernal goiter may originate in a pretracheal location, but wrap posteriorly around the trachea and extend into the middle or, occasionally, posterior mediastinal compartment.",
"   </p>",
"   <p>",
"    In adults, masses in the anterior compartment are more likely to be malignant than those found in the other compartments [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31111/abstract/1,5\">",
"     1,5",
"    </a>",
"    ]. As an example, a series of 400 patients with mediastinal tumors noted that 59, 29, and 16 percent of anterior, middle, and posterior mediastinal masses were malignant, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31111/abstract/5\">",
"     5",
"    </a>",
"    ]. In children, the anterior mediastinum is found to harbor comparatively fewer malignant masses than in adults, and the converse is true for the posterior mediastinum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31111/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     AGE DISTRIBUTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The age of the patient can help predict the etiology of a mediastinal mass. In infants and children, neurogenic tumors and enterogenous cysts are the most common mediastinal masses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31111/abstract/15\">",
"     15",
"    </a>",
"    ]. In adults, neurogenic tumors, thymomas, and thymic cysts are most frequently encountered lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31111/abstract/16\">",
"     16",
"    </a>",
"    ]. Since both Hodgkin's and non-Hodgkin lymphoma and germ cell tumors are most common between the ages of 20 and 40, the likelihood of a mediastinal mass being malignant is increased among patients in this age group [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31111/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     SIGNS AND SYMPTOMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most mediastinal tumors in adults are either asymptomatic (found on plain chest radiographs or computed tomographic (CT) scans obtained for other reasons) or are associated with vague complaints such as aching pain or cough. By comparison, tumors in children are more often symptomatic and may cause respiratory difficulty and recurrent pulmonary infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31111/abstract/5\">",
"     5",
"    </a>",
"    ]. Severe pain is typically a sign of advanced, invasive disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31111/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Multiple signs and symptoms may arise due to involvement of different mediastinal or surrounding structures:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Airway compression can lead to recurrent pulmonary infection",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      hemoptysis",
"     </li>",
"     <li>",
"      Esophageal compression can cause dysphagia",
"     </li>",
"     <li>",
"      Involvement of the spinal column can result in paralysis",
"     </li>",
"     <li>",
"      Phrenic nerve damage can present with an elevated hemidiaphragm",
"     </li>",
"     <li>",
"      Hoarseness can occur due to recurrent laryngeal nerve involvement",
"     </li>",
"     <li>",
"      Horner's and superior vena cava syndromes arise due to sympathetic ganglion and superior vena caval involvement, respectively",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some mediastinal tumors are associated with systemic diseases such as thymoma with myasthenia gravis, immune deficiencies, and red cell aplastic anemia, thymic carcinoid tumor with Cushing syndrome, goiter with thyrotoxicosis, and parathyroid adenoma with hyperparathyroidism. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/51/17206?source=see_link\">",
"     \"Clinical manifestations of myasthenia gravis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/41/30361?source=see_link\">",
"     \"Pathogenesis and etiology of primary hyperparathyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     NONINVASIVE EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of a newly diagnosed mediastinal mass is directed by its anatomic location and by patient age (",
"    <a class=\"graphic graphic_figure graphicRef56637 \" href=\"mobipreview.htm?10/31/10743\">",
"     figure 1",
"    </a>",
"    ). The presence of specific symptoms (such as those found in myasthenia gravis) and the imaging characteristics of the plain radiograph (eg, calcification, central airway compression) may also provide helpful clues. Appropriate imaging techniques are subsequently selected, which frequently lead to a specific diagnosis or at least a limited differential diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31111/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Ultrasonography, radionuclide scanning, and measurements of serum levels of tumor-associated hormones may provide further diagnostic information in selected patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Chest radiograph",
"    </span>",
"    &nbsp;&mdash;&nbsp;The PA and lateral chest radiographs should be carefully evaluated. The anterior junction line, the posterior superior junction line, the pleuroesophageal stripe, right paratracheal stripe, aortopulmonary window, azygoesophageal recess, right and left paraspinal line, the retrosternal clear space, the retrotracheal space (Raider's Triangle), and the retrocardiac space should be specifically examined. Previous radiographs should be obtained for comparison with current studies. Small masses that were initially overlooked may be visible retrospectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Computed tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;A chest computed tomography (CT) scan, preferably with intravenous water soluble contrast material, is indicated whenever a mediastinal mass is detected on a chest radiograph. The CT scan can help define the anatomic location of the mass, determine its morphology and attenuation coefficient (cystic, fatty, enhancement characteristics, and soft tissue), and multiplicity of masses, and also relate the mass to vascular structures in the mediastinum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31111/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. CT angiography and multiplanar and three dimensional reconstruction can provide additional anatomic information.",
"   </p>",
"   <p>",
"    Although the CT scan cannot give a pathologic diagnosis, it will often yield all the information needed to direct further therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the evaluation of mediastinal masses, MRI typically adds little additional information to that obtained by a CT scan obtained with intravenous contrast material enhancement. It is helpful, however, when a history of previous contrast material anaphylaxis or renal failure precludes the performance of an adequate CT or when chest wall, spinal, or vascular involvement is suspected. A comparison of the roles of CT and MRI in the evaluation of mediastinal masses is provided in the table (",
"    <a class=\"graphic graphic_table graphicRef73333 \" href=\"mobipreview.htm?33/53/34652\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/52/3910?source=see_link\">",
"     \"Magnetic resonance imaging of the thorax\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    MRI is specifically indicated in the evaluation of neurogenic tumors, since the multiplanar imaging potential often gives significant additional information. It is especially useful in detecting an intraspinal component to a neurogenic \"dumbbell\" tumor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31111/abstract/22\">",
"     22",
"    </a>",
"    ]. It may also provide valuable information in cases of possible vascular invasion and in the evaluation of cystic lesions. As an example, bronchogenic and esophageal duplication cysts often have a nonspecific appearance on chest CT, but highly characteristic findings on MRI (",
"    <a class=\"graphic graphic_table graphicRef73333 \" href=\"mobipreview.htm?33/53/34652\">",
"     table 1",
"    </a>",
"    ). Finally, in cases of thymic lesions, chemical shift MRI imaging may distinguish between thymic hyperplasia and thymic neoplastic disease, and this could obviate the need for tissue diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31111/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H344103788\">",
"    <span class=\"h2\">",
"     Ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasonographic evaluation may be used to differentiate cystic from solid masses and relate them to surrounding structures. Although CT and MRI are typically more accurate than ultrasound, the latter may be useful in selected situations. As an example, ultrasound is used in the evaluation of masses and cystic structures in close proximity to the heart and pericardium, a setting in which an assessment of extracardiac and intracardiac structures may be helpful [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31111/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Both transbronchial and transesophageal ultrasound may be valuable in select cases, for example, when middle and posterior mediastinal metastatic cancer is suspected (",
"    <a class=\"graphic graphic_figure graphicRef63771 \" href=\"mobipreview.htm?0/10/167\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31111/abstract/25-29\">",
"     25-29",
"    </a>",
"    ]. Transesophageal ultrasound is helpful in the evaluation of posterior mediastinal lymph nodes. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/16/12552?source=see_link\">",
"     \"Endoscopic ultrasound-guided fine-needle aspiration in the mediastinum\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H344104020\">",
"    <span class=\"h2\">",
"     Laboratory testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Selected biochemical studies are indicated in the following settings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Thyroid function studies should be obtained in patients with known or potential mediastinal goiter.",
"     </li>",
"     <li>",
"      Serum calcium, phosphate, and parathyroid hormone levels are obtained in patients with suspected parathyroid adenoma.",
"     </li>",
"     <li>",
"      Fractionated 24-hour urinary metanephrines and catecholamines, and fractionated plasma free metanephrines should be measured in cases of suspected functioning paragangliomas (pheochromocytoma). Twenty-four hour urinary homovanillic acid and vanillylmandelic acid should also be measured to identify neurogenic tumors of ganglion cell origin, which may produce catecholamines. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/14/23786?source=see_link&amp;anchor=H10#H10\">",
"       \"Clinical presentation and diagnosis of pheochromocytoma\", section on 'Diagnostic tests'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/15/15609?source=see_link\">",
"       \"Clinical presentation, diagnosis, and staging evaluation of neuroblastoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Alpha fetoprotein",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      beta human chorionic gonadotropin levels may be elevated in patients with nonseminomatous germ cell tumors and should be obtained from all males with an anterior mediastinal mass. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/40/32392?source=see_link\">",
"       \"Anterior mediastinal mass lesions\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Radionuclide scanning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several radionuclide agents are helpful in the evaluation of mediastinal masses.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Thyroid 123-I scanning may be used to define the nature and extent of a suspected substernal thyroid. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/2/46?source=see_link\">",
"       \"Clinical manifestations and evaluation of obstructive or substernal goiter\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Sestamibi scanning may help localize potential mediastinal parathyroid adenomas. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/60/18377?source=see_link&amp;anchor=H2#H2\">",
"       \"Preoperative localization for parathyroid surgery in patients with primary hyperparathyroidism\", section on 'Imaging modalities'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Scanning agents, such as (123-I)-metaiodobenzylguanidine (MIBG), are available for catecholamine-secreting paraganglionic tumors. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/14/23786?source=see_link&amp;anchor=H24#H24\">",
"       \"Clinical presentation and diagnosis of pheochromocytoma\", section on 'Radiologic tests'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Combining PET scanning with the modified radiotracers, (18-F)-fluorodopamine, (18-F)-fluorohydroxyphenylalanine, (11-C)-epinephrine, or (11-C)-hydroxyephedrine, has been reported to help localize pheochromocytomas, paragangliomas, neuroblastomas, and ganglioneuromas by targeting their metabolic pathways [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31111/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      FDG ((18-F)-fluorodeoxyglucose)-positron emission tomography (PET) scans and the combination of an FDG-PET scan combined with CT",
"      <span class=\"nowrap\">",
"       (PET/CT)",
"      </span>",
"      have largely replaced gallium (Ga-67) imaging in the evaluation, staging, and monitoring of mediastinal lymphoma [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31111/abstract/31,32\">",
"       31,32",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/1/9238?source=see_link&amp;anchor=H10#H10\">",
"       \"Clinical manifestations, pathologic features, and diagnosis of primary mediastinal large B-cell lymphoma\", section on 'Further evaluation'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/33/29206?source=see_link&amp;anchor=H7#H7\">",
"       \"Initial evaluation and diagnosis of Hodgkin lymphoma in adults\", section on 'Imaging studies'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     MANAGEMENT CONSIDERATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of a patient with a mediastinal mass will be directed by the specific or likely diagnosis obtained through the history, physical examination, radiologic studies, and other diagnostic tests.",
"   </p>",
"   <p>",
"    Practically, one must first decide whether the lesion should be observed, aspirated, excised, or biopsied. As an example, pericardial cysts are most often benign and may be observed if they are asymptomatic and not compressing the heart. When the diagnosis is unclear or the lesion is symptomatic or compressing the heart, the cyst can be drained by needle aspiration or removed by open or video-assisted thoracoscopic surgery (VATS). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/40/32392?source=see_link&amp;anchor=H19#H19\">",
"     \"Anterior mediastinal mass lesions\", section on 'Pericardial cysts'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If excision of a mediastinal mass is indicated, as is the case with teratoma, thymoma, and most isolated masses likely to be benign, further studies are usually not needed, and a definitive operation should be performed. Depending on local expertise and the expected nature of the mass, one of the following procedures is selected:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Resection via minimally invasive video-assisted (VATS) procedures (may be appropriate for bronchogenic and esophageal duplication cysts, localized neurogenic tumors, and selected thymic masses)",
"     </li>",
"     <li>",
"      Exploration and resection through a limited or full median sternotomy or thoracotomy (eg, resection of teratoma and more extensive thymic neoplasms)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If the mass is likely to be a lymphoma, germ cell tumor, or unresectable invasive malignancy, a diagnostic biopsy, rather than major surgery, is the procedure of choice. There are no randomized, prospective studies comparing various needle aspirate and biopsy techniques, however, multiple series have found a higher sensitivity and specificity for procedures that obtain larger tissue samples compared with needle cytology for the diagnosis of malignancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31111/abstract/25,33-37\">",
"     25,33-37",
"    </a>",
"    ]. Thus, it is our preference to pursue a surgical biopsy via cervical mediastinoscopy, anterior mediastinotomy, or thoracoscopy, depending upon the location of the lesion. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/43/4794?source=see_link\">",
"     \"Pathology of mediastinal tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chest wall implantation of tumor is a rare complication of needle aspiration of mediastinal masses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31111/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with mediastinal masses, who undergo surgical treatment, appear to be at increased risk of perioperative morbidity, related primarily to central airway obstruction. In one retrospective study of 105 operative procedures performed on 98 patients with anterior or middle mediastinal masses, 11 patients (10 percent) developed postoperative cardiorespiratory complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31111/abstract/39\">",
"     39",
"    </a>",
"    ]. Patients who presented with cardiorespiratory symptoms, had radiographic evidence of tracheal obstruction, or had mixed obstructive and restrictive defects on pulmonary function testing, were at greatest risk of postoperative respiratory morbidity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H104459998\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The mediastinum includes those structures bounded by the thoracic inlet, diaphragm, sternum, vertebral bodies, and pleura. It is typically described as having three compartments, anterior, middle, and posterior (",
"      <a class=\"graphic graphic_figure graphicRef56637 \" href=\"mobipreview.htm?10/31/10743\">",
"       figure 1",
"      </a>",
"      ), although some experts prefer an alternate classification (",
"      <a class=\"graphic graphic_figure graphicRef53534 \" href=\"mobipreview.htm?37/40/38531\">",
"       figure 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Mediastinal anatomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In adults, masses in the anterior compartment are more likely to be malignant than those found in the other compartments. The likelihood of a mediastinal mass being malignant is also increased among patients 20 to 40 years old. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Anatomic distribution'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Age distribution'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most mediastinal tumors in adults are either asymptomatic or are associated with vague complaints such as aching pain or cough. However, some mediastinal masses cause symptoms by compression of adjacent structures. By comparison, tumors in children are more often symptomatic and may cause respiratory difficulty and recurrent pulmonary infection. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Signs and symptoms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The noninvasive evaluation of a newly diagnosed mediastinal mass is directed by its anatomic location and patient age (",
"      <a class=\"graphic graphic_figure graphicRef56637 \" href=\"mobipreview.htm?10/31/10743\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Anatomic distribution'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Age distribution'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A chest computed tomography (CT) scan, preferably with intravenous water soluble contrast material, is indicated whenever a mediastinal mass is detected on a chest radiograph. In general, MRI typically adds little additional information to that obtained by a contrast-enhanced CT scan. &nbsp;However, MRI is helpful in the evaluation of potential intraspinal extension of neurogenic tumors and in the assessment of duplication cysts that have a nonspecific appearance on CT (",
"      <a class=\"graphic graphic_table graphicRef73333 \" href=\"mobipreview.htm?33/53/34652\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Computed tomography'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Magnetic resonance imaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Both transbronchial and transesophageal ultrasound may be valuable in select cases, for example when metastatic cancer to mediastinal lymph nodes is suspected (",
"      <a class=\"graphic graphic_figure graphicRef63771 \" href=\"mobipreview.htm?0/10/167\">",
"       figure 3",
"      </a>",
"      ). Transesophageal ultrasound is helpful in the evaluation of posterior mediastinal lymph nodes. (See",
"      <a class=\"local\" href=\"#H344103788\">",
"       'Ultrasound'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/16/12552?source=see_link\">",
"       \"Endoscopic ultrasound-guided fine-needle aspiration in the mediastinum\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/32/19976?source=see_link&amp;anchor=H9#H9\">",
"       \"Endobronchial ultrasound: Indications, advantages, and complications\", section on 'Mediastinal lesions'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Specialized laboratory testing, such as thyroid tests, fractionated 24-hour urinary metanephrines and catecholamines, fractionated plasma free metanephrines alpha-fetoprotein, beta human chorionic gonadotrophin, is used as indicated by review of the chest CT scan and consideration of the mediastinal compartment where the mass is located. (See",
"      <a class=\"local\" href=\"#H344104020\">",
"       'Laboratory testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Radionuclide scanning techniques, such as thyroid 123, sestamibi, (123-I)-metaiodobenzylguanidine (MIBG), and FDG ((18-F)-fluorodeoxyglucose)-positron emission tomography (PET), have specialized uses and are obtained when review of the chest CT scan suggests a particular diagnosis, such as substernal thyroid, parathyroid adenomas, paraganglionic tumors, pheochromocytomas. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Radionuclide scanning'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The management of a patient with a mediastinal mass will be directed by the specific or likely diagnosis obtained through the history, physical examination, radiologic studies, and other diagnostic tests. Choices may include aspiration of cystic masses, needle aspiration biopsy, open biopsy via mediastinoscopy (for suspected lymphoma, germ cell tumor, or unresectable invasive malignancy), or excision via video-assisted thoracoscopic surgery (VATS) or",
"      <span class=\"nowrap\">",
"       sternotomy/thoracotomy",
"      </span>",
"      (for teratoma, thymoma, and most isolated masses). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Management considerations'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11158801\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to acknowledge Dr. Sidhu Gangadharan, who contributed to an earlier version of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/1\">",
"      Macchiarini P, Ostertag H. Uncommon primary mediastinal tumours. Lancet Oncol 2004; 5:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/2\">",
"      Strollo DC, Rosado de Christenson ML, Jett JR. Primary mediastinal tumors. Part 1: tumors of the anterior mediastinum. Chest 1997; 112:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/3\">",
"      Strollo DC, Rosado-de-Christenson ML, Jett JR. Primary mediastinal tumors: part II. Tumors of the middle and posterior mediastinum. Chest 1997; 112:1344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/4\">",
"      Minniti S, Valentini M, Pinali L, et al. Thymic masses of the middle mediastinum: report of 2 cases and review of the literature. J Thorac Imaging 2004; 19:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/5\">",
"      Davis RD Jr, Oldham HN Jr, Sabiston DC Jr. Primary cysts and neoplasms of the mediastinum: recent changes in clinical presentation, methods of diagnosis, management, and results. Ann Thorac Surg 1987; 44:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/6\">",
"      Lupinski RW, Agasthian T, Lim CH, Chua YL. Extralobar pulmonary sequestration simulates posterior neurogenic tumor. Ann Thorac Surg 2004; 77:2203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/7\">",
"      Raman SP, Pipavath SN, Raghu G, et al. Imaging of thoracic lymphatic diseases. AJR Am J Roentgenol 2009; 193:1504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/8\">",
"      Sing TM, Wong KP, Young N, Despas P. Chemodectoma of the trachea. Thorax 1996; 51:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/9\">",
"      Bizekis CS, Pua B, Glassman LR. Thoracic splenosis: mimicry of a neurogenic tumor. J Thorac Cardiovasc Surg 2003; 125:1155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/10\">",
"      Falk RH. A posterior mediastinal mass diagnosed by echocardiogram. Chest 1995; 108:1447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/11\">",
"      Gentry SE, Harris MA. Posterior mediastinal mass in a patient with chest pain. Chest 1995; 107:1757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/12\">",
"      Kline RM, Reyna PA, Reyna TM. Azygous lobe presenting as a posterior mediastinal mass in a 2-year-old boy. J Pediatr Surg 1998; 33:1829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/13\">",
"      Moran CA, Suster S, Fishback N, Koss MN. Extramedullary hematopoiesis presenting as posterior mediastinal mass: a study of four cases. Mod Pathol 1995; 8:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/14\">",
"      Azarow KS, Pearl RH, Zurcher R, et al. Primary mediastinal masses. A comparison of adult and pediatric populations. J Thorac Cardiovasc Surg 1993; 106:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/15\">",
"      Bower RJ, Kiesewetter WB. Mediastinal masses in infants and children. Arch Surg 1977; 112:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/16\">",
"      Rubush JL, Gardner IR, Boyd WC, Ehrenhaft JL. Mediastinal tumors. Review of 186 cases. J Thorac Cardiovasc Surg 1973; 65:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/17\">",
"      Silverman NA, Sabiston DC Jr. Mediastinal masses. Surg Clin North Am 1980; 60:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/18\">",
"      Shaham D, Skilakaki MG, Goitein O. Imaging of the mediastinum: applications for thoracic surgery. Thorac Surg Clin 2004; 14:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/19\">",
"      Laurent F, Latrabe V, Lecesne R, et al. Mediastinal masses: diagnostic approach. Eur Radiol 1998; 8:1148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/20\">",
"      Kim JH, Goo JM, Lee HJ, et al. Cystic tumors in the anterior mediastinum. Radiologic-pathological correlation. J Comput Assist Tomogr 2003; 27:714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/21\">",
"      Gaerte SC, Meyer CA, Winer-Muram HT, et al. Fat-containing lesions of the chest. Radiographics 2002; 22 Spec No:S61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/22\">",
"      Grillo HC, Ojemann RG, Scannell JG, Zervas NT. Combined approach to \"dumbbell\" intrathoracic and intraspinal neurogenic tumors. Ann Thorac Surg 1983; 36:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/23\">",
"      Inaoka T, Takahashi K, Mineta M, et al. Thymic hyperplasia and thymus gland tumors: differentiation with chemical shift MR imaging. Radiology 2007; 243:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/24\">",
"      Patel J, Park C, Michaels J, et al. Pericardial cyst: case reports and a literature review. Echocardiography 2004; 21:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/25\">",
"      Herth FJ, Ernst A. Innovative bronchoscopic diagnostic techniques: endobronchial ultrasound and electromagnetic navigation. Curr Opin Pulm Med 2005; 11:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/26\">",
"      Panelli F, Erickson RA, Prasad VM. Evaluation of mediastinal masses by endoscopic ultrasound and endoscopic ultrasound-guided fine needle aspiration. Am J Gastroenterol 2001; 96:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/27\">",
"      Fritscher-Ravens A, Soehendra N, Schirrow L, et al. Role of transesophageal endosonography-guided fine-needle aspiration in the diagnosis of lung cancer. Chest 2000; 117:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/28\">",
"      Herth FJ, Lunn W, Eberhardt R, et al. Transbronchial versus transesophageal ultrasound-guided aspiration of enlarged mediastinal lymph nodes. Am J Respir Crit Care Med 2005; 171:1164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/29\">",
"      Vincent BD, El-Bayoumi E, Hoffman B, et al. Real-time endobronchial ultrasound-guided transbronchial lymph node aspiration. Ann Thorac Surg 2008; 85:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/30\">",
"      Ilias I, Shulkin B, Pacak K. New functional imaging modalities for chromaffin tumors, neuroblastomas and ganglioneuromas. Trends Endocrinol Metab 2005; 16:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/31\">",
"      Kostakoglu L, Leonard JP, Coleman M, Goldsmith SJ. The role of FDG-PET imaging in the management of lymphoma. Clin Adv Hematol Oncol 2004; 2:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/32\">",
"      Sch&ouml;der H, Meta J, Yap C, et al. Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma. J Nucl Med 2001; 42:1139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/33\">",
"      Sklair-Levy M, Polliack A, Shaham D, et al. CT-guided core-needle biopsy in the diagnosis of mediastinal lymphoma. Eur Radiol 2000; 10:714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/34\">",
"      Zinzani PL, Corneli G, Cancellieri A, et al. Core needle biopsy is effective in the initial diagnosis of mediastinal lymphoma. Haematologica 1999; 84:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/35\">",
"      Elia S, Cecere C, Giampaglia F, Ferrante G. Mediastinoscopy vs. anterior mediastinotomy in the diagnosis of mediastinal lymphoma: a randomized trial. Eur J Cardiothorac Surg 1992; 6:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/36\">",
"      Porte H, Roumilhac D, Eraldi L, et al. The role of mediastinoscopy in the diagnosis of mediastinal lymphadenopathy. Eur J Cardiothorac Surg 1998; 13:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/37\">",
"      Gossot D, Girard P, de Kerviler E, et al. Thoracoscopy or CT-guided biopsy for residual intrathoracic masses after treatment of lymphoma. Chest 2001; 120:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/38\">",
"      Matsumoto K, Ashizawa K, Tagawa T, Nagayasu T. Chest wall implantation of thymic cancer after computed tomography-guided core needle biopsy. Eur J Cardiothorac Surg 2007; 32:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31111/abstract/39\">",
"      B&eacute;chard P, L&eacute;tourneau L, Lacasse Y, et al. Perioperative cardiorespiratory complications in adults with mediastinal mass: incidence and risk factors. Anesthesiology 2004; 100:826.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6967 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-562547D45F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_24_31111=[""].join("\n");
var outline_f30_24_31111=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H104459998\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MEDIASTINAL ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ANATOMIC DISTRIBUTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      AGE DISTRIBUTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      SIGNS AND SYMPTOMS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      NONINVASIVE EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Chest radiograph",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Computed tomography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H344103788\">",
"      Ultrasound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H344104020\">",
"      Laboratory testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Radionuclide scanning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      MANAGEMENT CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H104459998\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11158801\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/6967\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6967|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?28/53/29520\" title=\"diagnostic image 1\">",
"      Thymoma CT I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?15/34/15919\" title=\"diagnostic image 2\">",
"      Thymoma CT II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?9/27/9648\" title=\"diagnostic image 3\">",
"      Multilobulated mass CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?11/5/11344\" title=\"diagnostic image 4\">",
"      Hodgkins disease CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?20/60/21440\" title=\"diagnostic image 5\">",
"      Retrosternal goiter CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?31/34/32303\" title=\"diagnostic image 6\">",
"      Pericardial cyst PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?27/41/28319\" title=\"diagnostic image 7\">",
"      Bronchogenic cyst CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?5/50/5920\" title=\"diagnostic image 8\">",
"      Paraspinal ganglioneuroma CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?18/62/19438\" title=\"diagnostic image 9\">",
"      Paraspinal neurilemmoma CT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6967|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?10/31/10743\" title=\"figure 1\">",
"      Mediastinal mass compartment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?37/40/38531\" title=\"figure 2\">",
"      Mediastinal compartments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?0/10/167\" title=\"figure 3\">",
"      Mediastinal LN approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6967|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?33/53/34652\" title=\"table 1\">",
"      Radiography mediastinal masses",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/40/32392?source=related_link\">",
"      Anterior mediastinal mass lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/2/46?source=related_link\">",
"      Clinical manifestations and evaluation of obstructive or substernal goiter",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/51/17206?source=related_link\">",
"      Clinical manifestations of myasthenia gravis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/1/9238?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of primary mediastinal large B-cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/14/23786?source=related_link\">",
"      Clinical presentation and diagnosis of pheochromocytoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/15/15609?source=related_link\">",
"      Clinical presentation, diagnosis, and staging evaluation of neuroblastoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/32/19976?source=related_link\">",
"      Endobronchial ultrasound: Indications, advantages, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/16/12552?source=related_link\">",
"      Endoscopic ultrasound-guided fine-needle aspiration in the mediastinum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/33/29206?source=related_link\">",
"      Initial evaluation and diagnosis of Hodgkin lymphoma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/52/3910?source=related_link\">",
"      Magnetic resonance imaging of the thorax",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/41/30361?source=related_link\">",
"      Pathogenesis and etiology of primary hyperparathyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/43/4794?source=related_link\">",
"      Pathology of mediastinal tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/60/18377?source=related_link\">",
"      Preoperative localization for parathyroid surgery in patients with primary hyperparathyroidism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_24_31112="PTCL NOS pathology";
var content_f30_24_31112=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F83592&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F83592&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Peripheral T cell lymphoma, not otherwise specified",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Lymph node biopsy showing a peripheral T cell lymphoma, not otherwise specified with a high content of epitheliod histiocytes and eosinophils&nbsp;intermixing with lymphoma cells. Hematoxylin and eosin, 50x magnification.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Sun T. Clinical application. In: Flow Cytometry, Immunohistochemistry, and Molecular Genetics for Hematologic Neoplasms, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_24_31112=[""].join("\n");
var outline_f30_24_31112=null;
var title_f30_24_31113="ECG type I sinoatrial block";
var content_f30_24_31113=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F68081%7ECARD%2F54936&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F68081%7ECARD%2F54936&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1056px;\">",
"  <div class=\"figure\" style=\"width: 486px\">",
"   <div class=\"ttl\">",
"    Single-lead electrocardiogram (ECG) showing lead V1 in type I (Wenckebach type) sinoatrial block",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 466px; height: 87px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    There is a 3:2 SA block, resulting in group beating of pairs of sinus beats. The P-P interval during the pause has a duration (1040 msec) that is less than two P-P cycles (1360 msec); this finding distinguishes this arrhythmia from type II SA block in which the pause duration is the same as that of two P-P cycles.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton Arnsdorf, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal rhythm strip",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 165px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal rhythm strip in lead II. The PR interval is 0.15 sec and the QRS duration is 0.08 sec. Both the P and T waves are upright.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton F Arnsdorf, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1056px;\">",
"  <div class=\"figure\" style=\"width: 486px\">",
"   <div class=\"ttl\">",
"    Single-lead electrocardiogram (ECG) showing lead V5 in type II sinoatrial block",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 466px; height: 87px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    There is a 3:2 SA block, resulting in group beating of pairs of sinus beats. The P-P interval during the pause has a duration (1840 msec) that is approximately equal to two P-P cycles (920 msec); this finding distinguishes this arrhythmia from type I SA block in which the pause duration is less than that of two P-P cycles. There may be some sinus variability, as in this case, due to sinus arrhythmia and possibly to baroreceptor responses to varying diastolic filling intervals.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton Arnsdorf, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal rhythm strip",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 165px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal rhythm strip in lead II. The PR interval is 0.15 sec and the QRS duration is 0.08 sec. Both the P and T waves are upright.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton F Arnsdorf, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_24_31113=[""].join("\n");
var outline_f30_24_31113=null;
var title_f30_24_31114="Hepatitis C virus infection in patients on maintenance dialysis";
var content_f30_24_31114=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Hepatitis C virus infection in patients on maintenance dialysis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/24/31114/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/24/31114/contributors\">",
"     Svetlozar Natov, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/24/31114/contributors\">",
"     Brian JG Pereira, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/24/31114/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/24/31114/contributors\">",
"     Steve J Schwab, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/24/31114/contributors\">",
"     Martin S Hirsch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/24/31114/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/24/31114/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/24/31114/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the past, hepatitis B virus (HBV) was the major cause of viral hepatitis in end-stage renal disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/1\">",
"     1",
"    </a>",
"    ]. However, the introduction of rigorous infection&ndash;control strategies (such as standard barrier precautions and universal precautions), routine screening of patients and staff for hepatitis B virus surface antigen (HBsAg) and anti&ndash;HBs antibody, vaccination of susceptible patients and staff, use of separate rooms and dedicated machines for hemodialysis of HBsAg positive patients, and prohibition of dialyzer reuse in HBsAg positive patients have all led to a decline in the spread of HBV infection in dialysis units [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, hepatitis G virus is an increasingly recognized infectious agent that is highly prevalent among hemodialysis patients. Approximately 21 to 44 percent of hemodialysis patients have been exposed to hepatitis G virus as assessed by the presence of viral RNA",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    antibody directed towards the putative surface envelope viral protein E2.",
"   </p>",
"   <p>",
"    Furthermore, approximately 5 to 30 percent of patients with HCV-infection are co-infected with hepatitis G virus. However, the clinical significance of such infections remains unclear since the bulk of evidence suggests that HGV does not cause hepatitis in humans. In addition, coinfection with hepatitis G virus does not increase the risk of liver disease and does not adversely affect survival among HCV infected patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/24/7557?source=see_link\">",
"     \"GB virus C (hepatitis G) infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In comparison, liver disease caused by hepatitis C virus (HCV) causes significant morbidity and mortality among patients with end stage renal disease treated with dialysis. Issues relating to HCV infection and dialysis are reviewed in this topic review. Discussions relating to the molecular biology, detection and natural history of infection with HCV, and the role of HCV among renal transplant patients are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/1/1048?source=see_link\">",
"     \"Diagnosis of hepatitis C virus infection in patients on dialysis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31289?source=see_link\">",
"     \"Hepatitis C virus infection and renal transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PREVALENCE OF HCV INFECTION IN DIALYSIS PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of anti-HCV antibody among patients on dialysis is consistently higher than in healthy populations, suggesting that dialysis patients may be at higher risk of acquiring HCV infection. The reported incidence, however, varies based in part upon the type of laboratory assay used.",
"   </p>",
"   <p>",
"    Using a first generation enzyme linked immunosorbent assay (ELISA1), for example, the prevalence of anti-HCV antibodies among dialysis patients has been reported to range from [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      8 to 36 percent in North America",
"     </li>",
"     <li>",
"      39 percent in South America",
"     </li>",
"     <li>",
"      1 to 54 percent in Europe",
"     </li>",
"     <li>",
"      17 to 51 percent in Asia",
"     </li>",
"     <li>",
"      1.2 to 10 percent in New Zealand and Australia",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The advent of second generation tests (ELISA2) revealed an even higher prevalence of anti-HCV antibodies among hemodialysis (HD) patients. Pooled data from studies in which dialysis patients were tested by both ELISA1 and ELISA2 revealed that ELISA2 identified more than twice the number of patients with HCV antibodies than ELISA1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/55/41849?source=see_link\">",
"     \"Screening for and diagnosis of chronic hepatitis C virus infection\"",
"    </a>",
"    .) Using second generation anti-HCV tests, the prevalence of anti-HCV antibodies among dialysis patients has been reported to be [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      25 to 36 percent in the United States",
"     </li>",
"     <li>",
"      2 to 63 percent in Europe",
"     </li>",
"     <li>",
"      22 to 55.5 percent in Asia",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Third generation anti-HCV tests are currently largely in use. Compared to second generation tests, they have shown greater sensitivity and specificity in patients receiving renal replacement therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Using such tests, the prevalence of anti-HCV antibodies among dialysis patients was found to be:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      5.5 to 10 percent in the United States [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/8\">",
"       8",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      13.5 to 31 percent in Italy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/7,9,10\">",
"       7,9,10",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      42 percent in France [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/11\">",
"       11",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      75 percent in Moldavia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/12\">",
"       12",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      49 percent in Syria [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/13\">",
"       13",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The Dialysis Outcomes and Practice Patterns Study (DOPPS), a prospective, observational study reported the mean HCV facility prevalence of adult hemodialysis patients randomly selected from 308 representative dialysis facilities in France, Germany, Italy, Japan, Spain, the United Kingdom, and the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/14\">",
"     14",
"    </a>",
"    ]. The overall prevalence was 13.5 percent, with a wide variation among countries from 2.6 to 22.9 percent.",
"   </p>",
"   <p>",
"    In addition to the wide range in the prevalence of HCV infection among different countries, there is also a wide variation in the prevalence of HCV infection among dialysis units and geographic regions within a single country [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/15\">",
"     15",
"    </a>",
"    ]. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among the 61,400 patients from dialysis centers participating in the National Surveillance of Dialysis Associated Diseases in the United States in 1995, the prevalence of anti-HCV by ELISA2 was 10.4 percent, with a range of 0 to 64 percent among centers with at least 40 patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In 2002, the prevalence of anti-HCV among the 164,632 HD patients tested was 7.8 percent and ranged from 5.5 to 9.8 percent among the ESRD networks, which represents different geographic areas of the United States [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The incidence and prevalence of HCV infection among patients on dialysis is steadily",
"    <strong>",
"     declining",
"    </strong>",
"    . Among member nations in the European Dialysis and Transplant Association, for example, the prevalence of anti-HCV declined from 21 percent in 1992 to 12.5 percent in 1999 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. Among hemodialysis patients in the United States, the incidence of NANBH, which is principally due to HCV, declined from 1.7 percent in 1982 to 0.2 percent in 1997 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This decline was initially due to the reduction in post-transfusion HCV infection; subsequently, it has reflected the implementation of infection-control measures to prevent nosocomial transmission within dialysis units. Nonetheless, the 0.4 to 15 percent incidence of anti-HCV in HD units continues to be a cause for concern [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/4,20\">",
"     4,20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     RISK FACTORS FOR HCV INFECTION IN DIALYSIS PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of risk factors have been identified for HCV infection among dialysis patients, including the number of blood transfusions, the duration of end-stage renal disease (ESRD) (eg, vintage), the mode of dialysis, and the prevalence of HCV infection in the dialysis unit.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Number of blood transfusions",
"    </span>",
"    &nbsp;&mdash;&nbsp;In numerous studies, anti-HCV-positive HD patients had received significantly more units of blood products than anti-HCV negative patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/21\">",
"     21",
"    </a>",
"    ]. Fortunately, since the introduction of erythropoietin and screening of blood products for anti-HCV, the risk of acquiring post-transfusion HCV infection has declined to less than one per 3000 units of blood products transfused [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Duration of ESRD",
"    </span>",
"    &nbsp;&mdash;&nbsp;The interval since beginning dialysis has been reported to be significantly longer among anti-HCV-positive patients compared to anti-HCV negative patients, and the likelihood of HCV infection increases considerably after a decade of HD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Mode of dialysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients on peritoneal dialysis (PD) are at lower risk for HCV infection and, in contrast to hemodialyzed patients, the duration of dialysis does not appear to be a risk factor for acquiring HCV infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/4\">",
"     4",
"    </a>",
"    ]. In a group of 129 anti-HCV negative patients on chronic dialysis, for example, the rate of seroconversion was 0.15 per patient-year on HD compared to 0.03 per patient-year on CAPD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/23\">",
"     23",
"    </a>",
"    ]. In addition, the majority of anti-HCV positive CAPD patients may have acquired HCV infection while on HD. Consistent with this observation are the findings from one Israeli study in which the prevalence of HCV infection was 18 and 7 percent among HD and PD patients, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One or more of the following factors can account for the lower risk of HCV infection among PD patients:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      PD patients have a lower requirement for blood transfusion than HD patients.",
"     </li>",
"     <li>",
"      The absence of access site and extracorporeal blood circuit reduces the risk for parenteral exposure to the virus.",
"     </li>",
"     <li>",
"      PD offers a more isolated environment since it is primarily a home procedure. The observation that the prevalence of anti-HCV is lower in patients receiving home HD than in those receiving in-center HD is consistent with the importance of an isolated environment.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Prevalence of HCV infection in the dialysis unit",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients treated in HD units with a high prevalence of HCV infection are at increased risk of acquiring infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/14,25,26\">",
"     14,25,26",
"    </a>",
"    ]. A survey by the Portuguese Society of Nephrology, for example, found that the incidence of HCV correlated directly with the prevalence of the infection in the HD unit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/25\">",
"     25",
"    </a>",
"    ]. Among units with a prevalence of less than 19 percent, the annual incidence of seroconversion for anti-HCV was 2.5 percent. By comparison, among units with a prevalence greater than 60 percent, the annual incidence of seroconversion was 35.3 percent.",
"   </p>",
"   <p>",
"    Molecular biological techniques have been used to provide evidence for or against nosocomial transmission of HCV within individual hemodialysis units [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/27-31\">",
"     27-31",
"    </a>",
"    ]. As an example, HCV genotyping by polymerase chain reaction and nucleotide sequencing of 23 seroconverters in a Belgian hemodialysis unit revealed that 20 were infected with exactly the same HCV strain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/27\">",
"     27",
"    </a>",
"    ]. In addition, phylogenetic analysis of the nucleotide sequences of the hypervariable region 1 of the viral genome in two studies supported nosocomial transmission including possible patient-to-patient cross-infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Similarly, comparison of sequences in the E1 variable region of the viral genome provided epidemiological evidence of nosocomial transmission within a dialysis unit in Southern France and permitted the reconstitution of the ways in which the dissemination of one specific HCV strain had occurred [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other investigators have used a technique called heteroduplex tracking analysis to screen for HCV genetic relatedness in a group of HCV-infected HD patients attending HD centers in one geographic area [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/32\">",
"     32",
"    </a>",
"    ]. Nucleotide sequencing and phylogenetic analysis of the apparently related HCV isolates were further used as the gold standard method to detect the truly related infections. This study of HCV molecular epidemiology allowed the authors to identify the source of the infections and to demonstrate that 10 percent of HCV infected patients had genetically related HCV infections. These data strongly supported the probability that HCV transmission had occurred within the dialysis centers.",
"   </p>",
"   <p>",
"    In contrast, another study also using molecular biological techniques found that patient to patient transmission of HCV was uncommon within a single dialysis facility [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Other factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other risk factors for anti-HCV positivity are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A history of previous organ transplantation. This may reflect transmission from the organ donor [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Intravenous drug abuse (IVDA) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/34-36\">",
"       34-36",
"      </a>",
"      ]. A history of IVDA was present in 30 percent of anti-HCV positive patients receiving HD at the Northwest Kidney Center, Seattle [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/35\">",
"       35",
"      </a>",
"      ], and 73 percent in two urban HD units in Miami [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Male gender. Males have been reported to have a higher prevalence of HCV infection than females [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/34,37\">",
"       34,37",
"      </a>",
"      ]. In addition, one study found that male HD patients infected with HCV had a significantly higher concentration of serum HCV RNA than females [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     NOSOCOMIAL TRANSMISSION IN HEMODIALYSIS UNITS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several of the following factors may affect the risk of transmission of HCV to patients and staff in hemodialysis units:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Transmission of infection to dialysis staff by needle-stick injury",
"     </li>",
"     <li>",
"      Breakdown in standard infection control practices",
"     </li>",
"     <li>",
"      Physical proximity to an infected patient",
"     </li>",
"     <li>",
"      Dialysis machines",
"     </li>",
"     <li>",
"      Dialyzer membranes, hemodialysis ultrafiltrate, and peritoneal fluid",
"     </li>",
"     <li>",
"      Reprocessing of dialyzers",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Transmission of infection by needle-stick injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;HCV is not readily transmitted through accidental percutaneous exposure from an HCV-positive source. The risk of transmission of HCV from infected patients to medical staff by needle stick injury has been reported to range from 0 to 10 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/38-42\">",
"     38-42",
"    </a>",
"    ]. In one study, transmission occurred only from hollow-bore needles and not from any other sharps [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the risk, the prevalence of anti-HCV among dialysis staff is comparable to that in blood donors. In one study, for example, 16 percent of dialysis centers in the United States tested staff members for anti-HCV; among the 6236 staff members tested, the prevalence of anti-HCV was 2.0 percent (range 0 to 10 percent in centers with at least 20 staff members) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Breakdown in standard infection control practices",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several outbreaks of HCV infection in HD units have been associated with a failure to rigidly enforce universal precautions and standard infection-control measures, such as sharing of a multi-dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    vial between patients with and without HCV infection and failure to change gloves between patients while performing HD treatments [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/43-45\">",
"     43-45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    HCV RNA has also been detected on the hands of some dialysis personnel despite apparent adherence to standard precautions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/46\">",
"     46",
"    </a>",
"    ]. This observation raises the possibility that dialysis staff could be a potential vector for HCV transmission between HD patients.",
"   </p>",
"   <p>",
"    Indirect evidence suggesting that infection results from breaks in infection control practices was provided by an Italian study of 58 HD units [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/47\">",
"     47",
"    </a>",
"    ]. An increased risk for HCV infection was associated with being dialyzed in a center with a high prevalence of HCV-infected patients and a low personnel to patient ratio.",
"   </p>",
"   <p>",
"    Rigorous infection-control measures, cleaning and disinfection of all instruments and environmental surfaces that are routinely touched, and a ban on sharing of articles among patients results in a decline in the incidence of HCV infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. A multicenter prospective study from Belgium unequivocally demonstrated that enforcement of universal precautions alone could fully prevent transmission of HCV in HD units [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Physical proximity to an infected patient",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a multicenter study in Belgium, 38 percent of the HD patients who seroconverted had never been transfused and had no apparent risk factor for HCV infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/26\">",
"     26",
"    </a>",
"    ]. Clustering of seroconversion occurred only in dialysis units in which anti-HCV positive patients were being treated. In addition, a higher risk of seroconversion was found in patients dialyzed at a station adjacent to that of an anti-HCV positive patient as compared to other patients in the same unit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/26\">",
"     26",
"    </a>",
"    ]. A Portuguese Society of Nephrology survey found the lowest incidence of HCV infection in HD units that used isolated rooms to treat anti-HCV positive patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Dialysis machines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several reports have linked a high incidence of HCV infection in dialysis patients who shared dialysis machines in the HD unit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/51-53\">",
"     51-53",
"    </a>",
"    ]. In addition, the use of dedicated machines and isolated areas for anti-HCV positive patients along with strict enforcement of universal precautions was associated with a decrease in the incidence of seroconversion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/49,54,55\">",
"     49,54,55",
"    </a>",
"    ]. Similarly, a survey of HD units by the Portuguese Society of Nephrology found a significantly lower incidence of HCV infection in units that used dedicated machines for anti-HCV positive patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, the need for isolation and use of dedicated machines for anti-HCV positive patients has been challenged. In a multicenter study from Belgium, for example, no new cases of HCV transmission occurred over a 54-month study period, despite the observation that none of the participating HD centers used dedicated machines for anti-HCV positive patients, and over 70 percent of the patients were dialyzed in units whose monitors were not disinfected after each session [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another study also questioned the benefit of using dedicated machines but provided evidence favoring the practice of separating anti-HCV-positive from anti-HCV negative patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/56\">",
"     56",
"    </a>",
"    ]. Despite the use of dedicated dialysis machines for anti-HCV positive patients, the rate of nosocomial transmission of HCV was higher in a HD unit, in which both anti-HCV-positive and anti-HCV-negative patients were treated together, than in another unit where HD treatment was provided only for anti-HCV-negative patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While vertical transmission of HCV by dialysis machines may be possible, systematic monitor disinfection is an effective tool in preventing nosocomial transmission of HCV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/57\">",
"     57",
"    </a>",
"    ]. Furthermore, in an experimental study, autoclaving of dialysate circuits was shown to eliminate HCV particles from artificially contaminated hemodialysis monitors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/58\">",
"     58",
"    </a>",
"    ]. Therefore, systematic monitor disinfection appears to be a simple, but valuable means of controlling HCV transmission in the hemodialysis unit and, in the opinion of some, its use should be mandatory [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/57\">",
"     57",
"    </a>",
"    ]. If implemented in conjunction with strict adherence to universal precautions, this makes the use of dedicated machines for anti-HCV positive patients unnecessary.",
"   </p>",
"   <p>",
"    Overall, data suggest that HD machines do not have a significant role in the nosocomial transmission of HCV infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/59\">",
"     59",
"    </a>",
"    ]. Therefore, it is likely that HCV transmission in hemodialysis settings principally results from environmental contamination and horizontal, patient-to-patient, transmission.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Dialyzer membranes, hemodialysis ultrafiltrate, and peritoneal fluid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Theoretically, the passage of HCV through intact dialyzer membranes seems improbable as the viral particles have an estimated diameter of 35 nm, much higher than the pores of even the most permeable dialysis membrane. Nevertheless, the passage of the virus into the dialysate compartment could result from any alteration in pore size or disruption of the membrane integrity associated with the process of filter assembly, the dialysis session itself, or with dialyzer reuse.",
"   </p>",
"   <p>",
"    Two studies have reported that neither low-flux (cellulose) nor high-flux (cellulose-diacetate, polysulfone and polyacrylonitrile) dialyzers permit contamination of the dialysis ultrafiltrate with HCV RNA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]. In similar reports, other investigators, using a continuous syringe extraction method (which is very precise for monitoring hemodialysis ultrafiltrate), have detected no HCV extravasation to spent dialysate with the use of fresh polysulfone dialyzers and transmembrane pressure of less than 18.72 mmHg, despite the finding that serum HCV RNA levels decreased significantly postdialysis as compared to predialysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/62\">",
"     62",
"    </a>",
"    ]. These data suggest that lower transmembrane pressure should be used in anti-HCV-positive patients to minimize the risk for HCV transmission [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, others have detected HCV RNA by PCR in the dialysate of apparently intact polyacrylonitrile membranes, but not cellulose membranes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/63\">",
"     63",
"    </a>",
"    ]. It is important to emphasize that detection of HCV RNA in the dialysate by PCR may only imply the presence of fragments of viral RNA, not the infective virus itself, a situation which may not lead to transmission of the infection. To date, a higher prevalence of anti-HCV among HD patient has not been associated with any particular dialysis membrane.",
"   </p>",
"   <p>",
"    HCV has been found in several organic fluids including ascites; thus, the peritoneal fluid of HCV-infected PD patients may represent a potential infectious risk. Since most studies suggest that HCV RNA is present in the CAPD effluent of some patients, the effluent should be considered infectious material [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Reprocessing of dialyzers",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a prospective study in 15 HD units in Belgium, the incidence of HCV infection in patients treated in units that reprocessed dialyzers was comparable to those that did not [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/26\">",
"     26",
"    </a>",
"    ]. Similar findings were noted by a Portuguese Society of Nephrology survey [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/25\">",
"     25",
"    </a>",
"    ]. However, among units that did reprocess dialyzers, the lowest incidence was observed in patients in units that used separate rooms to reprocess dialyzers from anti-HCV positive and anti-HCV negative patients or had a ban on reprocessing dialyzers from anti-HCV positive patients.",
"   </p>",
"   <p>",
"    In another study, a decline in the prevalence of HCV seropositivity among HD patients occurred in the presence of routine reuse of dialyzers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/65\">",
"     65",
"    </a>",
"    ]. This observation suggests that dialyzer reprocessing could not have any significant contribution to the nosocomial transmission of HCV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     STRATEGIES TO CONTROL THE TRANSMISSION OF HCV INFECTION IN HEMODIALYSIS UNITS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Difficulties in formulating policies regarding HCV infection in HD units arise from the high prevalence of HCV infection among patients on HD, the limitations of current tests in identifying these patients, and the uncertainties regarding the modes of transmission within dialysis units.",
"   </p>",
"   <p>",
"    Unresolved debate continues on whether transmission of HCV in HD units may be affected by routine testing for anti-HCV antibodies, patient isolation, use of dedicated machines, and a ban on dialyzer reuse. Arguments in favor of such strategies in HD units include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      HCV is parenterally transmitted, and HD patients are at risk of nosocomial transmission.",
"     </li>",
"     <li>",
"      Other parenterally transmitted viruses such as hepatitis B virus (HBV) have been shown to be transmitted within HD units.",
"     </li>",
"     <li>",
"      Similar strategies to reduce the transmission of HBV have resulted in a decrease in the incidence of HBV infection in HD units [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/1,59\">",
"       1,59",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, there are strong arguments against a policy of isolating anti-HCV positive patients and their machines because:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      HCV is not as infective as HBV, circulates in low titers in infected serum, and is rapidly degraded at room temperature.",
"     </li>",
"     <li>",
"      Currently licensed anti-HCV tests detect non-neutralizing antibodies, do not distinguish between current and past infection, and a negative test does not exclude HCV infection. As a result, isolation of anti-HCV positive patients does not eliminate the risk of transmission. Although the last problem could potentially be circumvented by testing for HCV RNA by polymerase chain reaction (PCR), this test is expensive, requires a specialized laboratory, and technical limitations can lead to false positive and false negative results. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/1/1048?source=see_link\">",
"       \"Diagnosis of hepatitis C virus infection in patients on dialysis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Although isolation may protect uninfected patients, it might also increase the risk of superinfection in patients originally infected with a single strain. Indeed, infection with two or more different HCV genotypes has been observed in HD patients and 13 percent of patients referred for renal transplantation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/66\">",
"       66",
"      </a>",
"      ]. The clinical impact of such polygenotype infections is currently incompletely elucidated.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In view of the above debate, the Centers for Disease Control and Prevention in the United States (CDC) does",
"    <strong>",
"     not",
"    </strong>",
"    recommend dedicated machines, patient isolation, or a ban on reuse in HD patients with HCV infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/67\">",
"     67",
"    </a>",
"    ]. However, strict adherence to \"universal precautions\", careful attention to hygiene, and strict sterilization of dialysis machines is recommended. The adoption of such \"universal precautions\" helped prevent transmission of infection in one Belgian multicenter study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/50\">",
"     50",
"    </a>",
"    ]. In this report, the enforcement of such measures decreased the yearly incidence of seroconversion from 1.4 percent to yearly rates of 0.6 and 0.0 percent for the subsequent two reporting periods, respectively. Conventional cleansing and sterilization appear to be adequate to inactivate the virus. However, eliminating the spread of HCV infection in HD units may require the development of treatments to eradicate the virus or vaccines to prevent infection.",
"   </p>",
"   <p>",
"    In 2001, the Centers for Disease Control (CDC) released new recommendations for preventing transmission of infections among chronic HD patients. In this document, the CDC offers schedules for routine HCV serologic testing of chronic HD patients. The CDC recommends that all HD patients should be tested for anti-HCV on admission. Subsequently, anti-HCV negative patients should be tested for anti-HCV antibodies semiannually [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/57\">",
"     57",
"    </a>",
"    ]. Undoubtedly, serologic surveillance for HCV will allow detecting on time episodes of nosocomial transmission, which should therefore prompt a thorough epidemiological investigation to identify the source of the infection and the mechanism of transmission. This will ultimately lead to corrective measures preventing further spread and outbreaks of HCV infection in the HD unit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     KDIGO 2008 guidelines",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guidelines for hepatitis C in chronic kidney disease were published in 2008 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/68\">",
"     68",
"    </a>",
"    ]. To help prevent HCV transmission in hemodialysis units, they recommend the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Units must implement and adhere to strict procedures aimed at preventing transmission of blood-borne pathogens. Isolation of infected patients is not recommended as an alternative to such procedures. In addition, the use of dedicated dialysis machines for infected patients is not recommended. Strict infection-control procedures must be utilized if dialyzer reuse is unavoidable.",
"     </li>",
"     <li>",
"      Hygienic precautions that prevent the transfer between patients of blood or fluids contaminated with blood must be a part of infection-control procedures.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     TREATMENT OF HCV INFECTION IN ESRD PATIENTS ON MAINTENANCE DIALYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The recommended therapy of most patients with chronic HCV infection who do not have renal dysfunction consists of interferon alfa (preferably pegylated interferon) in combination with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"     ribavirin",
"    </a>",
"    and, for patients with genotype 1, a protease inhibitor. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/37/600?source=see_link\">",
"     \"Treatment regimens for chronic hepatitis C virus genotypes 2, 3, and 4\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/47/24314?source=see_link\">",
"     \"Treatment regimens for chronic hepatitis C virus genotype 1\"",
"    </a>",
"    .) However, the manufacturer has issued warnings for patients with renal dysfunction because the clearance of ribavirin is impaired in these individuals and the drug and its metabolites are not removed by hemodialysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thus,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"     ribavirin",
"    </a>",
"    is",
"    <strong>",
"     not recommended",
"    </strong>",
"    for patients with a creatinine clearance below 50",
"    <span class=\"nowrap\">",
"     mL/min,",
"    </span>",
"    outside its use in controlled trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/70\">",
"     70",
"    </a>",
"    ]. Similar concerns currently apply to pegylated interferon because of its long half-life. Until data that demonstrate efficacy and safety are available, we do not recommend pegylated interferon in patients with renal insufficiency, unless they are enrolled in a clinical trial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/70\">",
"     70",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H28\">",
"     'Pegylated interferon alfa and ribavirin'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Interferon alfa in ESRD patients with HCV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pegylated interferon alone has not been well-studied in patients on dialysis (see",
"    <a class=\"local\" href=\"#H29\">",
"     'Pegylated interferon alfa'",
"    </a>",
"    below). The role of standard, nonpegylated interferon-alfa (IFNa) alone therapy in the treatment of HCV infection in ESRD patients on maintenance dialysis is still evolving. A majority of patients show a decrease in serum ALT levels and an improvement in liver histology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/71-80\">",
"     71-80",
"    </a>",
"    ]. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study of 19 HD patients with chronic HCV infection evaluated the effects of treatment with IFNa for six months [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/77\">",
"       77",
"      </a>",
"      ]. Six patients subsequently dropped out because of intolerance of side effects or complications from their primary disease. Benefits with therapy included a decrease to normal of AST and ALT levels by the second month of therapy in all patients, and HCV RNA became negative in 10 of 13 patients by the end of the treatment period.",
"     </li>",
"     <li>",
"      In a double-blind, controlled trial of dialysis patients, a nonsignificant trend toward biochemical and virological improvement at 12 months was observed among patients given IFNa compared to those given placebo [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/79\">",
"       79",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A multicenter, randomized, open-label study evaluated the efficacy and tolerance of IFNa treatment in 19 HCV RNA positive HD patients who received subcutaneous IFNa three times a week compared to a control group of untreated 17 HCV RNA positive HD patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/80\">",
"       80",
"      </a>",
"      ]. IFN was discontinued in 10 patients due to side effects. The other nine who tolerated IFN therapy completed the treatment course. Of these, eight (89 percent) displayed a virological response at the end of treatment, and seven (78 percent) remained HCV RNA negative during a mean follow-up on dialysis of 21 months. Mean ALT values significantly decreased following IFN therapy and remained within normal limits during the follow-up period in all patients in the treatment group, while no changes were observed in the control group.",
"      <br/>",
"      <br/>",
"      In this study, 3 of the 10 treated patients who received a renal transplant were HCV RNA negative at the time of surgery. Virological relapse occurred in one patient at 20 months after transplantation, while the other two remained HCV RNA negative at 3 and 24 months after transplantation. Among the patients who underwent renal transplantation, the mean ALT values during the posttransplant follow-up were significantly lower in patients who had received IFN treatment as compared to those in patients from the control group.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    At least three meta-analyses have been performed showing that IFN therapy alone is associated with a sustained virological response [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/81-83\">",
"     81-83",
"    </a>",
"    ]. In a meta-analysis of 20 clinical trials, the overall sustained virologic response rate with IFN was 41 percent (95% CI 33 to 49 percent), with a discontinuation rate of 26 percent (95% CI 20 to 34 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/83\">",
"     83",
"    </a>",
"    ]. The response rate was increased with a regimen of 3 million units or higher of IFN 3 times weekly. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Drug administration and duration of treatment'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    These observations demonstrate that IFN therapy in HD patients results in good biochemical and virological response and appears to exert a beneficial effect on the course of liver disease following renal transplantation, regardless of the virological response [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/80\">",
"     80",
"    </a>",
"    ]. Other reports, but not all [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/84\">",
"     84",
"    </a>",
"    ], have also documented that IFNa therapy for treatment of HCV-infected ESRD patients on maintenance dialysis, administered prior to renal transplantation, is associated with high rates of sustained biochemical and virological response in the posttransplant period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/80,85-89\">",
"     80,85-89",
"    </a>",
"    ]. Interferon-treated renal transplant candidates have also shown a significantly better posttransplant hepatic function and significantly lower rates of chronic allograft nephropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/90\">",
"     90",
"    </a>",
"    ]. Thus, IFNa therapy seems to be advisable for HCV-infected dialysis patients who are candidates for renal transplantation. In accordance with these findings, KDIGO guidelines recommend that HCV-infected kidney transplant candidates should be treated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, as in the case in patients without renal failure, relapses are common after stopping treatment and long-term outcomes are not yet adequately defined [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/71,72\">",
"     71,72",
"    </a>",
"    ]. Furthermore, although disappearance of HCV RNA from the serum is common, recurrence of viremia from extra-vascular sites remains a distinct possibility [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/72,91,92\">",
"     72,91,92",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Predictors of response to IFNa therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The factors that appear to be associated with response to IFNa therapy include the dose, duration of therapy, pretreatment viral load, and liver histology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/93\">",
"     93",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Drug administration and duration of treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Higher doses of IFNa and longer duration of treatment seem to be associated with higher response rates in hemodialysis patients; however, such regimens may result in more adverse effects. As examples [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/15,85-87,94,95\">",
"     15,85-87,94,95",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The efficacy and adverse effects of IFNa administered at a dosage of three million units (MU) three times weekly for a period of one year were assessed in 17 hemodialysis patients with biopsy-proven HCV-associated chronic hepatitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/85\">",
"       85",
"      </a>",
"      ]. A virological response was observed in 88 and 71 percent of patients at the end of treatment and at six months after completion of therapy, respectively. End-of-treatment and sustained biochemical responses were observed in 83 and 67 percent, respectively. After six months of treatment, 11 of the 13 patients (85 percent) who underwent liver biopsies showed histological improvement. Severe side effects (marked lethargy and myalgia) prompted the discontinuation of treatment in only one patient. The two patients who received a cadaver renal transplant one year after IFN treatment demonstrated sustained biochemical and virological responses at follow up of 17 and 28 months.",
"     </li>",
"     <li>",
"      Six HCV-infected HD patients were treated with IFNa administered subcutaneously at a dose of 5 to 10 MU daily for the first two weeks, followed by 5 to 10 MU three times a week for 22 weeks [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/86\">",
"       86",
"      </a>",
"      ]. Sustained biochemical and virological response at follow-up (6.6 to 26.9 months after completion of IFN therapy) were observed in 100 and 50 percent of patients, respectively. Two of the patients underwent renal transplantation after they became HCV RNA negative. At a mean follow-up of 16.8 months posttransplantation, both patients remained HCV RNA negative with a functioning renal allograft.",
"     </li>",
"     <li>",
"      A regimen of three million units (MU) or 6 MU of recombinant IFN-alfa-2b or natural IFN-alfa administered intramuscularly daily for the first two weeks, followed by three times a week for 22 weeks (six HD patients) was compared to a regimen of 3 MU of IFN-alfa-2b given three times a week for 24 weeks (three HD patients) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/94\">",
"       94",
"      </a>",
"      ]. In the group with daily IFN administration in the first two weeks, three of the six patients had biochemical and virological response at six months after completion of therapy. However, IFN therapy had to be discontinued in the other three patients due to serious side effects (depression, loss of consciousness and persistence of high-grade fever). No such events occurred in the group that received 3 MU three times a week for 24 weeks.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Daily or high-dose administration of IFNa has therefore been associated with serious adverse events in hemodialysis patients with chronic hepatitis C virus infection. This increased risk may be due to the pharmacokinetics of IFNa in patients with impaired renal function. Compared to nonuremic patients, hemodialysis patients have one-half the clearance of IFNa [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/91\">",
"     91",
"    </a>",
"    ], significantly longer half-lives of IFN-alfa-2b, and markedly larger areas under the serum IFN concentration curve. These observations question the safety of using daily and high-dose IFNa regimens in hemodialysis patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Pretreatment viral load",
"    </span>",
"    &nbsp;&mdash;&nbsp;A low pretreatment viral load has been correlated with a sustained response to IFNa therapy, whereas relatively high HCV RNA levels have been associated with a nonsustained or no response. In the individual patient, however, HCV RNA levels correlate poorly with response to IFN [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/96,97\">",
"     96,97",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     HCV genotype",
"    </span>",
"    &nbsp;&mdash;&nbsp;The value of HCV genotype as a predictor of response to IFN therapy is debatable. In the general population, infections with HCV genotypes 1 and 4 have been associated with a lower response rate to IFN therapy than infections with HCV genotypes 2 and 3 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/98,99\">",
"     98,99",
"    </a>",
"    ]. Thus, a 48-week interferon treatment is recommended for infections with HCV genotypes 1 and 4 as compared to a 24-week treatment for infections with HCV genotypes 2 and 3 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/99\">",
"     99",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In hemodialysis patients, however, some studies have failed to find any correlation between HCV genotype and response to IFN therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/86,96\">",
"     86,96",
"    </a>",
"    ]. By comparison, a meta-analysis and literature review reported a sustained virologic response of 37 and 33 percent, respectively, in the whole group as compared to 30 and 26 percent, respectively, in patients with HCV genotype 1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/82,96,100\">",
"     82,96,100",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Liver histology",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the general population with HCV infection, the presence of liver cirrhosis on the pretreatment biopsy specimen has been associated with a lower response rate to IFN treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/98\">",
"     98",
"    </a>",
"    ]. Similarly, in HD patients, mild liver pathology has been found to be a predictor of sustained response. Patients with decompensated cirrhosis should not be considered for IFN therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/97,101\">",
"     97,101",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Overview of side effects of IFNa therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment with IFNa is associated with a \"flu-like\" syndrome with asthenia, myalgia, headache, neutropenia, thrombocytopenia, and depression; the incidence of these complications is partly related to the dose administered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/102\">",
"     102",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite these side effects, the drop-out rate among non-renal patients treated with IFNa has been surprisingly low [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/102\">",
"     102",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, treatment was stopped for reasons other than transplant rejection in a range of 0 to 54 percent of dialysis and transplant recipients treated with IFNa in a number of studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/71-74,103\">",
"     71-74,103",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the largest prospective study, for example, the trial was terminated after only 37 patients had been enrolled (with 120 initially planned) because of severe side effects requiring treatment discontinuation in 19 (51 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/103\">",
"       103",
"      </a>",
"      ]. Side effects include severe asthenia, cardiac, digestive problems, neuropsychiatric, and acute graft necrosis in 9, 4, 3, 2, and 1 patient, respectively. The dose was 3 million units of alpha-interferon three times weekly, with reduction to 1.5 million units three times weekly because of side effects.",
"     </li>",
"     <li>",
"      In a 2003 meta-analysis of 14 trials of 269 dialysis patients, the most frequent side-effects requiring interruption of treatment were flu-like symptoms (17 percent), neurological (21 percent) and gastrointestinal (18 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/81\">",
"       81",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although the reasons for this difference between non-renal and renal patients are not completely elucidated, this may be related to the pharmacokinetics of IFNa in patients with impaired renal function (see above).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     KDIGO guidelines",
"    </span>",
"    &nbsp;&mdash;&nbsp;For HCV-infected patients with CKD stage 5D on maintenance hemodialysis, the 2008 KDIGO guidelines recommend monotherapy with standard interferon that is dose adjusted for a glomerular filtration rate less than 15",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m2 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Approach to treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;At present, monotherapy with standard IFNa is recommended in HCV-infected patients with CKD stage 5D on maintenance hemodialysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/68\">",
"     68",
"    </a>",
"    ]. In addition, IFNa therapy is strongly advisable for HCV-infected kidney transplant candidates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/68,80,104\">",
"     68,80,104",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31289?source=see_link&amp;anchor=H11#H11\">",
"     \"Hepatitis C virus infection and renal transplantation\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although there is a paucity of evidence to be able to make firm recommendations concerning dose and treatment duration, a regimen of three million units of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/56/29576?source=see_link\">",
"     interferon alfa-2b",
"    </a>",
"    administered subcutaneously three times per week for 6 to 12 months (if tolerated) appears to be safe and effective in inducing biochemical and sustained virological responses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/105\">",
"     105",
"    </a>",
"    ]. Close observation for significant side effects is mandatory. A detailed summary of our recommendations for the treatment of hepatitis C virus including additional issues of concern (such as genotype and viral clearance) and a discussion relating to the different interferons can each be found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/45/43735?source=see_link\">",
"     \"Overview of the management of chronic hepatitis C virus infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/47/24314?source=see_link\">",
"     \"Treatment regimens for chronic hepatitis C virus genotype 1\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/37/600?source=see_link\">",
"     \"Treatment regimens for chronic hepatitis C virus genotypes 2, 3, and 4\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/23/41337?source=see_link\">",
"     \"Mechanism of action and efficacy of peginterferon for the treatment of chronic hepatitis C virus infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/59/35768?source=see_link\">",
"     \"Mechanism of action and efficacy of standard interferon alfa for the treatment of chronic hepatitis C virus infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/8/14474?source=see_link\">",
"     \"Predictors of a sustained virologic response following treatment with peginterferon and ribavirin for chronic hepatitis C virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     PEGYLATED INTERFERON ALFA AND RIBAVIRIN",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Pegylated interferon alfa",
"    </span>",
"    &nbsp;&mdash;&nbsp;A modified form of IFNa, pegylated IFNa or peginterferon alfa, was developed by attaching a polyethylene glycol moiety to interferon alfa. This reduces renal and cellular clearance, and decreases the immunogenicity of the protein. All of these effects tend to enhance the half-life of the drug.",
"   </p>",
"   <p>",
"    Large randomized trials in patients",
"    <strong>",
"     without",
"    </strong>",
"    renal failure have demonstrated that pegylated interferons alfa-2a and alfa-2b are superior to their standard counterparts (IFNa-2a and IFNa-2b) with respect to sustained virologic response and tolerability and for the treatment of HCV-infected patients with cirrhosis or bridging fibrosis, which typically have a poor response to standard IFNa monotherapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/23/41337?source=see_link\">",
"     \"Mechanism of action and efficacy of peginterferon for the treatment of chronic hepatitis C virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While pegylated interferons have demonstrated clear therapeutic advantages in HCV-infected patients without renal failure, there is limited published information about their use in patients on renal replacement therapy and there has been concern about dosing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/83,106-110\">",
"     83,106-110",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study, HCV-infected hemodialysis patients were randomly assigned to 1.0 or 0.5",
"      <span class=\"nowrap\">",
"       mcg/kg",
"      </span>",
"      of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/36/24137?source=see_link\">",
"       pegylated interferon alfa-2b",
"      </a>",
"      administered subcutaneously weekly for up to 48 weeks [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/109\">",
"       109",
"      </a>",
"      ]. The study was terminated early because of adverse events after only 9 and 7 patients had been randomized to the high and low dose arms, respectively. Serious adverse events requiring treatment discontinuation occurred among five in the 1.0",
"      <span class=\"nowrap\">",
"       mcg/kg",
"      </span>",
"      group and two in the 0.5",
"      <span class=\"nowrap\">",
"       mcg/kg",
"      </span>",
"      arm, with hypertension and infection being the most common events. A sustained viral response was observed in two patients in the 1.0",
"      <span class=\"nowrap\">",
"       mcg/kg",
"      </span>",
"      group (both genotype 1), but none in the 0.5",
"      <span class=\"nowrap\">",
"       mcg/kg",
"      </span>",
"      group.",
"     </li>",
"     <li>",
"      In a second study, the efficacy of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?26/27/27064?source=see_link\">",
"       pegylated interferon alfa-2a",
"      </a>",
"      was evaluated in three HCV-infected patients undergoing maintenance hemodialysis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/106\">",
"       106",
"      </a>",
"      ]. The initial dose (180 &micro;g per week) was adjusted based upon weekly blood values, with downward dosing determined by decreases in neutrophil or platelet counts. HCV RNA was undetectable in all three patients by 12 weeks; in one patient, viremia returned at 24 weeks, which was considered a treatment failure. By comparison, HCV RNA remained undetectable at 48 weeks in the remaining two patients. Two unusual adverse reactions, pseudoporphyria cutanea and mixed interstitial and obstructive bronchopneumopathy, may have been the result of interferon therapy.",
"     </li>",
"     <li>",
"      A randomized open label study compared two dosages of pegylated interferon (135 and 90",
"      <span class=\"nowrap\">",
"       mcg/week)",
"      </span>",
"      administered to 85 HCV-infected hemodialysis patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/110\">",
"       110",
"      </a>",
"      ]. There was a sustained virologic response (defined as undetectable HCV RNA at 24 weeks) in 39.4 and 34.9 percent of patients treated with the higher or lower dosage, respectively. Among those with undetectable HCV RNA at 12 weeks, 60.9 and 87.5 percent of patients treated with the higher and lower dosage achieved a sustained response. A decrease in hemoglobin to less than 8.5",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      occurred in 26.3 and 20.9 percent of patients who received the higher and lower dosages.",
"      <br/>",
"      <br/>",
"      There was no placebo group in this study which limits conclusions regarding the safety of these dosages in the general hemodialysis population.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although current data on pegylated interferon in hemodialysis remain limited, it appears that hemodialysis has only negligible effects on the clearance of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/27/27064?source=see_link\">",
"     pegylated interferon alfa-2a",
"    </a>",
"    or alfa-2b [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/111,112\">",
"     111,112",
"    </a>",
"    ]. However, it is still unclear whether pegylated interferon treatment of dialysis patients, compared with standard interferon monotherapy, provides more benefit in terms of virologic response. In addition, some safety concerns have been expressed. Consequently, standard interferon monotherapy should remain the treatment of choice in hemodialysis patients",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Ribavirin",
"    </span>",
"    &nbsp;&mdash;&nbsp;As previously mentioned, the recommended therapy of most patients with chronic HCV infection who do",
"    <strong>",
"     not",
"    </strong>",
"    have renal dysfunction consists of interferon alfa (preferably pegylated interferon) in combination with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"     ribavirin",
"    </a>",
"    and, for patients with genotype 1, a protease inhibitor. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/37/600?source=see_link\">",
"     \"Treatment regimens for chronic hepatitis C virus genotypes 2, 3, and 4\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/47/24314?source=see_link\">",
"     \"Treatment regimens for chronic hepatitis C virus genotype 1\"",
"    </a>",
"    .). However, the manufacturer has issued warnings for patients with renal dysfunction because the clearance of ribavirin is impaired in these individuals and the drug and its metabolites are not removed by hemodialysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite this, several small pilot studies have examined the safety and efficacy of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"     ribavirin",
"    </a>",
"    in patients with advanced renal disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/70,113,114\">",
"     70,113,114",
"    </a>",
"    ]. To better address the response rates and safety of ribavirin, a prospective trial is ongoing in which dialysis patients with serum HCV RNA and chronic hepatitis C are randomly assigned to peginterferon alfa-2a (1.0",
"    <span class=\"nowrap\">",
"     &micro;g/kg",
"    </span>",
"    per week) with or without ribavirin (3",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    once per week) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/70\">",
"     70",
"    </a>",
"    ]. The dose of ribavirin is increased based upon tolerance and the maintenance of hemoglobin levels above 9.5",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    by support with erythropoietin only.",
"   </p>",
"   <p>",
"    Outside its use in controlled ongoing trials,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"     ribavirin",
"    </a>",
"    is",
"    <strong>",
"     not",
"    </strong>",
"    recommended for patients with a creatinine clearance below 50",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/70\">",
"     70",
"    </a>",
"    ]. Similar concerns currently apply to pegylated interferon because of its long half-life. Thus, we also do",
"    <strong>",
"     not",
"    </strong>",
"    recommend pegylated interferon in patients with renal insufficiency, unless they are enrolled in a clinical trial.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     SURVIVAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the absence of renal failure, the long-term survival of patients with chronic HCV infection is good, except for those with decompensated cirrhosis. In one series of 384 patients with compensated cirrhosis, for example, the three, five, and ten year survival rates were 96, 91, and 79 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/115\">",
"     115",
"    </a>",
"    ]. However, once decompensated cirrhosis occurred, the five-year survival fell to 50 percent. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/50/31530?source=see_link\">",
"     \"Clinical manifestations and natural history of chronic hepatitis C virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A paucity of data is available concerning survival among chronic dialysis patients with hepatitis C virus infection. Overall, HCV infection is a poor prognostic factor for survival among patients with end stage renal failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/100,105,116-121\">",
"     100,105,116-121",
"    </a>",
"    ]. This was perhaps best studied in a 2004 meta-analysis of four clinical trials of over 2000 patients in which HCV infection was associated with an increased risk of mortality of 1.57 (95% CI of 1.33 to 1.86) versus uninfected dialysis patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/24/31114/abstract/100\">",
"     100",
"    </a>",
"    ]. Hepatocellular carcinoma and cirrhosis were also significantly more frequent in HCV-infected patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6144511\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Liver disease caused by hepatitis C virus (HCV) causes significant morbidity and mortality among patients with end-stage renal disease (ESRD) treated with dialysis.(See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Prevalence of hcv infection in dialysis patients'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Major risk factors for HCV infection among dialysis patients include the number of blood transfusions, longer duration of ESRD, the mode of dialysis (hemodialysis is higher risk than peritoneal dialysis), and the prevalence of HCV infection in the dialysis unit. Other risk factors include a previous organ transplantation, intravenous drug abuse and male gender. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Risk factors for hcv infection in dialysis patients'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Factors that may affect the risk of transmission of HCV to patients and staff in hemodialysis units include transmission needle-stick injuries, breakdown in standard infection control practices, physical proximity to an infected patient, and factors related to the dialysis machines, dialyzer membranes, hemodialysis ultrafiltrate, and peritoneal fluid. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Nosocomial transmission in hemodialysis units'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Difficulties in formulating policies regarding HCV infection in hemodialysis units arise from the high prevalence of HCV infection among patients on hemodialysis, the limitations of current tests in identifying these patients, and the uncertainties regarding the modes of transmission within dialysis units. Neither the Centers for Disease Control and Prevention in the United States (CDC) nor the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend the use of dedicated machines, patient isolation, or a ban on reuse in HD patients with HCV infection. Both the CDC and KDIGO guidelines recommend strict adherence to universal precautions, careful attention to hygiene, and strict sterilization of dialysis machines.",
"      <br/>",
"      <br/>",
"      In addition, the CDC recommends that all HD patients should be tested for anti-HCV antibodies on admission and anti-HCV negative patients should be tested for anti-HCV antibodies semiannually thereafter. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Strategies to control the transmission of hcv infection in hemodialysis units'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The recommended therapy of most patients with chronic HCV infection who do not have renal dysfunction consists of interferon alfa (preferably pegylated interferon) in combination with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"       ribavirin",
"      </a>",
"      . However ribavirin is",
"      <strong>",
"       not recommended",
"      </strong>",
"      for patients with a creatinine clearance below 50",
"      <span class=\"nowrap\">",
"       mL/min,",
"      </span>",
"      except for its use in controlled trials. We also do not recommend pegylated interferon in patients with renal insufficiency, unless they are enrolled in a clinical trial. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Pegylated interferon alfa and ribavirin'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The role of standard, nonpegylated interferon-alfa (IFNa) alone therapy in the treatment of HCV infection in ESRD patients on maintenance dialysis is still evolving. A majority of patients show a decrease in serum ALT levels and an improvement in liver histology. For HCV-infected patients with ESRD on maintenance hemodialysis and especially for HCV-infected kidney transplant candidates, we agree with the 2008 KDIGO guidelines that recommend monotherapy with standard interferon that is dose adjusted for a glomerular filtration rate less than 15",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      per 1.73 m2. There is a paucity of evidence concerning dose and treatment duration. We suggest a regimen of three million units of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/56/29576?source=see_link\">",
"       interferon alfa-2b",
"      </a>",
"      administered subcutaneously three times per week for 6 to 12 months (if tolerated). Close observation for significant side effects is mandatory. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Interferon alfa in ESRD patients with HCV infection'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H27\">",
"       'Approach to treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A detailed summary of our recommendations for the treatment of hepatitis C virus including additional issues of concern (such as genotype and viral clearance) and a discussion relating to the different interferons can each be found elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/45/43735?source=see_link\">",
"       \"Overview of the management of chronic hepatitis C virus infection\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/47/24314?source=see_link\">",
"       \"Treatment regimens for chronic hepatitis C virus genotype 1\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/37/600?source=see_link\">",
"       \"Treatment regimens for chronic hepatitis C virus genotypes 2, 3, and 4\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/23/41337?source=see_link\">",
"       \"Mechanism of action and efficacy of peginterferon for the treatment of chronic hepatitis C virus infection\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/59/35768?source=see_link\">",
"       \"Mechanism of action and efficacy of standard interferon alfa for the treatment of chronic hepatitis C virus infection\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/8/14474?source=see_link\">",
"       \"Predictors of a sustained virologic response following treatment with peginterferon and ribavirin for chronic hepatitis C virus infection\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/1\">",
"      Tokars JI, Alter MJ, Favero MS, et al. National surveillance of hemodialysis associated diseases in the United States, 1990. ASAIO J 1993; 39:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/2\">",
"      Alter MJ, Favero MS, Maynard JE. Impact of infection control strategies on the incidence of dialysis-associated hepatitis in the United States. J Infect Dis 1986; 153:1149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/3\">",
"      Tokars JI, Miller ER, Alter MJ, Arduino MJ. National surveillance of dialysis associated diseases in the United States, 1995. ASAIO J 1998; 44:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/4\">",
"      Pereira BJ, Levey AS. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997; 51:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/5\">",
"      Natov SN, Pereira BJ. Hepatitis C in dialysis patients. Adv Ren Replace Ther 1996; 3:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/6\">",
"      Soffredini R, Rumi M, Lampertico P, et al. Increased detection of antibody to hepatitis C virus in renal transplant patients by third-generation assays. Am J Kidney Dis 1996; 28:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/7\">",
"      Fabrizi F, Lunghi G, Raffaele L, et al. Serologic survey for control of hepatitis C in haemodialysis patients: third-generation assays and analysis of costs. Nephrol Dial Transplant 1997; 12:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/8\">",
"      Finelli L, Miller JT, Tokars JI, et al. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 2005; 18:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/9\">",
"      Biamino E, Caligaris F, Ferrero S, et al. [Prevalence of anti-HCV antibody positivity and seroconversion incidence in hemodialysis patients]. Minerva Urol Nefrol 1999; 51:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/10\">",
"      Di Napoli A, Pezzotti P, Di Lallo D, et al. Epidemiology of hepatitis C virus among long-term dialysis patients: a 9-year study in an Italian region. Am J Kidney Dis 2006; 48:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/11\">",
"      Courouc&eacute; AM, Bouchardeau F, Chauveau P, et al. Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays). Nephrol Dial Transplant 1995; 10:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/12\">",
"      Covic A, Iancu L, Apetrei C, et al. Hepatitis virus infection in haemodialysis patients from Moldavia. Nephrol Dial Transplant 1999; 14:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/13\">",
"      Othman B, Monem F. Prevalence of antibodies to hepatitis C virus among hemodialysis patients in Damascus, Syria. Infection 2001; 29:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/14\">",
"      Fissell RB, Bragg-Gresham JL, Woods JD, et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2004; 65:2335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/15\">",
"      Kamar N, Ribes D, Izopet J, Rostaing L. Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant. Transplantation 2006; 82:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/16\">",
"      Geerlings W, Tufveson G, Ehrich JH, et al. Report on management of renal failure in Europe, XXIII. Nephrol Dial Transplant 1994; 9 Suppl 1:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/17\">",
"      Valderr&aacute;bano F, Jones EH, Mallick NP. Report on management of renal failure in Europe, XXIV, 1993. Nephrol Dial Transplant 1995; 10 Suppl 5:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/18\">",
"      Jadoul M, Poignet JL, Geddes C, et al. The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study. Nephrol Dial Transplant 2004; 19:904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/19\">",
"      Tokars JI, Miller ER, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 1997. Semin Dial 2000; 13:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/20\">",
"      Espinosa M, Martn-Malo A, Ojeda R, et al. Marked reduction in the prevalence of hepatitis C virus infection in hemodialysis patients: causes and consequences. Am J Kidney Dis 2004; 43:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/21\">",
"      Natov SN, Lau JY, Bouthot BA, et al. Serologic and virologic profiles of hepatitis C infection in renal transplant candidates. New England Organ Bank Hepatitis C Study Group. Am J Kidney Dis 1998; 31:920.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/22\">",
"      Donahue JG, Mu&ntilde;oz A, Ness PM, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992; 327:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/23\">",
"      Cendoroglo Neto M, Draibe SA, Silva AE, et al. Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: evidence for environmental transmission. Nephrol Dial Transplant 1995; 10:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/24\">",
"      Weinstein T, Tur-Kaspa R, Chagnac A, et al. Hepatitis C infection in dialysis patients in Israel. Isr Med Assoc J 2001; 3:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/25\">",
"      dos Santos JP, Loureiro A, Cendoroglo Neto M, Pereira BJ. Impact of dialysis room and reuse strategies on the incidence of hepatitis C virus infection in haemodialysis units. Nephrol Dial Transplant 1996; 11:2017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/26\">",
"      Jadoul M, Cornu C, van Ypersele de Strihou C. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. The UCL Collaborative Group. Kidney Int 1993; 44:1322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/27\">",
"      Stuyver L, Claeys H, Wyseur A, et al. Hepatitis C virus in a hemodialysis unit: molecular evidence for nosocomial transmission. Kidney Int 1996; 49:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/28\">",
"      Halfon P, Roubicek C, Gerolami V, et al. Use of phylogenetic analysis of hepatitis C virus (HCV) hypervariable region 1 sequences to trace an outbreak of HCV in an autodialysis unit. J Clin Microbiol 2002; 40:1541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/29\">",
"      Grethe S, Gemsa F, Monazahian M, et al. Molecular epidemiology of an outbreak of HCV in a hemodialysis unit: direct sequencing of HCV-HVR1 as an appropriate tool for phylogenetic analysis. J Med Virol 2000; 60:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/30\">",
"      Olmer M, Bouchouareb D, Zandotti C, et al. Transmission of the hepatitis C virus in an hemodialysis unit: evidence for nosocomial infection. Clin Nephrol 1997; 47:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/31\">",
"      Sypsa V, Psichogiou M, Katsoulidou A, et al. Incidence and patterns of hepatitis C virus seroconversion in a cohort of hemodialysis patients. Am J Kidney Dis 2005; 45:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/32\">",
"      Sullivan DG, Kim SS, Wilson JJ, et al. Investigating hepatitis C virus heterogeneity in a high prevalence setting using heteroduplex tracking analysis. J Virol Methods 2001; 96:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/33\">",
"      Zeuzem S, Scheuermann EH, Waschk D, et al. Phylogenetic analysis of hepatitis C virus isolates from hemodialysis patients. Kidney Int 1996; 49:896.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/34\">",
"      Bergman S, Accortt N, Turner A, Glaze J. Hepatitis C infection is acquired pre-ESRD. Am J Kidney Dis 2005; 45:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/35\">",
"      DuBois DB, Gretch D, dela Rosa C, et al. Quantitation of hepatitis C viral RNA in sera of hemodialysis patients: gender-related differences in viral load. Am J Kidney Dis 1994; 24:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/36\">",
"      Jeffers LJ, Perez GO, de Medina MD, et al. Hepatitis C infection in two urban hemodialysis units. Kidney Int 1990; 38:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/37\">",
"      Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992; 327:1899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/38\">",
"      Kiyosawa K, Sodeyama T, Tanaka E, et al. Hepatitis C in hospital employees with needlestick injuries. Ann Intern Med 1991; 115:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/39\">",
"      Mitsui T, Iwano K, Masuko K, et al. Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology 1992; 16:1109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/40\">",
"      Alter MJ. The epidemiology of acute and chronic hepatitis C. Clin Liver Dis 1997; 1:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/41\">",
"      Lanphear BP, Linnemann CC Jr, Cannon CG, et al. Hepatitis C virus infection in healthcare workers: risk of exposure and infection. Infect Control Hosp Epidemiol 1994; 15:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/42\">",
"      Puro V, Petrosillo N, Ippolito G. Risk of hepatitis C seroconversion after occupational exposures in health care workers. Italian Study Group on Occupational Risk of HIV and Other Bloodborne Infections. Am J Infect Control 1995; 23:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/43\">",
"      Okuda K, Hayashi H, Kobayashi S, Irie Y. Mode of hepatitis C infection not associated with blood transfusion among chronic hemodialysis patients. J Hepatol 1995; 23:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/44\">",
"      Gilli P, Moretti M, Soffritti S, et al. Non-A, non-B hepatitis and anti-HCV antibodies in dialysis patients. Int J Artif Organs 1990; 13:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/45\">",
"      Centers for Disease Control and Prevention (CDC). Hepatitis C virus transmission at an outpatient hemodialysis unit--New York, 2001-2008. MMWR Morb Mortal Wkly Rep 2009; 58:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/46\">",
"      Alfurayh O, Sabeel A, Al Ahdal MN, et al. Hand contamination with hepatitis C virus in staff looking after hepatitis C-positive hemodialysis patients. Am J Nephrol 2000; 20:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/47\">",
"      Petrosillo N, Gilli P, Serraino D, et al. Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney Dis 2001; 37:1004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/48\">",
"      Niu MT, Alter MJ, Kristensen C, Margolis HS. Outbreak of hemodialysis-associated non-A, non-B hepatitis and correlation with antibody to hepatitis C virus. Am J Kidney Dis 1992; 19:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/49\">",
"      Garcia-Valdescasas, J, Bernal, MC, Cerezo, S, et al. Strategies to reduce the transmission of HCV infection in hemodialysis (HD) units (abstract). J Am Soc Nephrol 1993; 4:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/50\">",
"      Jadoul M, Cornu C, van Ypersele de Strihou C. Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgian Multicenter Study. The Universitaires Cliniques St-Luc (UCL) Collaborative Group. Kidney Int 1998; 53:1022.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/51\">",
"      Brugnano R, Francisci D, Quintaliani G, et al. Antibodies against hepatitis C virus in hemodialysis patients in the central Italian region of Umbria: evaluation of some risk factors. Nephron 1992; 61:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/52\">",
"      Mitwalli A, al-Mohaya S, al Wakeel J, et al. Hepatitis C in chronic renal failure patients. Am J Nephrol 1992; 12:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/53\">",
"      Rais-Jalali G, Khajehdehi P. Anti-HCV seropositivity among haemodialysis patients of Iranian origin. Nephrol Dial Transplant 1999; 14:2055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/54\">",
"      Vagelli G, Calabrese G, Guaschino R, Gonella M. Effect of HCV+ patients isolation on HCV infection incidence in a dialysis unit. Nephrol Dial Transplant 1992; 7:1070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/55\">",
"      Calabrese G, Vagelli G, Guaschino R, Gonella M. Transmission of anti-HCV within the household of haemodialysis patients. Lancet 1991; 338:1466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/56\">",
"      Taskapan H, Oymak O, Dogukan A, Utas C. Patient to patient transmission of hepatitis C virus in hemodialysis units. Clin Nephrol 2001; 55:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/57\">",
"      Aucella F, Vigilante M, Valente GL, Stallone C. Systematic monitor disinfection is effective in limiting HCV spread in hemodialysis. Blood Purif 2000; 18:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/58\">",
"      Barril G, Bartolom&eacute; J, Traver JA, et al. Autoclaving eliminates hepatitis C virus from a hemodialysis monitor contaminated artificially. J Med Virol 2000; 60:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/59\">",
"      Froio N, Nicastri E, Comandini UV, et al. Contamination by hepatitis B and C viruses in the dialysis setting. Am J Kidney Dis 2003; 42:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/60\">",
"      Hubmann R, Zazgornik J, Gabriel C, et al. Hepatitis C virus--does it penetrate the haemodialysis membrane? PCR analysis of haemodialysis ultrafiltrate and whole blood. Nephrol Dial Transplant 1995; 10:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/61\">",
"      Caramelo C, Navas S, Alberola ML, et al. Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid. Nephron 1994; 66:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/62\">",
"      Noiri E, Nakao A, Oya A, et al. Hepatitis C virus in blood and dialysate in hemodialysis. Am J Kidney Dis 2001; 37:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/63\">",
"      Lombardi M, Cerrai T, Dattolo P, et al. Is the dialysis membrane a safe barrier against HCV infection? Nephrol Dial Transplant 1995; 10:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/64\">",
"      Castelnovo C, Sampietro M, De Vecchi A, et al. Diffusion of HCV through peritoneal membrane in HCV positive patients treated with continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1997; 12:978.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/65\">",
"      Taal MW, van Zyl-Smit R. Hepatitis C virus infection in chronic haemodialysis patients--relationship to blood transfusions and dialyser re-use. S Afr Med J 2000; 90:621.",
"     </a>",
"    </li>",
"    <li>",
"     Natov, SN, Pereira, BJG. Transmission of disease by organ transplantation. In: Organ and Tissue Donation for Transplantation, Chapman, JD, M, Wight, C (Ed), Edward Arnold, London, 1996.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/67\">",
"      Centers for Disease Control and Prevention. Recommemdations for preventing transmission of infections among chronic hemodialysis patients. MMWR 2001; 50:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/68\">",
"      KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int 2008; 73(Suppl 109):S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/69\">",
"      Glue P. The clinical pharmacology of ribavirin. Semin Liver Dis 1999; 19 Suppl 1:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/70\">",
"      Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH. Hepatitis C and renal disease: an update. Am J Kidney Dis 2003; 42:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/71\">",
"      Pol S, Thiers V, Carnot F, et al. Efficacy and tolerance of alpha-2b interferon therapy on HCV infection of hemodialyzed patients. Kidney Int 1995; 47:1412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/72\">",
"      Rostaing L, Izopet J, Baron E, et al. Preliminary results of treatment of chronic hepatitis C with recombinant interferon alpha in renal transplant patients. Nephrol Dial Transplant 1995; 10 Suppl 6:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/73\">",
"      Casanovas, TT, Baliellas, C, Sese, E, et al. Interferon may be useful in hemodialysis patients with hepatitis C virus chronic infection who are candidates for kidney transplant. Transplantation Proc 1995; 27:2229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/74\">",
"      Koenig P, Vogel W, Umlauft F, et al. Interferon treatment for chronic hepatitis C virus infection in uremic patients. Kidney Int 1994; 45:1507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/75\">",
"      Duarte R, Huraib S, Said R, et al. Interferon-alpha facilitates renal transplantation in hemodialysis patients with chronic viral hepatitis. Am J Kidney Dis 1995; 25:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/76\">",
"      Harihara Y, Kurooka Y, Yanagisawa T, et al. Interferon therapy in renal allograft recipients with chronic hepatitis C. Transplant Proc 1994; 26:2075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/77\">",
"      Raptopoulou-Gigi M, Spaia S, Garifallos A, et al. Interferon-alpha 2b treatment of chronic hepatitis C in haemodialysis patients. Nephrol Dial Transplant 1995; 10:1834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/78\">",
"      Ozg&uuml;r O, Boyacio��lu S, Telatar H, Haberal M. Recombinant alpha-interferon in renal allograft recipients with chronic hepatitis C. Nephrol Dial Transplant 1995; 10:2104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/79\">",
"      Fern&aacute;ndez JL, Rendo P, del Pino N, Viola L. A double-blind controlled trial of recombinant interferon-alpha 2b in haemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels. Nephrologists' Group for the Study of HCV infection. J Viral Hepat 1997; 4:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/80\">",
"      Campistol JM, Esforzado N, Mart&iacute;nez J, et al. Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment. Nephrol Dial Transplant 1999; 14:2704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/81\">",
"      Fabrizi F, Dulai G, Dixit V, et al. Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther 2003; 18:1071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/82\">",
"      Russo MW, Goldsweig CD, Jacobson IM, Brown RS Jr. Interferon monotherapy for dialysis patients with chronic hepatitis C: an analysis of the literature on efficacy and safety. Am J Gastroenterol 2003; 98:1610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/83\">",
"      Gordon CE, Uhlig K, Lau J, et al. Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: a systematic review of the literature and meta-analysis of treatment efficacy and harms. Am J Kidney Dis 2008; 51:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/84\">",
"      Rodrigues A, Morgado T, Areias J, et al. Limited benefits of INF-alpha therapy in renal graft candidates with chronic viral hepatitis B or C. Transplant Proc 1997; 29:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/85\">",
"      Huraib S, Tanimu D, Romeh SA, et al. Interferon-alpha in chronic hepatitis C infection in dialysis patients. Am J Kidney Dis 1999; 34:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/86\">",
"      Tokumoto T, Tanabe K, Ishikawa N, et al. Effect of interferon-alpha treatment in hemodialysis patients and renal transplant recipients with chronic hepatitis C. Transplant Proc 1999; 31:2887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/87\">",
"      Espinosa M, Rodriguez M, Martin-Malo A, et al. Interferon therapy in hemodialysis patients with chronic hepatitis C virus infection induces a high rate of long-term sustained virological and biochemical response. Clin Nephrol 2001; 55:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/88\">",
"      Casanovas-Taltavull T, Baliellas C, Benasco C, et al. Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation. Am J Gastroenterol 2001; 96:1170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/89\">",
"      Kamar N, Toupance O, Buchler M, et al. Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation. J Am Soc Nephrol 2003; 14:2092.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/90\">",
"      Mahmoud IM, Sobh MA, El-Habashi AF, et al. Interferon therapy in hemodialysis patients with chronic hepatitis C: study of tolerance, efficacy and post-transplantation course. Nephron Clin Pract 2005; 100:c133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/91\">",
"      Rostaing L, Chatelut E, Payen JL, et al. Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implications. J Am Soc Nephrol 1998; 9:2344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/92\">",
"      Oesterreicher C, Hammer J, Koch U, et al. HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis. Kidney Int 1995; 48:1967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/93\">",
"      Gordon CE, Uhlig K, Lau J, et al. Interferon for hepatitis C virus in hemodialysis--an individual patient meta-analysis of factors associated with sustained virological response. Clin J Am Soc Nephrol 2009; 4:1449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/94\">",
"      Uchihara M, Izumi N, Sakai Y, et al. Interferon therapy for chronic hepatitis C in hemodialysis patients: increased serum levels of interferon. Nephron 1998; 80:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/95\">",
"      Hanrotel C, Toupance O, Lavaud S, et al. Virological and histological responses to one year alpha-interferon-2a in hemodialyzed patients with chronic hepatitis C. Nephron 2001; 88:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/96\">",
"      Umlauft F, Gruenewald K, Weiss G, et al. Patterns of hepatitis C viremia in patients receiving hemodialysis. Am J Gastroenterol 1997; 92:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/97\">",
"      Chan TM, Wu PC, Lau JY, et al. Interferon treatment for hepatitis C virus infection in patients on haemodialysis. Nephrol Dial Transplant 1997; 12:1414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/98\">",
"      Davis GL, Lau JY. Factors predictive of a beneficial response to therapy of hepatitis C. Hepatology 1997; 26:122S.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.consensus.nih.gov/2002/2002HEPATITISC2002116MAIN.htm (Accessed on March 31, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/100\">",
"      Fabrizi F, Martin P, Dixit V, et al. Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis. Aliment Pharmacol Ther 2004; 20:1271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/101\">",
"      Management of hepatitis C. NIH Consensus Statement Online 1997; 15:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/102\">",
"      Poynard T, Bedossa P, Chevallier M, et al. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group. N Engl J Med 1995; 332:1457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/103\">",
"      Degos F, Pol S, Chaix ML, et al. The tolerance and efficacy of interferon-alpha in haemodialysis patients with HCV infection: a multicentre, prospective study. Nephrol Dial Transplant 2001; 16:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/104\">",
"      Fabrizi F, Lunghi G, Martin P. Treatment of HCV-related liver disease in the dialysis population: a novel challenge for clinical nephrologists. Int J Artif Organs 2001; 24:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/105\">",
"      Terrault NA, Adey DB. The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment. Clin J Am Soc Nephrol 2007; 2:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/106\">",
"      Teta D, L&uuml;scher BL, Gonvers JJ, et al. Pegylated interferon for the treatment of hepatitis C virus in haemodialysis patients. Nephrol Dial Transplant 2005; 20:991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/107\">",
"      Annicchiarico BE, Siciliano M. Pegylated interferon-alpha 2b monotherapy for haemodialysis patients with chronic hepatitis C. Aliment Pharmacol Ther 2004; 20:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/108\">",
"      Sporea I, Sirli R, Golea O, et al. Peg-Interferon Alfa 2a (40kDa) in patients on chronic haemodialysis with chronic C hepatitis. Preliminary results. Rom J Gastroenterol 2004; 13:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/109\">",
"      Russo MW, Ghalib R, Sigal S, Joshi V. Randomized trial of pegylated interferon alpha-2b monotherapy in haemodialysis patients with chronic hepatitis C. Nephrol Dial Transplant 2006; 21:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/110\">",
"      Peck-Radosavljevic M, Boletis J, Besisik F, et al. Low-dose peginterferon alfa-2a is safe and produces a sustained virologic response in patients with chronic hepatitis C and end-stage renal disease. Clin Gastroenterol Hepatol 2011; 9:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/111\">",
"      Gupta SK, Pittenger AL, Swan SK, et al. Single-dose pharmacokinetics and safety of pegylated interferon-alpha2b in patients with chronic renal dysfunction. J Clin Pharmacol 2002; 42:1109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/112\">",
"      Barril G, Quiroga JA, Sanz P, et al. Pegylated interferon-alpha2a kinetics during experimental haemodialysis: impact of permeability and pore size of dialysers. Aliment Pharmacol Ther 2004; 20:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/113\">",
"      Bruchfeld A, St&aring;hle L, Andersson J, Schvarcz R. Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection--a pilot study. J Viral Hepat 2001; 8:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/114\">",
"      Mousa DH, Abdalla AH, Al-Shoail G, et al. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C. Transplant Proc 2004; 36:1831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/115\">",
"      Fattovich G, Giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997; 112:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/116\">",
"      Fabrizi F, Martin P, Lunghi G, Locatelli F. Membrane compatibility, flux and HCV infection in dialysis patients: newer evidence. Int J Artif Organs 2000; 23:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/117\">",
"      Stehman-Breen CO, Emerson S, Gretch D, Johnson RJ. Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis 1998; 32:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/118\">",
"      Pereira BJ, Natov SN, Bouthot BA, et al. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group. Kidney Int 1998; 53:1374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/119\">",
"      Nakayama E, Akiba T, Marumo F, Sato C. Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 2000; 11:1896.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/120\">",
"      Seeff LB, Buskell-Bales Z, Wright EC, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med 1992; 327:1906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/24/31114/abstract/121\">",
"      Marcelli D, Stannard D, Conte F, et al. ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int 1996; 50:1013.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1861 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.234.146.186-93025ABAAB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_24_31114=[""].join("\n");
var outline_f30_24_31114=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H6144511\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PREVALENCE OF HCV INFECTION IN DIALYSIS PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      RISK FACTORS FOR HCV INFECTION IN DIALYSIS PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Number of blood transfusions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Duration of ESRD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Mode of dialysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Prevalence of HCV infection in the dialysis unit",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Other factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      NOSOCOMIAL TRANSMISSION IN HEMODIALYSIS UNITS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Transmission of infection by needle-stick injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Breakdown in standard infection control practices",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Physical proximity to an infected patient",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Dialysis machines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Dialyzer membranes, hemodialysis ultrafiltrate, and peritoneal fluid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Reprocessing of dialyzers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      STRATEGIES TO CONTROL THE TRANSMISSION OF HCV INFECTION IN HEMODIALYSIS UNITS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      KDIGO 2008 guidelines",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      TREATMENT OF HCV INFECTION IN ESRD PATIENTS ON MAINTENANCE DIALYSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Interferon alfa in ESRD patients with HCV infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Predictors of response to IFNa therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Drug administration and duration of treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Pretreatment viral load",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - HCV genotype",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Liver histology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Overview of side effects of IFNa therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      KDIGO guidelines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Approach to treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      PEGYLATED INTERFERON ALFA AND RIBAVIRIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Pegylated interferon alfa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Ribavirin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      SURVIVAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6144511\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/50/31530?source=related_link\">",
"      Clinical manifestations and natural history of chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/1/1048?source=related_link\">",
"      Diagnosis of hepatitis C virus infection in patients on dialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/24/7557?source=related_link\">",
"      GB virus C (hepatitis G) infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31289?source=related_link\">",
"      Hepatitis C virus infection and renal transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/23/41337?source=related_link\">",
"      Mechanism of action and efficacy of peginterferon for the treatment of chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/59/35768?source=related_link\">",
"      Mechanism of action and efficacy of standard interferon alfa for the treatment of chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/45/43735?source=related_link\">",
"      Overview of the management of chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/8/14474?source=related_link\">",
"      Predictors of a sustained virologic response following treatment with peginterferon and ribavirin for chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/55/41849?source=related_link\">",
"      Screening for and diagnosis of chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/47/24314?source=related_link\">",
"      Treatment regimens for chronic hepatitis C virus genotype 1",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/37/600?source=related_link\">",
"      Treatment regimens for chronic hepatitis C virus genotypes 2, 3, and 4",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_24_31115="Hachinski ischemic score";
var content_f30_24_31115=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F81210&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F81210&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Hachinski ischemic score",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Feature",
"       </td>",
"       <td class=\"subtitle1\">",
"        Value",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abrupt onset",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stepwise deterioration",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fluctuating course",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nocturnal confusion",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Preservation of personality",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Depression",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Somatic complaints",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Emotional incontinence",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypertension",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        History of stroke",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Associated atherosclerosis",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Focal neurologic symptoms",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Focal neurologic signs",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_24_31115=[""].join("\n");
var outline_f30_24_31115=null;
var title_f30_24_31116="Surrogates insulin resistance";
var content_f30_24_31116=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F71901&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F71901&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Surrogate measures of insulin resistance in children and adolescents",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Homeostatis model assessment (HOMA)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        [Fasting insulin concentration (in microU/mL) x fasting glucose concentration (in mmol/L)] &divide; 22.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        OR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        [Fasting insulin concentration (in milliunits/mL) x fasting glucose concentration (in mg/dL)] &divide; 405",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        The HOMA value increases with increasing insulin resistance. A threshold value to define insulin resistance in children and adolescents has not been defined. Proposed thresholds range from &gt;3.16",
"        <sup>",
"         [1]",
"        </sup>",
"        to &gt;4",
"        <sup>",
"         [2]",
"        </sup>",
"        .&nbsp; Other investigators propose cutoffs that vary with pubertal status, with a threshold of &gt;2.5 in prepubertal children (SMR stage I), and&nbsp;&gt;4.0 in pubertal-aged children (SMR stage II and above)",
"        <sup>",
"         [3]",
"        </sup>",
"        .&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Fasting glucose/insulin ratio (FGIR)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fasting glucose concentration/fasting insulin concentration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        The FGIR value decreases with increasing insulin resistance. FGIR &lt;7 suggests insulin resistance",
"        <sup>",
"         [4]",
"        </sup>",
"        .",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Quantitative insulin sensitivity check index (QUICKI)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1 &divide; [log fasting insulin concentration (microU/mL) + log glucose concentration (mg/dL)]",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        The QUICKI value decreases with increasing insulin resistance. The normal range of QUICKI in children and adolescents has not yet been determined. In one study of obese children and adolescents, mean QUICKI was 0.313 and 0.339 in subjects with and without insulin resistance, respectively",
"        <sup>",
"         [1]",
"        </sup>",
"        .",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     HOMA: homeostasis model assessment; SMR: sexual maturity rating (Tanner stage); FGIR: fasting glucose/insulin ratio; QUICKI: quantitative insulin sensitivity check index.",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <ol>",
"      <li>",
"       Keskin M, Kurtoglu S, Kendirci M, et al. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005; 115:e500.",
"      </li>",
"      <li>",
"       Reinehr T, Andler W. Changes in the atherogenic risk factor profile according to degree of weight loss. Arch Dis Child 2004; 89:419.&nbsp;",
"      </li>",
"      <li>",
"       Valerio G, Licenziati MR, Iannuzzi A et al. Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy. Nutr Metab Cardiovasc Dis 2006; 16:279.",
"      </li>",
"      <li>",
"       Dimartino-Nardi J. Premature adrenarche: findings in prepubertal African-American and Caribbean-Hispanic girls. Acta Paediatr Suppl 1999; 88:67.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_24_31116=[""].join("\n");
var outline_f30_24_31116=null;
var title_f30_24_31117="Rx entero endocarditis";
var content_f30_24_31117=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F50418&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F50418&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Suggested regimens for therapy of native valve endocarditis due to enterococcal strains susceptible to penicillin, gentamicin, and vancomycin",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        American Heart Association",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        British Society for Antimicrobial Chemotherapy",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        European Society of Cardiology*",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Adult",
"        <br/>",
"        (for patients with normal renal function)",
"       </td>",
"       <td class=\"subtitle2\">",
"        Pediatric",
"        <br/>",
"        (not to exceed dose of normal adult)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         Gentamicin",
"         <sup>",
"          &Delta;",
"         </sup>",
"         3 mg/kg per 24 hours IV or IM in three equally divided doses for four to six weeks",
"         <sup>",
"          &loz;",
"         </sup>",
"        </p>",
"        <p>",
"         <strong>",
"          Plus one of the following",
"         </strong>",
"         <sup>",
"          &loz;",
"         </sup>",
"         <strong>",
"          :",
"         </strong>",
"        </p>",
"        <p>",
"         Aqueous penicillin G 18 to 30 million units per 24 hours IV either continuously or in six equally divided doses for four to six weeks",
"         <sup>",
"          &loz;",
"         </sup>",
"        </p>",
"        <p>",
"         <strong>",
"          or",
"         </strong>",
"        </p>",
"        <p>",
"         Ampicillin 12 g per 24 hours IV in six equally divided doses for four to six weeks",
"         <sup>",
"          &loz;",
"         </sup>",
"        </p>",
"        <p>",
"         <strong>",
"          or",
"         </strong>",
"        </p>",
"        <p>",
"         Vancomycin",
"         <sup>",
"          &sect;",
"         </sup>",
"         30 mg/kg per 24 hours IV in two equally divided doses for six weeks; not to exceed 2 g per 24 hours unless concentrations in serum are inappropriately low",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Gentamicin",
"         <sup>",
"          &Delta;",
"         </sup>",
"         3 mg/kg per 24 hours IV or IM in three equally divided doses for four to six weeks",
"         <sup>",
"          &loz;",
"         </sup>",
"        </p>",
"        <p>",
"         <strong>",
"          Plus one of the following:",
"         </strong>",
"        </p>",
"        <p>",
"         Aqueous penicillin G 300,000 units/kg per 24 hours IV in four to six equally divided doses for four to six weeks",
"         <sup>",
"          &loz;",
"         </sup>",
"        </p>",
"        <p>",
"         <strong>",
"          or",
"         </strong>",
"        </p>",
"        <p>",
"         Ampicillin 300 mg/kg per 24 hours IV in four to six equally divided doses for four to six weeks",
"         <sup>",
"          &loz;",
"         </sup>",
"        </p>",
"        <p>",
"         <strong>",
"          or",
"         </strong>",
"        </p>",
"        <p>",
"         Vancomycin",
"         <sup>",
"          &sect;",
"         </sup>",
"         40 mg/kg per 24 hours IV in two or three equally divided doses for six weeks",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Gentamicin",
"         <sup>",
"          &Delta;",
"         </sup>",
"         1 mg/kg every 12 hours IV for four to six weeks",
"        </p>",
"        <p>",
"         <strong>",
"          Plus one of the following:",
"         </strong>",
"        </p>",
"        <p>",
"         Amoxicillin 2 g every four hours IV for four to six weeks",
"        </p>",
"        <p>",
"         <strong>",
"          or",
"         </strong>",
"        </p>",
"        <p>",
"         Penicillin 2.4 g every four hours IV for four to six weeks",
"        </p>",
"        <p>",
"         <strong>",
"          or",
"         </strong>",
"        </p>",
"        <p>",
"         Vancomycin",
"         <sup>",
"          &sect;",
"         </sup>",
"         1 g IV every 12 hours for four to six weeks",
"        </p>",
"        <p>",
"         <strong>",
"          or",
"         </strong>",
"        </p>",
"        <p>",
"         Teicoplanin",
"         <sup>",
"          &yen;",
"         </sup>",
"         10 mg/kg IV once every 24 hours for four to six weeks",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Gentamicin",
"         <sup>",
"          &Delta;",
"         </sup>",
"         3 mg/kg per 24 hours IV or IM in two or three equally divided doses for four to six weeks",
"         <sup>",
"          &loz;",
"         </sup>",
"        </p>",
"        <p>",
"         <strong>",
"          Plus one of the following:",
"         </strong>",
"        </p>",
"        <p>",
"         Amoxicillin 200 mg/kg per 24 hours IV in four to six equally divided doses for four to six weeks",
"         <sup>",
"          &loz;",
"         </sup>",
"        </p>",
"        <p>",
"         <strong>",
"          or",
"         </strong>",
"        </p>",
"        <p>",
"         Ampicillin 12 g per 24 hours (200 mg/kg per 24 hours) IV in six equally divided doses for four to six weeks",
"         <sup>",
"          &loz;",
"         </sup>",
"        </p>",
"        <p>",
"         <strong>",
"          or",
"         </strong>",
"        </p>",
"        <p>",
"         Vancomycin",
"         <sup>",
"          &sect;",
"         </sup>",
"         30 mg/kg per 24 hours IV in two equally divided doses for six weeks",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     IV: intravenously; IM: intramuscularly.",
"     <br/>",
"     * Pediatric doses (should not exceed adult doses): amoxicillin 300 mg/kg per 24 hours IV in four or six divided doses; gentamicin, ampicillin, and vancomycin dosing recommendations are same as American Heart Association, pediatric.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Alternative for penicillin-allergic patient provided isolate is teicoplanin susceptible (MIC &le;4 mg/L).",
"     <br/>",
"     &Delta; Renal function and gentamicin serum concentrations should be monitored at least once per week. Gentamicin dosage adjusted for peak serum concentrations 3 to 4 mcg/mL, trough &lt;1 mcg/mL when two to three divided doses used.",
"     <br/>",
"     <span class=\"lozenge\">",
"      &loz;",
"     </span>",
"     Four weeks of therapy recommended for patients with symptoms of illness &le;3 months; six weeks of therapy recommended for patients with symptoms &gt;3 months or receiving treatment with gentamicin plus vancomycin.",
"     <br/>",
"     &sect; Vancomycin therapy only recommended for patients allergic to penicillin and cephalosporins; vancomycin dose adjusted for peak serum concentrations (one hour after infusion) of 30 to 45 mcg/mL and trough concentration of 10 to 15 mcg/mL.",
"     <br/>",
"     &yen; Alternative for penicillin-allergic patient provided isolate is teicoplanin susceptible (MIC &le;4 mg/L).",
"    </div>",
"    <div class=\"reference\">",
"     Circulation 2005; 111:3167; J Antimicrob Chemother 2012; 67:269; Eur Heart J 2009; 30:2369.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_24_31117=[""].join("\n");
var outline_f30_24_31117=null;
var title_f30_24_31118="Regulation of fibrinolysis";
var content_f30_24_31118=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F81428&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F81428&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 508px\">",
"   <div class=\"ttl\">",
"    Regulation of fibrinolysis by plasminogen activator inhibitor-1 (PAI-1), &alpha;2-antiplasmin, and thrombin-activatable fibrinolysis inhibitor (TAFI)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 488px; height: 336px; background-image: url(data:image/gif;base64,R0lGODlh6AFQAcQAAP///wAAAIiIiLu7u0RERCIiIpmZmd3d3WZmZjMzM/Dw8BEREe7u7jAwMMzMzFVVVXd3d6CgoBAQEODg4CAgIKqqqmBgYICAgMDAwNDQ0EBAQJCQkLCwsFBQUHBwcAAAACH5BAAAAAAALAAAAADoAVABAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChooQHAQYABAIqBgEHo6+wYwGzswUkqbG5umcBqie4u8HCXb0lpqgEBQEFDgADARCzrK4BDwsBCQwiArUDIg4JtacA0djNAgUE0sPs7STF76cECc0Pts8IIs/UBAcMBapYeROwgAGDBar+nULXDIEtgqoIups4jNYsb8eAOWj1bMQ+AAG8AUCQ78GDEQsM/1RYMILAqQS+Sh0QQECETIo4c8EbkTFmyI76WoEUSRJVPhGpaLY8ZXHWzJoAbuacKmqniJ7fAjAA6kxoSBFFTaI0YCDBUgAJKpRQGlUo1beerIKUdxKAgZpcP34dmU8gAIIMSqk1UGBhXXB/oUqFy1hSBhNyMyrDpi2vV6JHuS0TyQpbYbC08rFd3Lj0IgUdAnCI4mCBK9OwL2GQMEvChCbqAqSMzZvQbRcemmroTZxiBA8tMjRoSgFD8efDFEhowGJD0wAWFEDfvsvCLBUKNDSVsJq7eVgYaDk/wYG2RQ2/z8sPtXzWBRMKvDfdML8/qAsWdVACBhQ01cBj/iW4yf8E7s1CAQkANuWBdgq6o9ky4/xVzQiT2YICAUddIl5Tt01QHy0SrFehhQGA9to8BbUElQmahVgJB9eptkGDs3RA4Yos8pRQABtlSMCMJxRliXQ58hiABBEAiRM3IjBQjABmiYUUkiYoWUlwORoYn5RBjuQaWgFptaUKXk6SXpgW3UfmlLQk4M1NVo5zJFK0vMaXJSfCqeKcE1FJwoWzQLVnCm1GEiGctZVHaJkjwDQCK9osikKjjzAIqXBjjpCBBhpYcMGpHGCAwY+TZmJoVn5aiU4tJyDqCyQjfmqRBHKWoJ9wrLYqbBw46ppjcyakZpEFfgDDw14c2jgsKEwaG2b/diQoEOgGwb7RWVMDOLsDtNPmAqa1FlHQwQaDilDtBal1ICkSHxlRLyq3jitSubG8ia4GF3DQbQkZ0KbdBBtQIIEHCNrrVhH3HhnOAs08U84BA0zmC4zLYHnRVQ/Mko1RXSEwi7T8UhJomA1YsEHDLuBIsAXTbRAqEPfuwAHMHj08jzdi4WNTMc94M08zBOwGgVkgPWBQAfmAWDIAGzVD1QELoDxSAdq08+h4AK9qQ5TspaZBBAPvkDMOE3QgAc9B+QkMYV2NIJEID0TtC1sVtDjUNrZIzdVnVCHAJQkJaJ3CzZd4SksDHkTA+A8KRBAv2s/m6GENClwgAbYnROwL/91coWN3TcCwBdRerJA8eIY4lbKvCWur0AHZmmigLrtOVH552jTULkPnEmgANwmii0C633+xhLfe20C1ukhYus484TlVrwJCL9jGyeRN+B6ABjbnIPwLxGvQbug+j34P86WoUjS+0Qd1lS8IqCL49bBT9AAEK8ibCybAvDmJrwHlq8H5WDAB71hgfShInl3ehzyNIWVv0vPbMk6GlHy8jiriqtXhUICB4QxLARygGeSOx4IFpqCEnwNfym7grAtliC2LKIU88mUCHbYhhRKggAfm5YPKUYAC3JphEP4XQMWZQGB3yE2fWsJDPGTAAwq7nQxlkAGanU2JQ9BeCrjHwP8AAM8NmipBCPeAsNRADoo0QFgDPsdCMPJAdilw4QgswKwocikjyVhGxaDhFEBOzGpuwMAFxEMBU4ltBRmIgAUUZgEi2lEIhktB4loQAe/50RjyoAcA7DG1q4QSaHWRAwY2YIERkQpgp1qk7gKgrgtA8JJCwJrWHNK1xQEgAnWEgxSLgRWqcaSAxaQbHhSgKg7EMmCqwqUYFDnHLQrzjzsc2gC4Mhf6TVCaxPHdY0oFRz2ksZsa0Qo3k7k5d6AQnCrwHPnO+Ml4oKIud6kbT7L5TYp0ADnwRIHkCHFOyYisMsjkpzLd0R562jEDFHBoQMmgAArgbqIiaECvMMqGRXL/dAQRMOFH15CBAFjTjpUcKRs0qtKWdpQ6HPUAtyLZOYC6dAwlDaYdI+CgAqnmpmRg6Uh96qBKWKQ0F4DpSL+20UgclTGz0SkuFWARiSLiqWQw2XXwthNEmSI0V5DORUeqnz5SAqtmMN0IDpKAGb1KSELQIwpaBtSSBuCWjkBrGdQqggoUoG+veev94vqwF1hAqTfVAGInoVcy8HWUACSjYEFSRR7ItQQXiChQRRCBsUqisWPgq5UawjREQUUuPbgsSN+22U2AVgx8VSZgNQSZyuIgTO0UKGtbq4nXhoGvIbNIRAo42CCotpNS5e0jfAsGtY52BAgwy2RRa9nCpoBm/8lVbl5pkQa1PrZvDnhrKTiIM+viR7En1e52vxMKF84GdOrNBHNHkR8ouRSHa6EF9kJm20PMNxSe89FN8Xsov5nMFWwd4VW5u4sIUEB9QH3GFAsMV7/OthH/3YQCEmZR3hLYbn6TFWQBQEZGZBgTXSweXlX64W0Y2DXPje56iduGExdxA3O0QHo5qjqwXshO/bzwCXZMBxvLgsFHmIDlAnC7+J4OBYINLi366+ALWFUORhZDlmuQARwzGXNOtluMaFTA54KFaSjwqQWyC4ctg8HN6JMkJcsZ5rWGw7pv/S6RUvC1BnjWDnD2wpatiQEPLId8bK4zD6g6ngsQOQ2BJv8Gkl2QWRR02Y1D3MUxcuCQQfyqKR1YMQw2jYNO+yDSXLDxBMQjoBFUbpKfG+goJDwLX5CaE/46FphbQGt43PoKqN7CiXdknwlwwNDje5ku5scKpvRvEyu7zsJOyuxj/NoKwdbCf1e9q/HZchjzuyc6aXGYOxNgKwHIDUkSBbiSkXeUInuNAa6hDATn5tzIOOQXeGosDViyBOEmwEkyQu5vmBvd6tYqVEyHj3fXINtZmC+x0zWRcCdg4LDbiFoSAEBwYAwaXTk31tTC8ADko2pbc8We5rcRlWeDAZv82ShT2QUnQQqJabM4xkmgcbR0PAEfB+AzRL4Akr/v5Hu2AcT/sTBfSa6sqcGotlp+jYu2Io95e7FUyTl0CjK2HAKpbIWZ6Ta33L4DXWhPu9pztGbafYUVU+9f1ZHElaxHhIIiwB4Nlg7sSa9glYcNQKI9QWsyHuMuU3bGnT2IdZHgYut5dzZPwnWrY1okcO5Lwdo3z3m0f7FnszD8KRBfa8VzsO6Ov7s+AaD3GfAd235/waM7Ee59luIo4npGBVB/wb/gnfVd90XLEQDAq/hDTbfIPAo6z/zm5+jzQZndXG7f+57tvvG9hzzwb/D6KnQfFrU35Ua8kTFVJOAUWNsm9umn/c84ROU1mbcruKHy0UGvnydwvv6Z33aAk2su4+cMAIEW/+i3AOo3edn3e60nA983BQ04a/93DFqVAAOoVUSzfo+ngOMQXEAHGukmFDAXevqjfF5gc3CCcxEUgacwgRWYeLzHfhrIfbHHBg+YMgu1BvymK/7WZjO4BjU4LHWCSGsQbePhAbP3Zj2oBj+oaE6Qa9dhUVdWBkvoBFPIhEvwaQEiajSYhJDGhVZIUdLmaG+gZMvXg7LGBWSYf2Z4hF8IBX32Z2xwRFZmDH7XOUcEBnIYLHplhw/ShmKgZoP3A98mBI/yQDyBZBjwK1CnBYWoIliViLSwiH6oBVUWhUHAIJK4A4z2OFFyVBGwMpb4BJs4C34GEtz1iU0RipPoBGwIBP+sRgRY+CTd1hRm9QWxyCM2V4urCAn8JgFEYFdoF4hQAIzoIoy7+AfVInhEQIRwslhfwIwsc4yS8Gn8MQQ5aCxwyAXXqCvZKI1m0DfPBnM0FwNO2GpDYIJNYgboKG3e+AYDeAJY82wtUFESkBoF0odD8DWQkoldoI9wwo/tOAbz1ks0YnbziCC3ASCtKHvWspBQQEDG4pABWQVMlAIoRwPVCAAZIJEtoCyQYo5l4JFwApITiQZFtwK7MQMJowROmCNayAUteR0vWZKCJn0msEYtwCAz2QNEdSxq0JNPSJM+uC9SJDf9pQKQwwTb2BTdCAZLaRFNKZRfcJLbI48s8G//RpCM46GKYYWOEsCVUkmRxYcCF+kC2rKTQHAuEsIGamkRNhWWZjCQKfBYV/k5DxkmHDkFEHkdeQmXT/COPZSSLbAjWKkEuUILIrUGhzkLiemXZQCOJiCOLOA7ClCZU1AsFlGYZYCZtKCZjlkHbuNnYBkEPYmPbVCan5kHgNdhCXQF1kELGdkGrzkLsZmabpABF9BKUeIBLmOMSTCKo6kFwGmbb/AYHiBTGNCXSFBWcsCcxMkG2tKYZGBXvtkF1PmcJGWXakAqdMCd2LmdUemU4XkGnfWdaBCc5hlf5JOeNJkw6MmemyUdaAmfYeZM9Hmfo2CBT8VfIGYR3+JE+MkE/xcwnsPwWAkGYrUVoFWwW4zxXX/lFtN1lAqaBJ9oGo/FRJJFY9Q1oUvQZKUhWnsmYxpCC6cloRxqBBPwnqIQWx4yWxF6ok+QorABXE0xXAkKo03goVcANSlIDVapAkLBo0UgAACqAs6VdCMhXRqKP7Two0zgElvzDdegDk6qD2YXgib3eyggpEpkUkEgRaLEAi3mdj7KgH5iAzhZK0U6lx6iZ+FVQONlciQgoj1QCmj2DAZ5k/3DcTCQMSawNP6nUhzgjDywJzCXp2uhYP5XpjFgXjOQpjSypkFAELTiA+MlEiGDqLfQPwbYp2b3ADzETRi1AW/pA4vyDA4gRXWBJf/qMBlOITU/5gp6YQBWIhK1M28bpHJHUQ4F4CHgMAvFVw4pcSG28KsgBwAMkBtcmgSCQQ6aWgOlIHBtkQwuthkGJw6+hwpNumnlEKa8mlsXkj/vE1y49wDhYDiMp1WSelOLAl4j0HMQUT8dRAL/IHResYJQkUn+5w0tRzLoMH+2cBAnlxIrMX/3J7BUsxuLIkBPWgvPSgM61Ao00Wl+ARgHkRCfoVZ7cQwMEaX/mq1qtDfvowpFggpAZj1IJ4TxZagJgGbZ51YzIjWHghf32hXHZ5NgxxO6iiZWCgArAV0IsBKzAww/CxYIYGZEGgcywXEG2GlaQmIq4TyosBAesrH/L+ETB2ApAniTIrt6AuQs+8N1iiZF/WAXUhQRMNsSJ2eBNMuoiaOxtOIsQiE1e+GnXpUPE2g0e9MUCFA66zoGMsEKttBpMosvOASlGisS1tYUeLS1IdtuXJFJYMt4YltnaUR97Je285oO89e23WQXCwCYc1p5O/tXPVsBLqtGZkG0qVsKdvO3YnATu+G0qZQS+YQUVHsVivsSakECBWCrZpc6v8dEk7t6C6hdaRSA5ZcYYtY1UsM9Weu5m3YQY1YCBlAX0bCzMsYApHQQViMA4Hu05FATDwAV3rsNqsAMVLNJcEAaFPsVgIE1yrMbiWtKf1FuI5EQ1Pq42Yqqeae3/2prvFUKVOfEgmhrZ6/aF7VgdbMawJsyCyGzs1i6vw4wGXYyAHfWgRW8DFRjwfyqDOkAuz2gnPBYWKamGb+rPCKTsVW7ux4op1hKSvxbcpOhJ7cStpEHo2VJA5yCBpWIo5SgrzJAa/jmBoAIxEz4hkK5rGokwozysHY0irUhhrsoqilQuN4Yiz0yn5tlxR/ixIbQGunGo2M6NAP8BjFJC1AYBJ1houyAq/TXQvqluNZAGaYoDftDrvMaq8iaG6L0gdhAqQUAsO4mp3TApzObCNBYG0boA1bSu1Rok4IwP3H8AuZ6Ff3wD/LDPPtDshlhI/VKDmbBvUxxbmzVDHxacv8pSwedmsiI8JTP55kxsBFR8H+DkLPG16cahBmrh8OjFDXSohRLc6Z7AQwQUBPtd8ZmIEV3IRoFcGfjYHLX0Gy+lxvKjAbr+IRJdFt9Is1flXh9XAuMl3DsFs7ppg3oYM3aejLJKjIquwdy6wq8ijR9wgAIcA3stRdFwRW+LLlrS6JRcW/UkHr1k8xF5njOvBBeUbbdFK93U8suecdN4RxhQtH8V52rl25nqiGZAhUCZDEhFxgnOQ8GsUkO7Tx7AaikDAj5o7OjVA/jmKTkt8tG28uUKwJ8KjWcy7wjcAAFAEDFjEH9yz8HvcczshvQwrGK4ahLUNESbREWLZNPzXn/0DfE62cMA4C0N/03aDJ2D7HUAy0CwzwI1yvWhYXLJFC+XKW7NR2A1tMMfvG8qhC9o+QLlhLUBR2Dc1DMojEjA5jUCwHWUuDUhB3R+lfVMfCCf3FnP8E8SfuCqdBrHDwal2ETAh0IWhXBHnEmJbDB1UDTfzISeMx4ypCSUtMZz4zM+FwXeM28Br3XCM3TJDZ1+6LUQ7PRTVDYUq3bnNd/CrR+82ZrA1AKXfPYGCgAVkKQPH0T/+fTY2kIhPHOOODF8hXb6KANWKMNgL3cTN0G2cwc23wDLwgYGuINP72+W43Xc9PXt01ivgCqOO3G8DwyPkDdmMDXvlcLVrPdlI3b/24Ay9exg2qzfjH8FRu8AJsE2QlxZ9zT33ZxMpS6IYcQp06BxHP1KdMmBTB3zRYuDGnsILvmBBfy3B3+FlrMZFxc4mAkxU9CxSoOVEr84rx1xDLOWz9c48pFwji+BC2r3dJnar8g3wjcIlo1DShg5DAgxopKB7pksz6gVQPQxtemwv6tAkrejnLJ1S4AqSgAqD7L2S5gyyiAyH2gr6r1AgWLrAEAyS0g5idA5t4ImG7+IUKON0I9apJ8Aq3MB4175i7AFrSM5y6w59K4Eb1UDdcwMmqFq/WWb7rxzsI1ohvUDV5RxyOzD1JkMrZaWMyctRC8DW3FwW8gRh+RMaVn6P/k4DwV2RIFR2uu2gqG9Og2m+laexCw0+l3tqqhDsUtJUYgkckDWHL8OrdA9rRklil3rhfAvslhPRL5ejh7kQ5REewl9garvg/x0xXecJLh0AxUaQLwmkH7ZLKo5OSsEyNZjoCsVxM+HRHV7mT4pc/OTA5hV3/Ko6lfkToZ1Oz7XNk2W6uQMezf+9Vz4Cz78NAC9D+tQQAQgOp0ztN1p1Dv0+y2zrNYbUwDL9t1Fu+8bDrx7E03COq0AMAQ7+/93uxoIa75N9Ov0RFlrAYGL7GboxRYIgAPUBa+rjxnW/LjXnbmvi8Q8Lvm9RX14vJL7mEuK+/ZSnwu7fMkENxsre//ccPVJ6/l8ya6CHiRpvPyaXDtEiu1ArQRMGElcN4WuHfAGS3xP9/T2BDTf6P1BM+EDk/18y5/GmLv+LcNMcINJN9j/M54rlBi1KvcbL3u0472cUDqrZDt4XYN2hAObG5M5Bfs4m6/Pv8R1a4Okhzt7E75XyjnHe8hCje3JFgluZ7vyW7ygP/ghozF7yASni7hXI8GfS4Upr4Tl8zRXbLCaB/xID/xrJ8ZeboXsb+qR89b6d4CIc8EO1wIQswF7w6XPc4CQRgFz28ITc4Fyb/j3N/93v8KUz4DQD4EkulfHM4mvI4D5e+X4b8F8Wj+gCuYYdn+W0CXgkD/WmD/VfzZ/4YMAoEBCIGZHICTmAQzBISJIC1AFgBcB8gNPE4pgGERKARSDFmMASAQWAvHzxGg/rLaLbfr/YLDYq2gwBLd0CWh6uyCMWk2nK43+wUDqFvxmAQstThBSWGpXI0lKi4yNjo+QkZKRsIIHI6g/TAUQAAkdK4cwHTCMRwsVNDtHFIhFKRA1Q0cwiYwMCT4RM0+PGQtjEwKDyeWjZSkZN5sdn62iQaQNp2mltX5WLW+PhHI0j7Z4uom8Pr+ABOnq6+zt7snwuD5KN8IdCd0/8SnzXpaWu8DUGDEAku0IJgDkIQBIiI5CBg0kOMHxHcWI9k7hynYj4z4sgQM0C/BvxwBB/8CKHjDygGEPxY2lPgk4sQbFS/izKlzp8WACLqhccAjho4zPkL2qwgwwA+UykTeVAjNhImHNLNE5al1S8YbBSwFHdptgNE6L5OWNOt149moSWBQPTKTT825W+/izatXradOaAoQSNH1BowKSG2mPUnQIEsEndIcYOgE61WNe+92ZZjqb2AS+QgHMMyUH2JVowUuXpnE8cvIASZTrHwD3eXatm9PgkHFgEiFqQ98TDDi1IDDc5c2HeEKVrcigv/cNKBLdjbcOss4QbDACRqVwO8NX1D8dO/jJk+jXM6NyILnsCJOp1ulofX69u+D9EMbDe8jH4daYpxS5yV3Qx57AMD/gwxKnKFSdDVZg987ZZyABX9V/UdVgOShZVqBQLCRYAt/4GKCg7JFKKGKK+oV0G0yKXIKRyymM9iLdYkhI4078oiTi3tRlYAhYuCSUI/C2AhkhYoUeaSTT0IZpZRTUlmllVdimaWWW3LZpZdfghmmmMNkoMCYlymQwZlrstljBhI0YGabWinQgARqzpmnnra9aUKce+JUpwl3AlqooTppENefh64jKFUaMBqppMQ46qeck0pSaQCLYtqpp4loyumni4R66ainoppFqamOsSqrr6LqKqxcyDqrrZjWemuut/LK6K6v/tqrsIAGe2qxwyI757GdLpuss2c2G2m0z1IL/+a0hV5brbZcZptnt9uCi+W3a44brrlUlhtmuueyC+W6Xb7brrw9xptlvfPiy+K9Ve6br7/49RtlwP8SbN3ARx5csMK1JUxjwwtDnNfDEk4cscV0NqCoqepmTJWoF4MscMeWjllxyCcHOvKmG3Or8scow0yvyyzbO3PMNz9pssQ249yzzBpvqbPPQ1PKsxdl4pYmGEIT3fQkx1qwAW4bWPAF005jDUmwCgRAAW4UBEAzAFdnXXYjv25gAga2YWCC1FuQbbbciuwKdgBV12aBCV5rEffcf4tRa9tUic0T11St/YPfgDNutdF6U/W2XmlThffYRjee+V6rHk4V33rZTf/45UBrXvrmM1MeFwd6cRCX24ubzi5vQ1A0Yzuhhk5VB3p14HrXmG9FT+yTxiWkJATYfrvKvpswAV4TMO/6y+9IRNVjwg8faQCW4IJjI8jnpCnzF+B1QfQeF85OJfUkkEby2R+6fT2jxWUQFEgUQAUMKaxQ1fvtDO58n9NK7piXuOssgAtoAI4JzIEKAFQAEQJoH/zEJL8DFMBIJHgNOKjwgPNERiWb+F86FBCB5UVvdVpp3fk8FoH0pSOCDxiSbwTSDQxa4gGdgID8dFhBC1JFg6S5CUv2V4EE2oSEwsiABSTQQtftTiu9eyJVJGABPFmEQkcwiAiqQ4cJpuQB7Xv/4A/BJL8EUJAEZ+jNTQ4gkv0NBnyNOiEVmee8nUCvjtJ7IU4OEIRZiGB/oDnEANojEg6W8UsXXEAnisDFWdwkgi9IggE+I0d1eECPzPMATzKpSddxso9o6GJDIrSABPgCjWlMZJfkB8HtCWA7G4SkL3AxliScgg+0adQGClhHCfDEiZ/s2gZgKAkaDEE7yRgBYACAQwOFBgA8fAwrW2kQaV7hDH98AhKaUIcU9CcBKHkHBiCnyQjoJALDtMABqccEPVhoONrsCAetkIpqAiorm7uAL6MHqZwkqo4UuIAx8RkyfdaGA1N84h0tkscndkCFBp1oOybAzxaG0iKejN5A/xtK0Y+2gwMB9R0wLaIAYfpOAxIFKUvdMQEPoJQq6HyHOl0nAQ94tKWzEqQYCuADMJQHEgT4qSRmN4wIjHRTFlGZBmbKCOx1wahfSFIjeBoJNypRp1yw6iSC+oih3uelwsTiOjIwKJxCAqqPoCojuKpVnbg1El51BFgBdkLLrcMCDeCjXLO6CLYuIq5vvcj+IGBJH/AwAOgAa/+8mYUAHOgW5eEqDPLwU7DC5QizCAQ8FcIEkhhhG4KErBFsMYycpgO1jxDBESdjjca+4Q+J3WU9zGCCEZBkGbTlBv7094f66dIEnSjDGexhAi4eAzC3HexWcdkbNw7giILRhQ+cEf8KLUD2Fj5NUD5+ooX1WWEEdcVD+yDQPgY8ABMuYMApqeCM0QZmE9c0IzMN8pW+PMOI7SEBUWt7DErKsgiwsYnxPvjNLJRAsqmoJAnQUYJOSLKGsfwHEpmbH1ggthtH7IdNqvuZLZRnKa7h8CANRN3vMsW8tFNIh6R5y2T0gwZjUkMOWuuJD+uXxAj+DDDYi9v5loYWbhUJQ+bblX0wBJDHyIcbV2xhQUbQAbThATmecJSyYLcfvLlBLlKkj9N4F6wM0A5VnMmEzpTnJhkZbYz7q8gRMKSSPyXLHQRJZR0P5r4QKEBc2/jGP0yQKrOIpWL/kY/DqIHJf7Dwl4dghgr/U6R9463DPc/CPl3eF8U/cAZYEVBlF2HQLy1e82/bPONgeJo+oBHNiqNABh6nwo2o5EIkX7M/R5KGngw4MockrGgnM5enJTCIABDgBMNa2RPh0bErEWAQ9soSxbthow8ekI8gAMEguU0zsV/M4hvI2ILBgMOmlw1HY7uYDAVwwikmIwMd26SWH4GjLEtQHAJQobW8tnSib9BkRjcaNEOgsx4wLKLjgrib/Z30l5FAG8Z2E9uEhmyu1ezt8oQ7TJnw8Q8A9E2CI6gj3cyfyLtAgG664JslgqxIDsAEPnumxN/utzMXDXAt9IIdXtQ0u2LZDpXQGsg33wp02eHd5rYr/9PqELDJhT70rGHVLlG1+dOrvhPX1QWhVt96Xly5Ba1zPew88br7eHsE3ybWqKTVw4DF7vbVAhkNUfDgeeb82/gq/e16f2pclGyXIp6GzeB2894LHway19DP4wk4xglv+McrMO7iZYytA1/qwUM+815AvNzNweCACD5Bjtd85jkv3m6aFvSXFz3pW+/618M+9rKfPe1rH6ZL1mj0WnCF7d+Ke2IUuws/6r1Wfz+M4COd+Dpt7DgTazxsHmEiPTBCfxAOiJcfhSowj4sBIrQGmHOjEMrXHHu5h5IyaAMHgpF+ZxDMwVgAwc1i5Is1eDNoWe4CCEIcv9yOWDt/+FsS5P+WDkgfvLEYQ2AB8n0Z/eVAzs3G5MkH/zFOHGGC6xQdAeaaGglaQATfmBmBCTBgspXGg0gg4zBYEnlCpXnFPQ1AAerSI7lRR/iAp81CPHBgAybEYslGCcpNLrHHMZjDCiTIeRnYtzWYE9ibQFDBClTbtTGFFfRD/fVGLA3CDvKg2YTTOA2FD6zcyeXaym2TA+APxDXQaPBA903E97UYjFwhK2VcG85eZqUcHNJhHdrhHeJhHoZdC+qh7PFhIsxVHw7dH45BIAri8FTWHTyBGPUAA1HcDSRWAbhgghDbBxrXDHDW8x1i5oCX3FWZDTnTfZXB+uWas73SCEiHEZoXIKS61yZqTkA8QHywQm0BIAYaoSnO32P1g4q5oun4RDfcBE/Fw2RNoikyXHm4XAsAWy+aTUBwGuUlYA6A3x9iXA6tkhH+QKgxI+PoBhGw0TU10zOZ4hJMhEpIhCXwxggMgA8A3QNom9NtI9bAgMMFQ1Q4ojmA4UTABRoRm4Z4Yw9M3P7FozyexkDu3fAZZEIq5EIyZEM65ENCZERK5ERSZEVa5EViZEZq5EZyZEd65EeCZEiK5EiSZElmSQgAADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    PAI-1 inhibits plasmin formation by inhibiting tissue-type plasminogen activator (t-PA). &alpha;2-antiplasmin inhibits the activity of plasmin, thereby inhibiting fibrinolysis. TAFI circulates in plasma as a zymogen. It is activated by thrombin when thrombin is bound on endothelial thrombomodulin,&nbsp;and therefore represents a link between blood coagulation and fibrinolysis. During fibrinolysis, plasmin cleaves intact fibrin at lysine residues, initially yielding large, insoluble fibrin fragments with lysine residues at their carboxyl termini. Plasminogen binds avidly to C-terminal lysine residues within the partially degraded fibrin clot and assumes a conformation that is susceptible to activation by t-PA, thereby promoting plasmin formation, continued fibrinolysis (\"rapid lysis by plasmin\"), and generation of smaller, soluble fibrin fragments that are dispersed by flowing blood. Activated TAFI (TAFI",
"    <sub>",
"     a",
"    </sub>",
"    ) is a carboxypeptidase that removes lysine residues from the carboxy (C) termini of partially degraded fibrin fragments. By removing C-terminal lysine residues from large fibrin fragments in the partially degraded clot, TAFI inhibits recruitment of plasminogen to the clot, thereby slowing fibrinolysis (\"slow lysis by plasmin\").",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Diagram supplied by William P Fay, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_24_31118=[""].join("\n");
var outline_f30_24_31118=null;
var title_f30_24_31119="PML monoclonal antibody staining";
var content_f30_24_31119=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F82868&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F82868&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 602px\">",
"   <div class=\"ttl\">",
"    Promyelocytic leukemia (PML) monoclonal antibody staining in acute promyelocytic leukemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 582px; height: 291px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Normal staining.",
"    <br>",
"     (B) Acute promyelocytic leukemia demonstrates a microspeckled pattern with PML monoclonal antibody staining.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_24_31119=[""].join("\n");
var outline_f30_24_31119=null;
       